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Abstract 
Vangl2 is a key member of the multi-protein planar cell polarity (PCP) pathway. 
Previous studies using the loop-tail (Lp) mouse, which carries a mutation in the 
Vangl2 gene, have shown that PCP is required for normal development of the 
cardiac outflow tract. The main cell types involved in development of the outflow 
tract are neural crest cells (NCC) and cells derived from the second heart field 
(SHF). The PCP pathway plays important roles in polarisation of cells within 
tissues and in directional cell movements. I hypothesised that PCP signalling is 
required for efficient movement of progenitor cells into the developing heart and 
that an abnormality in these processes is sufficient to cause common outflow tract 
defects.  
Whilst loss of Vangl2 in NCC has no affect on outflow tract development, 
deletion of Vangl2 from SHF cells (using Vangl2
flox
 crossed with Isl1-Cre mice) 
recapitulates the shortened outflow tract and malalignment defects seen in Lp 
mice. The cellular distribution of Vangl2 changes as SHF cells pass from a 
progenitor state, still expressing Isl1 protein, to differentiated myocardium. When 
Vangl2 is lost from the cells derived from the SHF, the cells within the distal 
walls of the outflow tract show altered localisation of polarised molecules such as 
β-catenin, fibronectin and laminin, as well as PCP proteins including Dvl2 and 
Celsr1, suggesting disrupted cellular polarity. The expression of PKCζ and E-
cadherin is also altered in the distal outflow tract walls of Vangl2
flox/flox
;Isl1-Cre 
embryos, supporting the idea that Vangl2 may regulate the polarity of this tissue. 
Together, these studies suggest that Vangl2 plays a role in imparting polarity on 
SHF cells as they contribute to the outflow and that this is important for its 
lengthening. Confirmation of the importance of the PCP pathway in regulating 
the polarity of the cells in the distal outflow tract, and its importance for outflow 
tract development, was obtained by examining upstream components (Wnt5a and 
Ror2) and downstream targets (Rac1 and ROCK) of the pathway, showing 
outflow defects and a similar expression pattern of polarised molecules.   
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Chapter 1 
Introduction 
 
The project aims to establish the importance of cell polarity in embryonic heart 
development, looking at Vangl2, a core planar cell polarity gene, the role it plays 
and the cell type/s which require Vangl2 during this process. 
 
1.1 Congenital heart defects 
 
Congenital heart defects (CHD) are the commonest form of abnormalities seen in 
newborn babies, affecting 1 in 145 live births (BHF). In the past, genetic studies 
of families with multiple affected individuals have provided insights into the 
genetic basis of several CHD, such as atrial septal defect or patent ductus atrieosis 
(Schott et al., 1998; Satoda et al., 2000). To pinpoint the genesis of CHD it is 
important to understand the embryological processes during heart development 
and how dysregulation at any step on its own or in combination may lead to CHD. 
Although the major cause of CHD can be attributed to the genetic contribution, 
there have been reports that genetic predisposition of an individual can interact 
with the environment and cause CHD (Jenkins et al., 2007). For instance, 
exposure to angiotensin-converting-enzyme inhibitors at prenatal stage can 
increase the risk of developing congenital malformations including those related 
to heart (Cooper et al., 2006). However, the environmental factors are more of the 
risk factors and to comprehend the mechanism underlying CHD it is crucial to 
understand the developmental genetics of heart.  
Medical care has increased and developed immensely and there have been 
tremendous advances in diagnosis and treatment of CHD, however knowledge 
about the causes of CHD is limited, although cardiovascular genetics is rapidly 
expanding. Determining the possible causes will help in understanding the 
pathobiological basis of these problems and define disease risk, which will lead to 
prevention. 
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There are a lot of defects which can be classified under CHD, but to make it easy 
to understand, CHD can be divided into 3 main categories – Cyanotic heart 
disease, Left sided obstruction defects, and septation defects (Bruneau, 2008). 
Cyanotic heart diseases are those in which the baby looks blue because of mixing 
of deoxygenated and oxygenated blood. In left sided obstruction defects, there is 
an obstruction or defect in the left side of the heart and septation defects involve 
any defect in different septums present in heart like ventricular septum, atrial 
septum or atrioventricular septum. Different defects under these categories are 
summarized in figure 1.1. In these, defects of cardiac valves and their associated 
structures (25-30% of all defects) (Armstrong and Bischoff, 2004), septation 
defects and outflow tract defects are of prime concern because of the relative high 
occurrence (Bruneau, 2008). 
Hence, a major goal for the biomedical profession is to design preventive 
measures that can be taken in the pre-conceptual period and this is an area of 
active research. Over the years, greater insights have been provided into the 
development of the cardiovascular system with the genes and signalling cascades 
involved in cardiovascular defects, although, there is still a lot to be understood. 
Therefore, it is necessary to fully understand normal development in order to 
unravel the aetiology of congenital cardiovascular defects and to develop 
therapies.  
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Figure 1.1: Classification of different congenital heart defects. Adapted from 
(Bruneau, 2008). 
 
 
 
 
 
Congenital 
Heart Defects 
 
Cyanotic Heart 
Disease Septation Defects 
 Transposition of great 
arteries 
 Tetralogy of fallot 
 Tricuspid atresia 
 Pulmonary atresia 
 Ebstein’s anomaly of 
tricuspid Valve 
 Double outlet right 
ventricle 
 Common arterial trunk 
 Total anomalous 
pulmonary venous 
connection 
 Hypoplastic left heart 
syndrome 
 Mitral stenosis 
 Aortic stenosis 
 Aortic coarctation 
 Interrupted aortic arch 
 Atrial septal defect 
 Ventricular septal 
defect 
 Atrioventricular septal 
defect 
 
Bicuspic aortic valve and patent ductus ateriosis do not fit neatly into 
above 3 categories 
Left Sided 
Obstructive Defects 
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1.2 Mouse as a model for human disease 
A number of factors are considered while decided a suitable animal model. 
Mammals have similar physiology and anatomy to humans which may make 
them more suitable for research purposes but it is also noteworthy that there is 
surprising degree of functional conservation in basic cell-biological processes 
between invertebrates and mammals suggesting that flies and worms can be used 
as a model to understand disruptions in these conserved cellular processes at a 
genetic and molecular level (Lieschke and Currie, 2007). Despite this, 
invertebrates lack many structures and organs, for example lack of heart 
sepatation and cannot be used to study cardiac sepatation defects.  
 “Its life cycle is man’s life cycle in miniature.” (Little, 1937), this comparison of 
similarity between physiology of mouse and human was done in Life magazine, 
but still holds relevance as now we know that mice and humans share ~99% of 
their genes (Waterston et al., 2002). They also share common inherited diseases 
(both Mendelian and polygenic) including diabetes, atherosclerosis, heart disease, 
cancer, glaucoma, anaemia, hypertension, obesity, osteoporosis, bleeding 
disorders, asthma and neurological disorders (Peters et al., 2007). Although other 
mammals also share physiology and disease inheritance, mice are preferred as a 
model because they are small and easily grow in lab setting, are cost effective to 
maintain, have a short life cycle and reproduce quickly producing large litters so 
show results quickly.  
However, of more significance is the amount of information, resource, 
experimental technology and approaches which are present today for mouse 
genetics. Vast understanding of mouse genetics and complete sequencing of its 
genome makes it relatively easy to manipulate genes in controlled conditions. By 
manipulating different genes, researches can study the functions of these genes.   
Therefore, mouse is a good and efficient model for studying human disease 
because they closely recapitulate human conditions and phenotype when 
associated gene is mutated. But there is a difference between being similar and 
being the same, so although mouse is a good model, intrinsic differences between 
mouse and human physiology, such as faster heart beat, shorter gestation period, 
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etc need to be carefully considered while doing interpretations and associating 
them with humans. 
 
1.3 Embryonic heart development 
 
Heart development in the developing embryo is a complex process and requires 
multiple cell types, signals, genes, transcription factors to work in coordination 
and any aberration at any step may lead to CHD. It is very important to 
understand normal heart development and then look at how any mutated gene 
leads to variation from that normal process. 
 
1.3.1 Basic heart development 
 
The heart is the first organ to start functioning in vertebrate embryos as it is 
required for providing oxygen and nutrients to the developing embryo. Whilst 
working, the heart starts from a linear muscular tube, undergoes a series of 
lengthening and looping steps and is transformed into a 4-chamber pump 
(Buckingham et al., 2005).  
During early embryogenesis, an embryonic structure called the primitive streak 
gives rise to cardiac progenitor cells and these progenitor cells migrate at about 
embryonic day (E) 6.5 in order to form two groups of cells in the lateral region of 
the embryo. By E 7.5 these cells come to lie under the head folds to form crescent 
shaped endocardial heart tube in the precephalic region (Tam et al., 1997; Zaffran 
and Frasch, 2002) (figure 1.2a). As a result of lateral body folding, the developing 
heart in the splanchnic mesoderm is moved in medial direction and comes to lie 
in front of the foregut. The two heart tubes move towards each other and fuse at 
the midline to form the early cardiac tube at E8 (figure 1.2b) (DeRuiter et al., 
1992). The significance of fusion is that at this point differentiated myocardial 
cells are observed and the tube begins to beat (Kramer and Yost, 2002). The 
cardiac progenitor cells present at the cardiac crescent, which give rise to the 
linear heart tube are called first heart field cells (FHF). The fused tube is 
surrounded by cardiac jelly, which is surrounded by a myocardial mantle. This is 
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the future heart and is positioned in front of the foregut and is attached to the 
posterior body wall by a dorsal mesocardium (figure 1.2b), which disappears and 
will only be attached at the inflow and outflow of the heart. At this point the heart 
tube can be divided into different parts of the future heart. Starting from the 
posterior pole, the heart tube has the inflow region, which receives blood from the 
veins, and has fused atria and ventricle over it, and finally the outflow tract which 
goes to the aortic sac which distributes blood into pharyngeal arches (figure 1.2c). 
In order to form the mature heart, this linear heart tube needs to expand, which 
occurs by two ways: cell proliferation and addition of additional extra-cardiac 
cells. Lineage labelling experiments in chick and mice have shown the addition of 
progenitor cells derived from pharyngeal mesoderm through the outflow and 
inflow regions of the linear heart tube, and this population of cells is known as 
second heart field cells (SHF) (Mjaatvedt et al., 2001; Waldo et al., 2001; 
Buckingham et al., 2005; Moorman et al., 2007). Blood from aortic sac goes to 
the aortic arches. Subsequent to this, looping of the heart tube to the right is 
observed to form the basic shape of the heart (at E 8.5) (figure 1.2d,e). Two loops 
are formed, bulbo-ventricular loop and atrio-ventricular loop. Bulbo-ventricular 
loop forms between bulbus cordis and primitive ventricle and goes forward 
ventrally and caudally. Atrio-ventricular loop goes posteriorly and cephalically so 
atria are posteriorly located and ventricle located anteriorly and by E 10.5 well 
defined chambers are seen in the heart (Brand, 2003) (figure 1.2f). However, the 
heart tube is still unseptated at this stage. The outflow tract is the region of the 
heart tube from the right ventricle to the aortic sac where the pharyngeal arch 
arteries originate; it is divided into distal and proximal regions. This single vessel 
divides to form two outflow vessels – the aorta and pulmonary trunk. The septum 
between the pulmonary trunk and the aorta develops in a spiral fashion, where 
pulmonary trunk comes from the right ventricle and aorta from the left ventricle. 
Aortico-pulmonary septum also contributes to the interventricular septum when it 
interacts with the muscular interventricular septum and the endocardial tissue to 
form the membranous interventricular septum. Development and septation of 
outflow tract is explained in more detail in the next section (1.3.2).  
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 Figure 1.2: Overview of cardiac development  
Different stages of embryonic heart development, starting from cardiac crescent 
at E7.5 (a), lateral body folding leading fusion of heart tubes (b) giving a linear 
heart tube at E8.0 (c). The heart tube undergoes looping by E8.5 (d) and forms the 
basic heart shape without any septations by E10.5 (e,f). Septation takes place 
between atria and ventricles along with outflow tract septation giving a 4-
chambered fully functional heart at E14.5 (g). E-embryonic day. Adapted from 
(Marino, 2005). 
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The aortic arches connect the outflow region of the heart with the developing 
dorsal aorta. By E11.0 pharyngeal arch arteries are formed and start remodelling 
to form aortic arch. There are in total 5 pharyngeal arch arteries, which appear 
sequentially and never at the same time. First and 2
nd
 aortic arches degenerate and 
have very little contribution to the great vessels. Distal 3
rd
 aortic arch along with 
dorsal aorta form the internal carotid artery and the proximal 3
rd
 aortic arch along 
with ventral aorta between 3
rd
 and 4
th
 arches contribute to the right common 
carotid artery (figure 1.3) (Hiruma and Nakajima, 2002). A new vessel is 
developed at the junction of common and internal carotid called the external 
carotid artery. The distal ventral aorta degenerates. Fourth aortic arch has 
different fates at different sites. On the left side the 4
th
 aortic arch contribute to 
the arch of the aorta and the right side contribute to the subclavian artery (Hiruma 
and Nakajima, 2002). Dorsal aorta between 3
rd
 and 4
th
 arches degenerate, 
however the ventral part remains on the right side and connects the aorta to the 
subclavian and the common carotid (figure 1.3). Fifth aortic arch never really 
appears and hence does not contribute. The proximal portion of 6
th
 aortic arch 
contributes to the pulmonary arteries. The right portion of 6
th
 aortic arch 
degenerates along with the rest of the descending aorta on the right and the left 
side of the 6
th
 arch forms the ductus arteriosus (figure 1.3), which closes after 
birth (Hiruma and Nakajima, 2002). The inflow region of the heart deals with the 
development of the major veins. There is common cardinal vein which empties 
blood in the heart into the sinus venosus. These common cardinal vein receive 
blood from the anterior cardinal and the posterior cardinal veins. By E14.5 atrial 
and ventricle septation also occurs to form distinct right and left atrial and 
ventricular chambers, connected to the pulmonary trunk and aorta respectively 
(Figure 1.2g) forming a fully developed heart with outermost layer formed from 
epicardial progenitor cells (Buckingham et al., 2005). 
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Figure 1.3: Overview of arch arteries development 
The fate of aortic arches, dorsal and ventral aorta. Adapted from (Marino, 2005) 
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1.3.2 Outflow tract development 
Outflow tract morphogenesis involves multiple cell types and signalling pathways 
making it complex and prone to anomalies. Outflow tract is formed from SHF, 
which are cardiac progenitor cells present in the pharyngeal mesoderm. SHF 
progressively add myocardium during the elongation of the heart tube (Kelly and 
Buckingham, 2002; Buckingham et al., 2005). As compared to the FHF, which 
give rise to the early heart tube, SHF show high level of proliferation and 
differentiation delay and continue adding to the heart tube through the inflow and 
outflow region. This addition of myocardium is essential for elongation of the 
heart tube before it starts to septate, which is regulated by NCC. After looping, 
outflow tract has a dog-leg bend which divides it into distal and proximal portions. 
Cardiac jelly is present in the lumen of the primary heart tube and this jelly 
concentrates itself into pairs of facing cushions lining the outflow tract, 
continuous through the proximal and distal regions (Anderson et al., 2003).  
NCC migrates from the neural tube through the caudal pharyngeal arches into the 
outflow tract. By E10.5 in mouse embryos, there is already invasion of cells from 
the NCC into the distal region of the outflow tract (Hutson and Kirby, 2007). 
They migrate to a circular ring like structure of nerves and ganglia surrounding 
the pharynx, known as circumpharyngeal ridge and then enter pharyngeal arches 
3, 4 and 6 (Kuratani and Kirby, 1991). NCC surround the endothelial cells which 
form the arch arteries and helps in their patterning (Kuratani and Kirby, 1992). At 
this stage the wedge of tissue is visible in the dorsal wall of the aortic sac that, 
which is called as the transient aortico-pulmonary septum (Anderson et al., 2003). 
By E11.5, there is a rapid increase in the number of NCC, as a consequence of 
their continuous migration into the outflow cushions and proliferation of cells 
already in the cushions (Hutson and Kirby, 2007), packing the distal outflow 
cushions and the dorsal wall of the aortic sac (figure 1.4c). Due to the increased 
number of NCCs the dorsal wall of the aortic sac comes in contact with the most 
distal regions of the expanded outflow cushions  (figure 1.4d,e) and fuses, along 
with the fusion of the two cushions with each other, initiating outflow septation 
and separating the systemic and pulmonary circulations (figure 1.4f) (Anderson et 
al., 2003). Thus, the fusion of the cushions divides the distal part of the outflow 
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vessel into the aorta and pulmonary trunk, and with the aorto-pulmonary septum 
connects the developing aortic channel to the artery of the fourth pharyngeal arch. 
Fusion of these cushions with the posterior mesenchyme connects the pulmonary 
trunk to the artery of the sixth pharyngeal arch. Once septation is initiated by the 
fusion of the dorsal wall of the aortic sac with the distal outflow tract cushions, it 
proceeds in a distal to proximal direction (De La Cruz et al., 1977; Waldo et al., 
1998). As the cusion fusion reaches till the point of dog-leg bend, they take a 
characteristic whorl (Anderson et al., 2003) (figure 1.4f). As the most proximal 
part of the cushions fuse, muscular tissue is added to the most proximal region, 
and this process is known as myocardialisation. The fusion of cushions and 
muscularisation continues and completes the separation between the aorta and the 
pulmonary trunk (Van Den Hoff et al., 1999; Kruithof et al., 2003). Right 
ventricle initially holds the whole outflow tract, but fusion of the cushions 
separates the aorta and pulmonary trunk and this septum joins the wall of right 
ventricle pushing the aorta to the left ventricle, and leaving the pulmonary trunk 
exiting from the right ventricle (figure 1.4g). 
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Figure 1.4: Outflow tract development 
Different stages from initiation to completion of septum between the aorta and 
pulmonary trunk. 
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1.4 Outflow tract congenital heart defects 
 
The outflow tract is susceptible to cardiac abnormalities accounting for 30% of all 
congenital heart defects (Srivastava and Olson, 2000; Bruneau, 2008). The reason 
for outflow tract being highly susceptible is that it requires the normal 
development and proliferation of multiple cell types, like SHF (abnormality leads 
to elongation defect), NCC (abnormality leads to septation defect), myocardium 
(abnormality leads to alignment defect), and endocardium (abnormality leads to 
cushion defect) (Kirby, 2007). NCC and SHF cells involved in the outflow tract 
development work in coordination and NCC regulates proliferation of SHF cells 
(Waldo et al., 2005a). Disruption in either of the two, SHF or NCC, contributes to 
a spectrum of outflow tract defects in humans and animal developmental models 
(Moon, 2008). As SHF cells are contributing to the myocardium of the 
lengthening heart tube (figure 1.5a), impairment of SHF leads to failure of heart 
tube elongation resulting in disruption of outflow tract rotation and modelling 
leading to alignment defects (Abu-Issa and Kirby, 2007) like double outlet right 
ventricle, transposition of great arteries, over-riding aorta (figure 1.5b). Complete 
loss of SHF leads to loss of outflow tract. As NCC contribute to the septation of 
outflow tract (figure 1.5a), loss or reduction of NCC leads to septation defects 
like common arterial trunk and double outlet right ventricle (figure 1.5b). 
Abnormalities in NCC can indirectly affect SHF, resulting in a composite 
septation and alignment defect (Hutson and Kirby, 2003). Hence, during outflow 
tract morphogenesis it is crucial that these different cell lineages are tightly 
controlled and regulated so that cells proliferate, move and differentiate at the 
correct time at the correct location. 
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Figure 1.5: Different cellular contributions to the heart development 
a) Contribution of extra cardiac cells to different regions of the heart. SHF 
contributes to the addition of myocardium and NCC helps in outflow tract 
septation. b) Abnormalities in SHF and NCC leading to defects like hypoplasia of 
right ventricle and outflow tract, malalignment of aorta and left ventricle leading 
to double outlet right ventricle and absence of outflow tract septum resulting in 
common arterial trunk. RV-right ventricle, PT- pulmonary trunk, DORV-double 
outlet right ventricle, CAT-common arterial trunk. Modified and reprinted by 
permission from Springer publishers: Anatomical Science International 
(Yamagishi et al., 2009), copyrights (2009). 
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1.4.1 Neural crest cells 
NCC are multipotent, migrating progenitor cells which originate from the neural 
tube and migrate to different regions of the body and differentiate into diverse 
cell types including melanocytes, smooth muscle cells, craniofacial connective 
tissue, cartilage, glia etc, reviewed in (Huang and Saint-Jeannet, 2004). They 
originate at the border of neural plate and non-neural ectoderm. During 
neurulation, the borders of the neural plate, known as neural folds, come together 
to fuse and form the neural tube. After the closure of the neural tube, neural crest 
cells delaminate and migrate towards different directions, reviewed in (Huang 
and Saint-Jeannet, 2004). All this happens under a genetic network of signals, 
transcription factors and genes.  
NCC can be divided into 4 categories based on their rostro-caudal location where 
they originate in the neural tube and their final destination (figure 1.6) – cranial, 
trunk, vagal and sacral, and cadiac NCC (Le Douarin, 1982; Gilbert, 2000). 
 
 
Figure 1.6: Different types of NCC  
Cranial, cardiac, vagal and trunk NCC and their migration pattern in the 
developing embryo. Adapted from (Le Douarin, 1982; Gilbert, 2000) 
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Extensive work done on chick and mice have showed ablation of NCC leads to 
outflow tract abnormalities and a particular section of NCC are essential for 
outflow tract septation and aortic arch development, and these are categorized as 
cardiac neural crest cells (CNCC) (Kirby and Waldo, 1990; Kirby and Creazzo, 
1995; Kirby and Waldo, 1995).  
 
1.4.1.1 NCC in heart development 
There are different molecular pathways which control initial induction, migration, 
proliferation, differentiation and apoptosis of NCC. Under the influence of 
signalling molecules like Wnt, fibroblast growth factor (Fgf) and bone 
morphogenetic protein (BMP), initial induction of NCC occurs and this leads to 
migration of these cells towards the heart (Kuratani and Kirby, 1992; Kirby and 
Hutson, 2010). The exact signalling cascade is unknown but it is known that 
intermediate BMP signalling is required, as low and high levels prevent cells 
from migrating (Kirby and Hutson, 2010).  
Following induction, NCC migrate towards the cirumpharyngeal region which is 
just above the pharyngeal arches (Kirby, 1987; Kuratani and Kirby, 1991; Gilbert, 
2000). They lose cell-cell contact and interact with extracellular matrix which 
helps in their migration (Kuratani and Kirby, 1992; Kirby and Hutson, 2010). The 
cells which lead the migration have a polygonal shape, have a longer filopodia 
and proliferate more than the trailing cells (Kirby and Hutson, 2010). The cells 
which are in the middle also have protrusions which aide in interaction with 
leading and trailing cells and also receiving extracellular signals from various 
growth and transcription factors (Kirby and Hutson, 2010). Wnt signalling has 
two signalling pathways, one which required β-catenin known as canonical Wnt 
pathway and one which is β-catenin independent, known as non-canonical Wnt 
pathway (Gessert and Kühl, 2010). Both pathways are important for NCC as 
canonical Wnt pathway is important for cell cycle regulation of NCC and their 
migration (Gessert and Kühl, 2010). Lower levels of β-catenin lowers NCC 
proliferation and downregulates Lrp6, which is a Wnt coreceptor and leads to 
reduction of NCC resulting in cardiac defects (Brault et al., 2001; Gessert and 
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Kühl, 2010). However, once the cells have reached their destination, non-
canonical Wnt pathway takes over and is responsible for NCC differentiation and 
outflow tract development (Gessert and Kühl, 2010). Non-canonical Wnt 
pathway is antagonistic to canonical Wnt pathway, therefore it is important the 
non-canonical Wnt pathway takes over once the cells no longer need to migrate 
and proliferate at a higher rate. Apart from differentiation, non-canonical Wnt 
signalling also regulates migration of NCC in Xenopus (De Calisto et al., 2005), 
however this is still to be established in mammals. 
Once these cells reach the circumpharyngeal region, they enter the pharyngeal 
arches 3, 4 and 6 (Kirby, 1987; Kuratani and Kirby, 1991; Gilbert, 2000) and 
through them pass in to the outflow tract (figure 1.7). They help in formation of 
connective tissue in the arches and smooth muscle cells and aortopulmonary 
septum in the outflow. Wnt5a acts as a ligand for activation of non-canonical Wnt 
signalling pathway and its loss in mice results is unseptated outflow tract 
resulting in common arterial trunk suggesting important role in NCC (Schleiffarth 
et al., 2007). CNCC ablation in both chick and mice leads to defects in the heart 
outflow and pharyngeal patterning, however they are not required for the initial 
formation of the arch arteries, but play a significant role in their patterning. Notch 
signalling is also required for differentiation of NCC into smooth muscle cells 
and disruption can lead to aortic arch branching defects and pulmonary stenosis 
along with defects in smooth muscle cells development in the 6
th
 arch artery in 
mice (Niessen and Karsan, 2008). In humans such mutation often leads to 
calcification of aortic valve and bicuspid aortic valve (Garg et al., 2005). 
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Figure 1.7: NCC migration into outflow tract 
Contribution and migration of NCC during heart development from their origin in 
neural tube to the outflow tract through pharyngeal arches. Adapted from (Kirby, 
2007). 
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Endothelin signalling plays a role in aortic arch patterning influencing the NCC. 
Mutation in Endothelin-1 (ET-1) signalling pathway leads to arch patterning 
defects (Kurihara et al., 1995) and Endothelin A (ETA) which is a receptor of 
ET-1 is expressed in NCC in the pharyngeal arches. The ETA null cells are 
excluded from the walls of the aortic arch which suggests that NCC which 
surround the endothelial cells in the arch arteries require ETA to interact with the 
endothelium of the aortic arch arteries (Yanagisawa et al., 1998; Clouthier et al., 
2003). Apart from these, Notch, BMP, and GATA transcription factors also play 
important roles in NCC migration and differentiation and any disruption in this 
complex leads to cardiac defects.  
 
1.4.1.2 Phenotype arising from ablation of NCC genes 
Ablation of NCC in associated with outflow tract defects, aortic arch defects, 
craniofacial skeletal abnormalities, pigmentation defects and defects in 
pharyngeal derivatives including thymus, parathyroids and thyroids (Leatherbury 
and Kirby, 1996). Human defects with similar phenotype, associated with NCC 
are also known, for example DiGeorge Syndrome which has cardiac-craniofacial-
pharyngeal defects, Waardenburg Syndrome with craniofacial-pigmentation 
defects, CHARGE association;Goldberg-Sprintzen having cardiac-craniofacial 
defects, and ABCD Syndrome which has pigmentation defects. Although all these 
syndromes have different combinations and variability of defects, but they all are 
associated with NCC (Creazzo et al., 1998). 
Majority of work on NCC and understanding their role has been carried out in 
quail-chicken chimeras, where cardiac neural crest cells were surgically removed 
prior to their migration and were replaced by quail-NCC or quail-chicken 
chimeras, which showed developmental defects like common arterial trunk, 
ventricular septal defects and abnormal patterning of pharyngeal arch arteries, 
apart from non-cardiac phenotype like absence or hypoplastic thymus, thyroid 
and parathyroids (Le Lievre and Le Douarin, 1975; Kirby et al., 1983; Phillips et 
al., 1987; Waldo et al., 1998). Although work in chick has given in-depth 
explaination of NCC’s role in cardiac morphogenesis, there are differences 
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between cardiac development in chicken and mouse. Therefore, similar work has 
been done on mouse models. Splotch and Patch are two naturally occurring 
mouse mutants for NCC and their cardiac phenotype is similar to the defective 
cardiac phenotype observed in chick embryos, but these mouse mutants have 
severe non-cardiac defects as well along with cardiac defects (Auerbach, 1954; 
Franz, 1989; Morrison-Graham et al., 1992; Epstein, 1996; Conway et al., 1997a; 
Conway et al., 1997b; Conway et al., 1997c). 
Splotch mouse have mutation in transcription factor gene, Pax3 (Goulding et al., 
1993) and embryos with this mutation die in utero. Apart from outflow tract 
abnormalities, they also have neural tube closure defect along with defects in 
limb musculature (Auerbach, 1954; Franz and Kothary, 1993). This implies Pax3 
is essential for NCC migration and can be used as marker for NCC (Conway et al., 
1997b). These mutant mice have common arterial trunk, alignment defect of 
outflow tract like double outlet right ventricle, aortic arch patterning defect, 
absent thymus, thyroid and parathyroids, spina bifida and pigmentation 
abnormalities. Pax3 is expressed in dorsal neural tube and early migrating NCC 
but expression is reduced when they reach the pharyngeal arch region and 
outflow tract. Cre-lox technology used to look at Pax3 expression in normal and 
splotch mice showed that there is decrease of migration on NCC in the arch 
arteries and outflow tract (Epstein et al., 2000; Kwang et al., 2002), and these 
splotch mutants have up-regulation of Msx2, which is downstream target of Pax3. 
Msx2 loss of function mutation rescues cardiac defects in splotch mice (Kwang et 
al., 2002). 
The Patch mouse has mutation (deletion) in the α-subunit of the platelet-derived 
growth factor (PDGF) receptor, which is important for NCC interaction with 
extracellular matrix which assists in their proliferation, survival and migration. 
This receptor is expressed in more cell types as compared to Pax3 and therefore 
the phenotype is more severe than Splotch mutants (Smith et al., 1991; Price et 
al., 2001). 
NCC express Cx43, which is a gap junction protein and plays a role in 
intracellular channels (Reaume et al., 1995; Lo et al., 1999). Cx43 is required for 
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NCC migration as Cx43 null embryos show reduced directionality and speed of 
NCC while they are migrating (Huang et al., 1998). Lo et al used a portion of 
Cx43 promoter and used it to drive LacZ expression to mark NCC and look at the 
migration and involvement in cardiac development (Lo, 1997). All subtypes of 
retinoic acid receptors (RAR) are expressed in NCC and RAR αβ2 and αγ 
homozygous double knockout mice also have outflow tract and aortic arch 
defects associated with NCC (Rowe et al., 1994). Use of Cre-lox technology has 
further enhanced the ability to track NCC and understand their role in embryonic 
development. Most commonly used promoter which drive Cre recombinase 
expression for NCC are Wnt1-Cre, Pax3-Cre, PO-Cre and PlexinA2-Cre (Lee et 
al., 1996; Jiang et al., 2000; Brown et al., 2001). Although there are slight 
differences in these models with respect to NCC labelling, but they all confirm 
major migration patterns and contributions of NCC in mice as seen in chick. The 
Wnt1-Cre transgenic mice have been widely used to study NCC lineage in 
context of their migration and fate, because Wnt1 gene is highly expressed in the 
dorsal neural tube prior to NCC migration (Hutson and Kirby, 2007; Lewis et al., 
2013). 
1.4.2 The Second Heart Field  
During early developmental stages of the embryo, the heart tube elongates by the 
addition of myocardium from progenitor cells that lie outside the heart. These 
mesodermal progenitor cells are called the SHF and reside in the anterior pharynx 
during the period when the heart tube is forming and as it lengthens (from E8.5-
E10.5) these cells migrate into the poles of the heart after formation of the linear 
heart tube. Therefore SHF cells are the progenitor cells situated in splanchnic 
pharyngeal mesoderm which migrate into the developing heart and facilitate 
maximal extension of the heart tube.  
Addition to the developing heart after formation of the linear heart tube was first 
suggested by studies done during the 1960s and 1970s (Stalsberg and DeHaan, 
1969; De La Cruz et al., 1977; Viragh and Challice, 1977), however it was only 
confirmed in 2001, where three separate studies on chick and mouse revealed the 
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origin of these extracardiac cellular additions (Kelly et al., 2001; Mjaatvedt et al., 
2001; Waldo et al., 2001).  
Mjaatvedt et al (2001) showed the source of myocardial cells that contribute to 
the lengthening of the outflow tract using chick as model. By labelling cells in the 
undifferentiated mesoderm surrounding the aortic sac and present anterior/cranial 
to the heart tube using Mitotracker or replication-deficient adenovirus which 
express β-gal, they observed destination of these cells in the distal and proximal 
regions of the outflow tract and named them anterior heart-forming field 
(Mjaatvedt et al., 2001). Waldo et al (2001) identified a similar source of 
myocardial cells by using quail-chick chimeras and mitotracker dye concluding 
the presence of these cells in proximal outflow tract and their contribution to 
heart development (Waldo et al., 2001). This work on chick was supported by 
work on mice by Kelly et al (2001). Using Fgf10-nLacZ reporter mouse they 
showed that right ventricle and outflow tract myocardium are added from both 
pharyngeal arch core and splanchnic mesoderm. As the myocardial cells are 
added to the heart tube, there is downregulation of Fgf10 and LacZ, however β-
galactosidase protein was still present in the cells, showing that these cells had 
their origin from Fgf10 expressing cells residing in the pharynx (Kelly et al., 
2001). These cells were given the name second heart field cells. 
Cardiac progenitor cells are divided into 2 types, and categorized on the basis of 
the function and fate, FHF and SHF. The SHF is distinguished from the FHF, 
which forms the linear heart tube, by the persistent expression of transcription 
factors such as Isl1 and Tbx1 and the growth factors Fgf8 and Fgf10, whereas 
they are expressed in the FHF only transiently (Thompson et al., 1985; Bartelings 
and Gittenberger-de Groot, 1989; Kelly et al., 2001).  Both FHF and SHF have 
expression of these genes, however FHF down-regulate Isl1 and Fgf8 expression 
as they differentiate and there is a prolonged expression of Isl1 and Fgf8 in SHF 
which helps in its elevated proliferation and delay in differentiation (Park et al., 
2006; Prall et al., 2007). 
 The FHF contributes to the formation of left ventricle, portions of right ventricle 
and inflow region of the heart whereas the SHF contributes to the formation of 
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outflow tract, right ventricle, and also to the inflow region (Kelly and 
Buckingham, 2002; Buckingham et al., 2005) (figure 1.8), as shown by many 
genetic tracing experiments extensively done on avian and mouse models (Kelly 
et al., 2001; Mjaatvedt et al., 2001; Waldo et al., 2001; Cai et al., 2003; Zaffran 
et al., 2004; Verzi et al., 2005; Tirosh-Finkel et al., 2006; Rana et al., 2007; Guo 
et al., 2011; Kelly, 2012). Hence outflow tract is exclusively from the SHF. Work 
on human embryos is in initial stages but supports previous work on mice, 
showing Isl1 positive SHF cells contributing to the outflow tract (Sizarov et al., 
2012; Yang et al., 2013). Apart from the myocardial contribution to the heart, 
SHF are also shown to contribute to the endocardium of the right ventricle and 
proximal outflow tract, and smooth muscle in the outflow tract (Moretti et al., 
2006). Therefore, once inside the heart, SHF gives rise to myocardial, endocardial 
and smooth muscle cells (Laugwitz et al., 2005; Moretti et al., 2006).  Cell 
labelling in chick showed that these SHF derived smooth muscle cells are at the 
proximal outflow tract and present between smooth muscle derived from NCC 
(distally) and myocardium of the outflow tract (proximally). Another study in 
chick shows the difference of position of SHF cells leads to different fate. 
Labelled SHF cells were traced revealing that right side of SHF cells are found in 
left side of spiralling outflow tract and generate smooth muscle cells of aorta and 
coronary stems (Waldo et al., 2005b; Sun et al., 2007), while the cells present at 
the left side contribute to smooth muscles cells of pulmonary trunk. During 
outflow tract formation, maximal extension of the outflow tract is required for the 
proper alignment of the base of the aorta with the left ventricle during aorto-
pulmonary septation (Sugishita et al., 2004; Rochais et al., 2009b). Disturbances 
in the SHF during early stages of their movement into the heart tube leads to 
many congenital heart defects ranging from failure of heart tube extension to 
alignment defects, including double outlet right ventricle, overriding aorta, 
suggesting that early SHF myocardial addition is essential for outflow tract 
elongation and alignment. When SHF are ablated at later stages, outflow tract 
alignment is normal; however coronary artery defects are present (Ward et al., 
2005). Hence time of SHF movement and addition in the heart tube is crucial 
with respect to outflow tract development. SHF which enter the heart tube from 
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the inflow region contribute to portions of atria, atrial septum and myocardium of 
the venous pole (Kelly, 2012).    
The targeted disruption of a number of genes within the SHF, including Isl1, Fgf8, 
Tbx1, and Tbx20, gives rise to outflow tract malformations in mice, reviewed in 
(Watanabe et al., 2010). Furthermore, human patients with outflow tract 
malformations have been shown to have potentially disease causing 
polymorphisms in SHF genes, including Tbx1 and Isl1 (Gruber et al., 2010), 
indicating a developmentally conserved role for the SHF during cardiac 
development.  
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Figure 1.8: Contribution of SHF in heart development  
SHF contribution (shown in green) to outflow tract, right ventricle, parts of right 
and left atria, and FHF contribution (shown in red) to left ventricle, right and left 
atria. Adapted from (Buckingham et al., 2005). 
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1.4.2.1 Signalling involved in SHF during heart development 
SHF cells originate in the splanchnic mesoderm and the mesodermal core of the 
pharyngeal arches. Signals necessary for the development, proliferation, 
movement and differentiation of SHF in the developing heart are likely to 
originate from interactions between the genes and signals which are present in 
this region and the neighbouring ectodermal and endodermal layers of the arches, 
including Fgf, BMP, canonical and non-canonical Wnt signalling (Evans et al., 
2010), apart from the interactions with the other cell types which populate these 
tissues.  
Heart development starts with the expression and activation of transcription 
regulator Mesp1, which activates cardiac transcription factors, including Isl1, 
Tbx5, Nkx2.5, Mef2c, Gata4 and Baf60c (Bruneau, 2002; Van Weerd et al., 2011; 
Miquerol and Kelly, 2013). Transcription factor Isl1 is a target of Wnt signalling 
and plays a central role in SHF development with regulating signalling pathway 
ligands and receptor gene expression (Cai et al., 2003; Lin et al., 2007). Study on 
ES cells show that Isl1, along with Mesp1 plays a role during cardiac 
specification (Kwon et al., 2009; Bondue et al., 2011). Interrupted Isl1 expression 
in embryos leads to disorganisation in SHF deployment at both inflow and 
outflow region of the heart tube, resulting in shortened outflow tract (Cai et al., 
2003). Cells which express Isl1 do not differentiate and continue to proliferate 
(Cai et al., 2003). These cells are present in the pharyngeal mesoderm are isolated 
at dorsal pericardial wall and enter from both poles contributing in heart tube 
elongation. Work on chick and mice show high proliferative rate in this region 
(Van Den Berg et al., 2009; de Boer et al., 2012). This proliferation is regulated 
by Sonic hedgehog (Shh) and Fgf signalling with Fgf3, Fgf8 and Fgf10 as ligands 
(Ilagan et al., 2006; Park et al., 2008; Dyer and Kirby, 2009; Watanabe et al., 
2010; Urness et al., 2011). Of these Fgf8 has the major driving effect for 
proliferation, with important contributions from Fgf3 and Fgf10 as Fgf8 is critical 
for heart tube elongation and Fgf10 null embryos show normal SHF deployment 
but when deleted along with Fgf8 show increased severity in cardiac defects 
(Ilagan et al., 2006; Park et al., 2006; Park et al., 2008; Watanabe et al., 2010; 
Urness et al., 2011; Francou et al., 2013). This Fgf ligand expression in the dorsal 
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pericardial wall is regulated by Notch and Wnt/β-catenin signalling (figure 1.9) 
(Cohen et al., 2007; High et al., 2009; Klaus et al., 2012). This proliferation is 
maintained with the help of Shh signalling through transcription factor Tbx5, 
which is a positive regulator for SHF proliferation (Goddeeris et al., 2007; Dyer 
and Kirby, 2009) (figure 1.9). T-box transcription factor Tbx1 regulates Fgf 
signal response (figure 1.9) (Cai et al., 2003; Baldini, 2005; Aggarwal et al., 2006) 
with Six1 and Eya1 playing intermediate roles (Guo et al., 2011). Notch 
signalling which is upstream of Wnt/β-catenin signalling has a target gene Hes1, 
which is also expressed in the dorsal pericardial wall and is important for 
proliferation (Rochais et al., 2009a). Fgf8 expression in SHF cells is regulated by 
Notch signalling, through Jag1 ligand (figure 1.9) (High et al., 2009).  
While SHF are proliferating, their survival and check on apoptosis is also 
important and bHLH transcription factor Hand2 plays a role in this process 
(Tsuchihashi et al., 2011). Retinoic acid signalling also plays a role in SHF 
maintenance in dorsal pericardial wall (Li et al., 2010). As SHF approach the 
distal heart tube, they are exposed to BMP and non-canonical Wnt signalling 
(figure 1.9). These both are involved in differentiation of SHF. However, 
proliferation needs to be regulated and balance between proliferation driving Fgf 
signalling and differentiation driving BMP signalling is influenced by NCC 
present in the pharyngeal region (Kelly, 2012). NCC act as a brake to Fgf 
signalling and hence on over-proliferation of SHF after the heart tube is optimally 
elongated (Yelbuz et al., 2002; Hutson et al., 2006). This is achieved by BMP 
signalling, through BMP induced transcription factor encoding genes Msx1 and 
Msx2 in NCC (figure 1.9) (Tirosh-Finkel et al., 2010). These Msx1 and Msx2 are 
also required for expression of Hand2 and survival of SHF (Chen et al., 2007). 
Apart from regulating proliferative effects of Fgf signalling, BMP also modulates 
proliferative effect of Hedgehog signalling (Dyer et al., 2010), and promotes 
differentiation of Isl1 expressing cells through transcriptional activation of 
microRNA 17-92, which targets SHF transcripts, Isl1 and Tbx1 (Yang et al., 2006; 
Wang et al., 2010). 
Transcription factors, Nkx2.5, Tbx20, Mef2c, Gata4 play important role in SHF 
cell differentiation (Waldo et al., 2001; Francou et al., 2013). In the absence of 
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Nkx2.5, BMP signalling is elevated which down regulates SHF proliferation 
(Prall et al., 2007; Barth et al., 2010) and favours its differentiation. In the 
absence of T-box transcription factors, BMP signalling is down regulated which 
increase the proliferation of SHF cells by elevated Fgf signalling (Mesbah et al., 
2012). Tbx1, which is a candidate gene for DiGeorge Syndrome is associated with 
craniofacial and cardiovascular defects and is known to prevent SHF cells 
differentiation (Baldini, 2005). Tbx1 is regulated by canonical Wnt signalling and 
hedgehog signalling and promotes Fgf ligand expression and have antagonistic 
effect of differentiation by negatively influencing BMP and retinoic acid 
signalling (figure 1.9) (Garg et al., 2001; Vitelli et al., 2002b; Hu et al., 2004; 
Roberts et al., 2005; Fulcoli et al., 2009; Huh and Ornitz, 2010). Embryos lacking 
Tbx1 have premature activation of differentiation markers and over expression of 
Tbx1 inhibit differentiation of SHF cells (Chen et al., 2009). Tbx1 controls 
several SHF markers, like Fgf8 and Fgf 10. In Tbx1 null mice there is decreased 
expression of both Fgf 8 and Fgf10 (Vitelli et al., 2002b; Xu et al., 2004). Fgf8, 
as mentioned before, is necessary for SHF proliferation and survival and is 
regulated by Tbx1 through an auto regulatory mechanism involving Foxc2 
(Brown et al., 2004; Hu et al., 2004) and it is suggested Fgf10 also controls SHF 
proliferation under the regulation of Tbx1 (Xu et al., 2004). However Fgf10 
expression is down regulated in Fgf8 deficient embryos (Frank et al., 2002) 
indicating its downstream position. Transcription factors Foxa2, Foxc2, and 
Foxc1 regulate Tbx1 activation in pharyngeal endoderm in SHF in a dosage 
dependent manner under the influence of Shh signalling (figure 1.9) (Yamagishi 
et al., 2003; Maeda et al., 2006). Foxc1 and Foxc2, along with Foxf1 also 
regulate Isl1 (figure 1.9), together with Gata4 (Kang et al., 2009). Other SHF 
markers, Mef2c and Foxh1 also contribute to SHF signalling in the developing 
heart. Foxh1 lies upstream of Mef2c and along with Nkx2.5 directs its expression 
in the SHF (figure 1.9) (von Both et al., 2004). Mef2c expression in SHF is also 
regulated by Isl1 and Gata4 (Dodou et al., 2004). Tbx20 is also involved in 
activation of Mef2c by physically interacting with Isl1 (Takeuchi et al., 2005). 
Cre-labelling experiments have helped in refinement of SHF model and their 
function, in particular Isl1-cre and Mef2cAHF-Cre. Isl1-Cre allele is expressed in 
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cells giving rise to outflow tract, right ventricle and portions of atria (Cai et al., 
2003) and Mef2cAHF-Cre in outflow tract, right ventricle, interventriular septum 
and atrial septum (Verzi et al., 2005). Isl1 expression contributes to the 
differentiation, by the activation of Mef2c expression (Dodou et al., 2004), which 
is required to initiate myogenic differentiation (Chen et al., 2009; Fulcoli et al., 
2009; Pane et al., 2012). This is negatively regulated by Wnt/β-catenin signalling, 
which favours proliferation by regulating Fgf signalling (Cohen et al., 2012). 
However, Wnt/β-catenin signalling is inhibited by non-canonical Wnt/PCP 
signalling (Cohen et al., 2012), which favours differentiation. Tbx1 targets Wnt5a, 
which is a ligand for non-canonical Wnt signalling (Chen et al., 2012). Mutations 
in non-canonical Wnt signalling ligands, Wnt5a and Wnt11 leads to outflow tract 
defects revealing their roles in its development (Schleiffarth et al., 2007; Zhou et 
al., 2007a). Wnt5a is expressed in SHF cells and Wnt5a-/- embryos have common 
arterial trunk along with abnormal NCC invasion (Schleiffarth et al., 2007). 
Wnt11-/- embryos have shortened outflow tract (Zhou et al., 2007a) suggesting 
role of non-canonical Wnt signalling pathway in addition of SHF to the outflow 
tract. Tbx1 is pro-proliferation and non-canonical Wnt signalling is pro-
differentiation suggesting a feedback regulation between the two. Therefore it can 
be stated that time specific gene expression and signalling intervention are 
required for regulating SHF in developing heart, starting from proliferation and 
migration in the outflow tract and then differentiating into cardiomyocytes. 
Summary of signalling pathways involved in regulating SHF is shown in figure 
1.9. 
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Figure 1.9: Signalling pathways regulating SHF  
 
1.4.2.2 Phenotype arising from ablation of SHF genes 
Absence or reduction of SHF specific genes leads to spectrum of cardiovascular 
defects. Isl1 expression labels the largest proportion of SHF and its absence 
results in failure of heart looping and complete absence of the outflow tract, right 
ventricle and parts of atria (Cai et al., 2003). Isl1 ablation results in embryonic 
death by E10.5 and large contribution of Isl1 expressing cells in heart are 
determined by outflow tract, right ventricle and atrial defects seen in Isl1 ablated 
embryos (Cai et al., 2003). Loss of other SHF genes which are less broad as 
compared to Isl1, like Mef2c and Foxh1 results in less severe but related 
phenotypes like abnormal looping, shortened outflow tract and right ventricle 
abnormalities (Lin et al., 1997; von Both et al., 2004). SHF specific Mef2c 
contribution is more restricted, with contributions to outflow tract, right ventricle 
and ventricular septum (Verzi et al., 2005). Like Mef2c, Foxh1 also contributes to 
the right ventricle and outflow tract with similar phenotype of Mef2c-/- and 
Foxh1-/- embryos (Lin et al., 1997; Lin et al., 1998; Bi et al., 1999). 
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Mice which have Tbx1 mutation die in-utero displaying features of DiGeorge 
syndrome, like common arterial trunk and defects in aortic arch arteries (Jerome 
and Papaioannou, 2001; Lindsay et al., 2001; Vitelli et al., 2002a). Cre labelling 
experiments have shown Tbx1 expression in SHF which contribute to inferior and 
lateral walls of outflow tract and to myocardium at the base of pulmonary trunk 
(Maeda et al., 2006; Huynh et al., 2007). Ablation in myocardium at the base of 
the pulmonary trunk is the prime cause of outflow tract alignments defects like 
overriding aorta, tetralogy of fallot, pulmonary hypoplasia and ventricular septal 
defect (Di Felice and Zummo, 2009; Van Praagh, 2009). There is reduced 
contribution of cells in the outflow tract in Tbx1-/- mice and Tbx1 regulates SHF 
cell proliferation (Xu et al., 2004). Tbx1-/- embryos have common arterial trunk 
(Vitelli et al., 2002a) which is associated with NCC as they form the septum 
between pulmonary trunk and aorta, however abnormally aligned outflow tract in 
these embryos is associated with SHF ablation. When Tbx1 was specifically 
deleted from mesoderm, similar phenotype of Tbx1-/- mice was observed and 
restoration of mesodermal Tbx1 expression gives normal outflow tract, however 
can only rescue partial pharyngeal arch artery development, and has no effect on 
non-SHF regions and derivatives like thymus, NCC migration (Zhang et al., 
2006). Fgf8 hypomorphic mouse also have alignment defects such as double 
outlet right ventricle and ventricular septal defect (Abu-Issa et al., 2002), which 
arise from SHF disturbance.  
At the venous pole, SHF contributes to atrial myocardium which results in atrial 
and atrioventricular septal structures, and defects in SHF developments results in 
atrial and atrioventricular septal defects (Snarr et al., 2007; Galli et al., 2008). 
Therefore SHF ablation studies demonstrate how reduced SHF contribution or 
aberrations in SHF during heart development generate major form of congenital 
heart anomalies and these findings should be taken into account while studying 
other mutants with SHF abnormalities. 
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1.4.3 CNCC interaction with SHF 
As mentioned in the section 1.4.2.1, NCC acts as a brake for SHF proliferation. 
The over-proliferation of SHF is due to excessive Fgf8 signalling in the caudal 
pharynx and increased expression of Fgf target genes resulting in SHF 
proliferation rather than their migration and differentiation into myocardium. This 
is normally buffered by the presence of NCC (Hutson et al., 2006). SHF adds 
myocardium and helps in elongation of the outflow tract, aiding in alignment with 
the ventricles. Absence of NCC primarily leads to failure of division of the 
outflow tract. However, NCC deficiency also results in cardiac alignment defects 
as a consequence of its effect on the SHF; the SHF cells proliferate abnormally 
instead of migrating into the outflow tract and differentiating into myocardium 
(Waldo et al., 2005a). Thus, the absence of NCC results in the over proliferation 
of SHF cells, disturbing the balance between proliferation and differentiation and 
resulting in abnormal myocardial bulges at the junction of myocardium and aortic 
sac (Waldo et al., 2005a). 
This close interaction between NCC and SHF cells is also suggestive from the 
overlapping phenotype in their ablations. Abnormal cardiac looping is observed 
in the absence of CNCC which is due to a lack of myocardium in the outflow 
tract. Direct or indirect perturbations in NCC or SHF can lead to a spectrum of 
outflow tract defects like common arterial trunk, overriding aorta, double outlet 
right ventricle and ventricular septal defects.  
Thus, both SHF and NCC are essential for normal cardiac outflow morphogenesis, 
which forms the basis for this project.  
 
 
 
 
33 
 
1.5 Wnt Signalling Pathway  
In the previous sections it was discussed that Wnt signalling plays a role in SHF 
and NCC during heart development. The Wnt signalling pathway is a group of 
signalling pathways which involve proteins that pass signals from outside the cell 
to inside and induce gene expression. These signals can be autocrine or paracrine, 
and lead to various cellular functions such as patterning of the body axis, cell fate 
specification, cell proliferation and cell migration. They are of very important 
clinical relevance because of their involvement in development and disease, 
including cancer and type-2 diabetes (Logan and Nusse, 2004; Komiya and Habas, 
2008). 
Discovery of Wnt signalling was initiated by Roel Nusse and Harold Vamus 
research on oncogenic retrovirus which lead to the identification of a proto-
oncogene in mice, which is called integration1 (int1) (Nusse et al., 1984; Nusse 
and Varmus, 2012). This int1 had high degree of conservation across different 
species and it was found out that int1 is the mammalian homologue of a gene 
discovered in Drosophila, known as Wingless (Wg) (Cabrera et al., 1987; 
Rijsewijk et al., 1987; Nusse and Varmus, 2012). Apart from mutants lacking 
wings, mutation in Wg gene also caused segmentation defects. A number of 
segment polarity gene mutations in Drosophila have been traced back in 
components of Wnt signalling pathway (Nusslein-Volhard and Wieschaus, 1980; 
Nüsslein-Volhard et al., 1984), suggesting role of int1 in Wnt signalling pathway 
during embryonic development (Klaus and Birchmeier, 2008). To identify more 
genes related to int1 and Wg, a new gene nomenclature was given to the 
int/wingless family and it came to be known as Wnt (Wg + int) standing for 
wingless related integration site (Nusse and Varmus, 2012). 
The Wnt proteins are a diverse family of glycoproteins but have conserved 
cystein rich residues which undergo palmitoylation which helps in binding these 
Wnt proteins to their receptors on plasma membrane through covalent 
attachments of fatty acids (Logan and Nusse, 2004).  
The Wnt signalling pathway can be classified as 3 types, canonical Wnt pathway, 
non-canonical Wnt/PCP pathway and non-canonical Wnt/Ca
2+
 pathway. The 
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difference between canonical and non-canonical is their dependence on β-catenin 
(Rao and Kühl, 2010). The canonical Wnt pathway is β-catenin dependent and 
requires it to regulate gene transcription. Non-canonical Wnt pathways are β-
catenin independent. Non-canonical Wnt/PCP pathway is required for cellular 
polarity and cytoskeleton arrangement and Wnt/Ca
2+
 pathway regulate calcium 
inside the cell. The basic foundation of all 3 pathways is the same as they share 
upstream proteins. The signalling starts when a Wnt protein binds to the N-
terminal of cystein rich extracellular domain of Frizzled (Fz) (Rao and Kühl, 
2010). This can be facilitated by other co-receptors like low density lipoprotein 
related protein 5/6 (LRP5/6), which is required in the canonical Wnt pathway (He 
et al., 2004), and Ryk and Ror2, which are involved in non-canonical Wnt 
pathways (Lu et al., 2004a; Nishita et al., 2006; Komiya and Habas, 2008; Gao et 
al., 2011; Andre et al., 2012). After this binding, signal is transduced to 
cytoplasmic Dishevelled (Dvl) which binds to Fz. Dvl has 3 conserved domains, 
amino terminal DIX domain, central PDZ domain and carboxy terminal DEP 
domain. These domains are important as their different combinations leads to 
these 3 different pathways (Habas and Dawid, 2005). 
 
 
1. Canonical Wnt/β-catenin Pathway – This pathway regulates cell proliferation 
during heart development and is β-catenin dependent, where β-catenin acts as 
a transcriptional activator. Wnt protein binds to Fz and activates it in the 
presence of LRP5/6 coreceptor which leads to binding of Dvl to Fz. Dvl is 
phosphorylated leading to translocation of β-catenin to the nucleus where it 
binds to the DNA and assists in transcription of target genes along with other 
transcription factors (figure 10) (Logan and Nusse, 2004; Komiya and Habas, 
2008). 
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Figure 1.10: Canonical Wnt/β-catenin Pathway 
β-catenin in the cytoplasm is phosphorylated by GSK-3beta, Axin, APC, PP2A, 
GSK2, CK1α complex (degradation complex) and undergoes polyubiquitination 
by β-TrCP and sent to proteosome where polu-ubiquitinated β-catenin is 
degraded. However, in the presence of Wnt signalling, Dvl is phosphorylated and 
β-catenin along with whole degradation complex (Axin, APC, etc.) binds to 
phosphorylated Dvl which frees β-catenin from repressive activity of GSK-3beta 
and β-catenin is translocated to nucleus where it binds to the DNA and assists in 
transcription of target genes. APC-adenomatosis polypsis coli, GSK3β-glycogen 
synthase kinase 3β, CK1α-casein kinase 1α. 
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2. Non-canonical Wnt/PCP Pathway – This pathway regulates cell 
differentiation during heart development and is β-catenin independent. Co-
receptors involved are not clearly defined, however there are putative 
candidates like neurotrophin-receptor-related protein (NRH1) (Sasai et al., 
2004), Ryk (Lu et al., 2004a; Andre et al., 2012), Ror2 (Nishita et al., 2006; 
Gao et al., 2011) and PTK7 (Lu et al., 2004b). The signal is transduced to 
Dvl which binds to Fz. Two domains of Dvl, PDZ and DEP play important 
role at this point they lead to two parallel pathways (Wallingford and Habas, 
2005; Habas and He, 2006). Utilization of PDZ domain leads to activation of 
Rho pathway through Dvl-Daam1 complex. Daam1 (Dishevelled associated 
activator of morphogenesis 1) binds to Dvl and leads to activation of Rho 
GTPase. Daam1 can bind to Dvl and also to Rho GTPase, which suggests the 
feedback loop in the signalling pathway (Habas et al., 2001). Activation of 
Rho GTPase leads to activation of Rho Kinase (ROCK) (Marlow et al., 
2002), resulting in cytoskeletal rearrangements and  modifications in actin-
cytoskeleton.  
When DEP domain of Dvl is utilised, it activates Rac pathway. Rac GTPase 
is activated, which in turn stimulates JNK (Li et al., 1999; Habas et al., 2003). 
Downstream factors of JNK are no clearly known, but have role in 
transcriptional regulation. Detailed explanation of non-canonical Wnt/PCP 
pathway will be done in section 1.6.1 keeping cardiovascular development as 
reference.          
 
3. Non-canonical Wnt/Calcium Pathway – This pathway is responsible for 
calcium release from endoplasmic reticulum and maintaining Ca
2+
 level in 
the cell (figure 11). Like other 2 pathways, Wnt protein binds to Fz which 
activates Dvl, which upon activation binds to Fz. However, along with Dvl, 
trimeric G-protein is also binded to Fz and this co-stimulation activates 
Phospholipase C (PLC) or Phosphodiesterase (PDE), leading to 2 different 
pathways. If PLC is activated, it leads to activation of nuclear factor 
associated with T cells (NFAT) which helps in ventral patterning (Komiya 
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and Habas, 2008), or activation of TAK1 and NLK kinase, which inhibits 
canonical wnt/ β-catenin signalling (Gordon and Nusse, 2006). As this 
pathway controls the calcium level, it also stops the release of Ca
2+
. If PDE is 
activated by co-stimulation of Dvl and G-protein, it inhibits calcium release 
through PKG (Komiya and Habas, 2008). 
 
Figure 1.11: Non-canonical Wnt/Calcium Pathway 
PLC-Phospholipase C, PDE-Phosphodiesterase, IP3-inositol 1,4,5-triphosphate, 
DAG-1,2 diacylglycerol, ER-Endoplasmic reticulum, PKC- Protein kinase C, 
CaMKII-calcium calmodulin-dependent protein kinase II, NAFT-nuclear factor 
associated with T cells. 
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1.5.1 Functions of Wnt signalling pathway 
In both vertebrates and invertebrates, Wnt signalling plays important role in 
different cellular processes ranging from axis patterning to cell fate specification, 
proliferation and migration. In early embryonic development Wnt signalling plays 
an important role in establishing anteroposterior axis and dorsoventral axis in 
several organisms including mammals, fish and frogs. In mammals, Wnt, BMPs, 
Fgfs, Nodal and Retinoic acid establish axis by forming a concentration gradient, 
the area of their high concentration establishes the posterior and lower 
concentration the anterior axis. In frogs and fish, β-catenin produced by canonical 
wnt signalling along with BMPs elicits posterior formation. In vertebrates Wnt 
along with Shh establish dorsoventral axis with high Wnt signalling establishing 
dorsal region and high Shh signalling as ventral region (Inoki et al., 2006). 
Canonical Wnt signalling also mediates cell proliferation through β-catenin. 
Increased levels of β-catenin activate proteins like cyclin D1 and c-myc, which 
facilitates G1 to S phase transition during cell cycle. As there is DNA replication 
in S phase which leads to mitosis, the result of this rise in β-catenin is an increase 
cell proliferation (Nusse, 2008). For example, Wnt3a activation leads to 
proliferation of hematopoietic stem cells which are needed for red blood cell 
formation (Bakre et al., 2007). Wnt signalling is also involved in cell 
differentiation into specific cell types such as endothelial, cardiac and smooth 
muscle cells (Ulloa and Martí, 2010). Wnt1 helps in self-renewal of neural stem 
cells and antagonizes neural differentiation. Wnt signalling is also involved in 
germ cell differentiation, lung tissue development, trunk neural crest cell 
differentiation (Van Amerongen et al., 2012), and limb induction, elongation, and 
patterning in whichWnt5a plays the role of ligand (Gao et al., 2011). 
Cell migration and movement are an important aspect during embryonic 
development, during processes like establishment of body axis, tissue formation 
and limb induction. Wnt signalling facilitates this, for example during convergent 
extensions (CE). Both Wnt PCP and canonical signalling pathways are required 
for CE during gastrulation, and Wnt/Ca
2+
 signalling pathway also controls this 
process by inhibiting it. Migration of neuroblasts, NCC, myocytes etc are also 
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controlled by Wnt signalling (Woll et al., 2008) which induces epithelial-
mesenchymal transition (EMT) that is required for cell migration (Kaldis and 
Pagano, 2009). During EMT epithelial cells transform into mesenchymal cells by 
down regulation of cadherins which leads to cell detachment from laminin which 
keeps it attached to basement membrane.  
 
1.6 Cell Polarity  
Cell polarity is the difference in the spatial characteristics of the cell which leads 
to differences in its structure, shape and function. Polarity of a cell happens by 
asymmetric cell division, asymmetric localization of proteins and concentration 
gradients of secreted receptor proteins, and regulates both collective and 
individual cell movements during developmental stages. The molecules 
responsible for regulation of cell polarity are highly conserved between species. 
The polarity in epithelial cells can be divided in two distinct types; apical-
basolateral polarity (ABP) and planar cell polarity (PCP) which work in 
coordination and are functionally linked. Polarized cells are divided into apical 
and basal sides and this division between the compartments is regulated by 
presence of adherens junctions (AJ), which are present at the border of apical and 
basolateral domain (Kaplan et al., 2009) (basal being the cell’s attachment to the 
basement membrane and attachment to the adjoining cells in the cell layer is the 
lateral) (figure 1.12). The AJ, apart from dividing the cell into two compartments, 
are also involved in cell-cell adhesion and migration. PCP is the polarization 
along the plane of the epithelial layer (perpendicular to the ABP), which divides 
the cell into proximal and distal sides (figure 1.12). For PCP signalling to be 
properly functional, the core PCP proteins are asymmetrically localized along the 
plane of the cell (Das et al., 2004; Wu et al., 2004), and ABP proteins regulate 
this process (Fedeles and Gallagher, 2013). Also, PCP signalling has been 
implicated to have a role in regulation of ABP, and directional cell migration 
(Tao et al., 2009; Goodrich and Strutt, 2011; Tao et al., 2012), for example 
migration of NCC has been shown to be regulated by PCP signalling in both 
Xenopus and zebrafish (De Calisto et al., 2005; Matthews et al., 2008), however 
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in mammals such a role has yet to be shown. The PCP protein Prickle1, when 
absent in mice, leads to death of embryos in uterus because of failure to establish 
ABP (Tao et al., 2009). These examples show the functional link between ABP 
and PCP and indicate that their correct establishment and maintenance is required 
for normal embryonic development. 
 
 
 
 
 
 
 Figure 1.12: Planes of cell polarity 
ABP - apical-basolateral polarity, PCP - planar cell polarity, AJ – adhesion 
junctions, TJ – tight junctions. 
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1.6.1 Planar Cell Polarity Signalling Pathway  
In tissues, cells require positional information to move or orient themselves in a 
directed fashion and to generate polarized structures. This type of polarization of 
cells is known as planar cell polarity (PCP) and the pathway controlling tissue 
organization is the PCP pathway. The core components to PCP signalling interact 
to establish polarity in the field of cells. PCP helps in interpreting the anterior-
posterior and left-right orientations. Disruption of PCP signalling has been shown 
to disrupt cell polarity and polarised cell movements in a wide range of species 
which results in abnormalities in morphogenesis. 
PCP first came into the picture because of work on Drosophila, by Lawrence and 
Adler groups (Lawrence and Shelton, 1975; Vinson and Adler, 1987). Later 
genetic analysis and molecular cloning of PCP gene from Drosophila lead to 
identification of PCP factors. In Drosophila all adult cuticular structures show 
PCP features (Adler, 2002; Mlodzik, 2002; Strutt, 2003), for example hair 
position on thorax, compound eye organization, and patterning of wings and 
disruptions of PCP signalling leading to disorganization in the tissues (Wang and 
Nathans, 2007; Simons and Mlodzik, 2008). In wing, cells orient themselves in 
proximal-distal axis and have distally pointing hair, on thorax, PCP is in anterior-
posterior axis and in the eye the regular arrangement of the ommatidia is because 
of both proximal-distal and anterior-posterior polarity (Adler, 2002; Mlodzik, 
2002; Strutt, 2003).  
Current evidence indicates that core PCP genes are conserved across tissues and 
species, instead of having different polarity regulating signalling pathways from 
tissue to tissue and organism to organism. In vertebrates PCP establishment and 
signalling pathway can be observed during CE during gastrulation (Keller, 2002; 
Myers et al., 2002; Wallingford et al., 2002). Mesodermal and ectodermal cells 
undergo CE, where polarised cells intercalate leading to mediolateral narrowing 
called convergence, and elongation along the anterior-posterior axis, which is 
called extension (Keller et al., 2003). PCP has been shown to regulate CE 
movement of dorsal mesodermal cells during gastrulation and neural tube closure 
(Veeman et al., 2003). In zebrafish and Xenopus as well, PCP regulates CE 
movements during gastrulation (Wallingford et al., 2002). Other examples in 
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vertebrates which require PCP signalling are organisation of hair follicles, 
orientation of stereo-cilia in the sensory epithelium of inner ear and abnormalities 
in the cilia orientation in the absence of PCP signalling (Montcouquiol et al., 
2003; Wang and Nathans, 2007). There are many similarities between PCP in 
Drosophila and vertebrates, however there are differences too. For examples, in 
mouse tyrosine kinase, Ryk receptor acts as an important PCP signalling factor 
(Lu et al., 2004b), but no similar factor has been found in Drosophila and none of 
fly Wnt genes have been implicated to have role in PCP activation, whereas in 
vertebrates there is evidence of involvement of Wnts in PCP signalling (Klein and 
Mlodzik, 2005). 
PCP signalling is a multi-protein signalling pathway and in flies these 
components (proteins) can be divided into 2 groups, global group and core group. 
The global group control polarization along the tissue and body axis and include 
Fat (Ft), Dachsous (Ds) and Four-jointed (fj) as its components, reviewed in 
(Henderson and Chaudhry, 2011). The core group is mainly responsible for 
polarization of individual cells and members of this group are Frizzled (Fz), 
Dishevelled (Dvl), Vang-gogh (Vang)/Strabismus (Stbm), Prickle (Pk), Flamingo 
(Fmi)/starry night (stan) and Deigo (Dgo), reviewed in (Henderson and Chaudhry, 
2011). Of these Fmi, Fz, Dvl and Dgo localize at distal side of the cell and Fmi, 
Vang and Pk localize at the proximal side resulting in an asymmetric localization 
of the proteins (Henderson and Chaudhry, 2011). Ft act as positive regulator of Fz 
and Ds as a Ft antagonist, Both Ft and Ds genetically interact with fj (Yang et al., 
2002; Matakatsu and Blair, 2004; Simon, 2004), which also regulates PCP as Ds 
and fj both act on Ft, which regulates Fz activity (Zeidler et al., 1999; Zeidler et 
al., 2000). Although PCP proteins are conserved and play similar roles in 
vertebrates as in fly, the mechanism of action is not shown to be conserved. As 
mentioned before, Wnt ligands do not activate Fz in flies, but vertebrate Wnts 
(Wnt4, Wnt5a and Wnt 11) are involved in PCP activation by binding to Fz. 
Celsr1 and Vangl2 are vertebrate homologues of Fmi and Vang/Stbm respectively 
(Formstone and Little, 2001; Montcouquiol et al., 2003). Other members of this 
pathway are Ptk7, Scrib and Daam1. Fz after activation binds to Dvl which 
interacts with Daam1 and activates RhoA and in turn ROCK which controls 
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cytoskeleton rearrangements. Dvl can also activate Rac1 independent of Daam1 
which activates JNK which impacts gene expression (figure 1.13). The 
downstream cascade can differ depending upon the context, for example 
cytoskeletal reorganisation versus transcriptional response. PCP responses can 
affect cytoskeletal organisation in Drosophila cuticular cells and mammalian 
inner ear epithelium (Adler, 2002; Mlodzik, 2002; Montcouquiol et al., 2003; 
Strutt, 2003), and nuclear signalling response in Drosophila eye and mammalian 
hair follicle (Mlodzik, 1999; Guo et al., 2004). Scrib interacts with Vangl2 and 
plays a role in its asymmetric localization along with Celsr1. Interaction is 
mediated by PDZ domain of Scrib and Vangl2 (Kallay et al., 2006), and this PDZ 
domain is also shared with Dvl (Bastock et al., 2003). Ptk7 also interacts with 
Vangl2, and Vangl2 recruits Pk which binds to Dvl and antagonises its binding 
with Fz. Fz-Dvl and Vangl2-Pk antagonise each other and are localised at 
opposite poles of each cell. 
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Figure 1.13: Planar Cell Polarity Signalling Pathway 
Dvl-Dishevelled, Pk-Prickel Fz- Frizzled, Dgo- Deigo, Daam1- Dishevelled 
associated activator of morphogenesis 1, JNK- c-jun terminal kinase. 
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1.6.1.1 Downstream targets of PCP pathway (ROCK and Rac1) 
Components of PCP pathway have been involved in cardiac outflow tract 
morphogenesis, with disruption of various PCP genes results in outflow tract 
malformations (Hamblet et al., 2002; Curtin et al., 2003; Phillips et al., 2007; 
Schleiffarth et al., 2007; Zhou et al., 2007b; Etheridge et al., 2008; Nagy et al., 
2010; Paudyal et al., 2010; Yu et al., 2010). While the mechanisms underlying 
these malformations are as yet unknown, there is a possibility of link between 
PCP signalling and the regulation of cellular migration into heart during 
embryogenesis. Rac1 and ROCK are both downstream targets of PCP pathway 
and have roles in cell adhesion, migration and polarity. Rac1 is a member of the 
Rho family of small guanosine triphosphatases (GTPases), which are a subgroup 
of Ras-superfamily of GTPases. The role of Rac1 has been investigated in 
cardiovascular development; in terms of cellular migration, adhesion, 
proliferation, transcription and apoptosis; in cardiac progenitor populations (Tan 
et al., 2008; Bosco et al., 2009; D'Amico et al., 2009; Thomas et al., 2010). Rho 
Kinase (ROCK) is a serine/threonine protein kinase downstream of the GTPase 
Rho A (Amano et al., 2010). ROCKs phosphorylate over 20 substrate proteins 
primarily involved in regulating assembly of actin filaments within the 
cytoskeleton (Riento and Ridley, 2003). Through this mechanism it regulates a 
broad variety of physiological processes, including cell migration (Worthylake 
and Burridge, 2003), proliferation (Sahai et al., 2001), transformation (EMT) 
(Zondag et al., 2000), apoptosis (Sebbagh et al., 2001), morphology (Sordella et 
al., 2002) and establishing cell polarity (Amano et al., 2010).  Activation of 
ROCK for each function is regulated by different signalling molecule. These 
signalling molecules activate RhoA GTPase which in turn activates ROCK. This 
process of RhoA GTPase activation can be direct or indirect (Zhao and Rivkees, 
2003; Loirand et al., 2006).  
As ROCK and Rac1 are seen to play an important role in cell migration and cell 
survival or cell apoptosis, their role in cardiac development is very important and 
raises the possibility of their involvement in congenital heart defects related to 
migrating cardiac progenitor populations (Bosco et al., 2009; Hildreth et al., 
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2009). Therefore, we aim to elaborate the role of PCP pathway downstream 
targets, Rac1 and ROCK in SHF for heart development. 
 
1.6.1.2 PCP Signalling Pathway and Heart Development 
During very early embryonic development (gastrulation), PCP signalling is 
involved in CE movements and abnormalities in that result in severe defects like 
neural tube defects (NTD), gastroschisis, axial rotation defects and cardiovascular 
defects (CVD) (Kibar et al., 2001; Hamblet et al., 2002; Curtin et al., 2003; 
Murdoch et al., 2003). Severe NTD, craniorachischisis (CRN), in which neural 
tube fails to close and is completely open from midbrain to tail was initially 
demonstrated in Vangl2 mutant, loop-tail (Lp) (Strong and Hollander, 1949), and 
is also displayed when other PCP genes are mutated, including Dvl1 and Dvl2 
(Hamblet et al., 2002), Celsr1 (spin-cycle and crash mutant) (Curtin et al., 2003), 
Scribble1 (circle tail mutant) (Murdoch et al., 2001b; Murdoch et al., 2003) and 
Fz (Wang et al., 2006). However, the CVD present in these PCP mutants could be 
secondary defects of the primary NTD and body axis abnormalities which might 
lead to defective remodelling of heart during developmental stages. However, 
Wnt11-/- (Majumdar et al., 2003) and Dvl3-/- (Etheridge et al., 2008) mutants do 
not have NTD and have cardiac defects, which suggest that cardiac defects are 
not secondary to NTD in the absence of PCP signalling and disrupted polarity. 
However this needs to be confirmed and established.  
There have been reports in zebrafish that PCP signalling might be involved in 
migration of cardiac precursor cells from the lateral plate mesoderm to the 
midline of the body where they form cardiac crescent and then the linear tube, 
reviewed in (Henderson and Chaudhry, 2011). Lp and circle-tail (Crc) mice  with 
mutations in Vangl2 and Scribble respectively show PCP type phenotype with 
abnormalities in polarization and organization of developing outflow tract and 
ventricular myocardium, with differences in the polarization of cardiomyocytes in 
the initial stages of development (Murdoch et al., 2003; Phillips et al., 2005; 
Phillips et al., 2007; Phillips et al., 2008). Mutation of Wnt11, which is a ligand 
for PCP pathway, in Wnt11-/- mice also have disorganized cardiomyocytes in the 
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developing ventricle along with misexpression of adhesion molecules N-cadherin 
and β-catenin (Nagy et al., 2010). Crc mutant embryos also have abnormal 
distribution of N-cadherin and β-catenin, which are components of AJ (Phillips et 
al., 2007). Vangl2 and Pk have also been implicated to have a role in cellular 
organization in the heart tube (Panáková et al., 2010). PCP mutants also exhibit 
outflow tract defects which suggest that PCP signalling could be regulating extra-
cardiac cells into the developing outflow which are responsible for the fully 
developed outflow tract. These cells include NCC and SHF. In frogs and 
zebrafish, ROCK and Rac are key effectors of the PCP pathway and are involved 
in NCC migration (De Calisto et al., 2005; Carmona-Fontaine et al., 2008b; 
Matthews et al., 2008), but in mice PCP signalling might not be controlling long 
range migration of NCC, as both Lp and Crc mutant mice have normal NCC 
migration in the OFT (Henderson et al., 2001; Phillips et al., 2007). SHF cells 
contribute to the myocardium of the outflow tract and right ventricle and 
abnormalities in them while adding cells in the developing outflow could lead to 
improper extension and looping leading to outflow remodelling defects. There is 
considerable evidence the PCP signalling pathway is important in outflow tract 
remodelling but which cell types it majorly regulates remains unclear. I aim to 
increase our understanding of this regulation in this thesis. In addition PCP 
signalling has been shown to play a crucial role in the SHF cells, but tissue 
specific dissection of PCP signalling in the cell types is required to confirm this. 
 
1.7 Vangl2 
Vangl2 is mouse homolog of the Drosophila core PCP gene, Strabismus 
(Stbm)/Van gogh (Vang) and is a core member of the PCP pathway (Taylor et al., 
1998; Wolff and Rubin, 1998; Katoh, 2002). Stbm is required to establish polarity 
in Drosophila and sequence analysis of both vertebrate and invertebrate 
homologs show that Stbm is highly conserved through species (Wolff and Rubin, 
1998). Vangl2 gene encodes for a transmembrane protein with 4 transmembrane 
domains, a N-terminal cytoplasmic serine motif (SxxSxxSxxSxxS) and a 
cytoplasmic C-terminal with PDZ-binding domain (Katoh, 2002) (figure 4). 
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Through interactions with this PDZ domain, Vangl2 recruits various proteins, like 
Scrib and Magi3 (Yao et al., 2004; Kallay et al., 2006). The second homolog of 
Stbm in vertebrates is Vangl1, which encodes a protein with 73.1% total amino 
acid homology with Vangl2 and also has a similar overall structure (Katoh, 2002). 
However studies to look at tissue and cell distribution of Vangl1 mRNA in 
zebrafish shows non-overlapping expression pattern with Vangl2 (Jessen and 
Solnica-Krezel, 2004). In mouse there is both co-expression and important 
differences in the expression patterns discussed later (Jessen and Solnica-Krezel, 
2004; Doudney et al., 2005). 
 
                                            Figure 1.14: Vangl2 protein  
 
Vangl2 along with other PCP proteins helps in regulation of coordinated 
polarization of the cells within the epithelial plane and is important during left-
right patterning (Adler, 2002; Mlodzik, 2002; Fanto and McNeill, 2004). It co-
localizes with Scrib to the basolateral plasma membrane of the polarized 
epithelial cells in mammals (Kallay et al., 2006). It activates non-canonical 
Wnt/PCP signalling pathway, and activates Rac-JNK and Rho-ROCK signalling 
(Yao et al., 2004; Ybot-Gonzalez et al., 2007; Phillips et al., 2008), which leads 
to cellular polarization and migration respectively. This cellular polarization and 
migration is crucial for correct patterning and morphogenesis during embryonic 
development e.g. during neural tube closure and organization of cardiomyocytes 
(Ybot-Gonzalez et al., 2007; Phillips et al., 2008). 
Vangl2 is present on mouse 1qH3/human 1q23.2 chromosome and Vangl1 on a 
duplicated block similar to the Vangl2 locus on mouse chromosome 
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3qF2.2/human 1p13.1 (Doudney et al., 2005). Vangl2 is highly expressed in the 
brain, testis, heart, retina, lungs, neural tube, cochlea, cerebral cortex, dorsal root 
ganglia, tubular tissues like intestine, bronchus, and kidney during embryonic 
development (Kibar et al., 2001; Phillips et al., 2005; Tissir and Goffinet, 2006; 
Phillips et al., 2007; Torban et al., 2007). Although Vangl2 and Vangl1 are 
closely related, their expression pattern is different. Vangl1 is expressed in neural 
tube like Vangl2; however Vangl1 is more restricted to the floor plate region of 
neural tube and notochord, and Vangl2 is expressed more broadly in the neural 
tube with overlapping Vangl1 in some floor plate cells, however with no 
expression in notochord making it exclusively express Vangl1 (Murdoch et al., 
2001a; Doudney et al., 2005; Torban et al., 2008). It has been suggested that 
Vangl1 is not expressed in cardiac regions, whereas Vangl2 is present in the 
cardiac region (Doudney et al., 2005), however another study has shown Vangl1 
expression in the heart (Torban et al., 2008). In Lp mice there was no major 
difference in Vangl1 expression pattern between control and mutant mice, for 
example asymmetric localisation of Vangl1 in the cochlea in embryos with 
Vangl2 mutation (Song et al., 2010), which could be the reason for the non-
redundancy between Vangl2 and Vangl1, as Vangl1 does not compensate for the 
loss of Vangl2 in Lp mutants (Torban et al., 2004; Doudney et al., 2005). 
However this is not straight forward and still to be confirmed as studies show 
genetic interaction between Vangl1 and Vangl2 and have suggested redundancy 
between them (Torban et al., 2008; Song et al., 2010). Vangl1 and Vangl2 
asymmetric expression is observed in hair cells of sensory epithelia of cochlea 
and in posterior-notochord cells (PNC) with cilia positioned randomly in their 
absence in PNC with turbulent nodal flow resulting in disruption of left-right 
asymmetry (Song et al., 2010). Their localisation patterns are also consistent in 
regulating CE (Jessen et al., 2002), indicating their genetic interaction and 
redundancy in PCP. A null allele of Vangl1 (Vangl1
gt
) generated using a gene-
trap embryonic stem-cell line showed that Vangl1
gt/gt 
homozygote appeared 
normal but had disorganisation in stereociliary bundles in cochlear hair cells 
(Torban et al., 2008). Double heterozygous Vangl2
Lp/+
;Vangl1
gt/+
 also had 
disrupted orientation of cochlear stereociliary bundles, CRN in more than 60% 
cases and remaining with just looped tail and cardiac defect aberrant right 
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subclavian arteries (Torban et al., 2008). Vangl2
Lp/+
;Vangl1
gt/+
 had multiple 
laterality defects, failed embryonic turning and heart looping (Song et al., 
2010).These defects have seen in Lp/Lp, indicating at the genetic interaction 
between Vangl1 and Vangl2, and Vangl1’s role in PCP. However there were no 
cardiac outflow abnormalities in Vangl1
gt/gt 
homozygote and 
Vangl2
Lp/+
;Vangl1
gt/+
 suggesting lesser sensitivity of myocardial cells to loss of 
Vangl1 and confirming that Vangl2 is solely responsible for causing double outlet 
right ventricle in Lp/Lp mutants. Also NTD are also absent in Vangl1
gt/gt
 but were 
present in Vangl2
Lp/+
;Vangl1
gt/+
, suggesting dominant role of Vangl2. Loss of 
Vangl1 on its own is masked by Vangl2 but loss of 50% or more Vangl2 along 
with loss of Vangl1 leads to developmental defects. Therefore Vangl2 is required 
in dosage dependent manner. However this is only in mice, as Vangl1 mutations 
have been found in human cases of NTD, even in heterozygous conditions 
(Torban et al., 2008).  
As mentioned before, Vangl2 is a core member of the PCP pathway and it has 
been shown that it is essential for normal neural tube closure, development of the 
female reproductive tract, lung and kidney branching and the organisation of 
sensory hair cells in the inner ear (Henderson et al., 2001). Vangl2 has also been 
implicated to have role in AJ formation, which are essential for cell ABP 
(Lindqvist et al., 2010). Previous studies in the Henderson laboratory suggest that 
Vangl2 is important for cardiac development, particularly the outflow region of 
the heart (Phillips et al., 2005). 
Preliminary data from the Henderson lab has shown  that Vangl2 is expressed in 
the pseudo-stratified epithelium of the SHF as these cells move into the outflow 
region, within the myocardium of the  outflow tract (which is derived from the 
SHF) (Phillips et al., 2005). Vangl2 expression is found in pharyngeal mesoderm, 
but which cell type is not known. Thus, it remains possible that Vangl2 is playing 
crucial roles within these tissues. To determine the role of Vangl2 a natural 
mutant of this gene, Lp mice has been looked into in great detail. 
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1.7.1 Natural mutant of Vangl2, loop-tail mice 
The loop-tail (Lp) mouse is a naturally occurring mutant with a single nucleotide 
mutation in Vangl2 (serine to asparagine substitution) producing a malfunctional 
protein product. In 2001 Kibar et al and Murdoch et al provided convincing 
evidence and identified Ltap/Lpp1, now called Vangl2, as the gene that is mutated 
in Lp mice. Mutation in Lp (G to A transition at position 1841) results in 
substitution of a highly conserved serine 464 to asparagine (S464N). The Lp 
mutations are found in the C-terminal tail of the protein, therefore it is possible 
that protein folding of this region in altered, leading to alteration in  protein–
protein interactions which are mediated by the PDZ domain at the C-terminal. 
Another possible explanation suggested is the serine to asparagine substitution 
may disrupt phosphorylation based intracellular signalling (Kapron C 2002). 
Mutation in Vangl2 leads to abnormalities in the embryo; with Lp/+ have 
abnormal head movement, brain ventricle and hippocampus morphology, 
urogenital defects along with delayed neural tube closure giving them the 
characteristic ‘looped’ tail (Torban et al., 2008). In homozygous condition, Lp/Lp 
embryos have more severe phenotype and embryos die in utero because of CRN 
(Strong and Hollander, 1949). Lp/Lp also have abnormal cochlea morphology, 
abnormal orientation of inner and outer hair cell stereociliary bundles, few cases 
of gastrochisis, and a spectrum of cardiac defects which exclusively affect the 
outflow region of the heart, including double outlet right ventricle, overriding 
aorta and ventricular septal defects (Henderson et al., 2001; Montcouquiol et al., 
2003). Aortic arch defects are also found in most Lp/Lp fetuses. Non-canonical 
Wnt signalling is necessary for the proper development of the outflow tract and 
interestingly, during remodelling of the proximal outflow tract, the pattern of 
Wnt-11 and Dvl2 expression is similar to Vangl2 in the myocardium of the 
outflow tract and in cardiomyocytes which extend into the proximal outlet septum 
in the process of myocardialization (Phillips et al., 2005). These migrating 
cardiomyocytes normally display characteristics of polarized cells, which are not 
seen in Lp/Lp mice. Therefore, it has been suggested that polarized cell 
movements are regulated by noncanonical Wnt signalling (Brade et al., 2006). 
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Therefore Vangl2 is essential for normal heart development; however as the 
defects observed in outflow tract development in the Lp mouse may arise from 
disruptions to multiple cell types, and despite a thorough description of the 
cardiac defects in the Lp/Lp mutant it is still to be established which cell types 
requires Vangl2 signalling during outflow tract development and the role that 
Vangl2 plays in these cells. While cells from the SHF make a significant 
contribution to the outflow tract, including the myocardium, endocardium and 
smooth muscle cells (Waldo et al., 2005b; Moretti et al., 2006), NCC are 
responsible for its septation and alignment (Kirby et al., 1983; Bradshaw et al., 
2009). Thus, the cardiac defects seen in Lp/Lp mice could result from disruption 
to either NCC or SHF cells as they are added to the heart. To unravel this, a more 
specific conditional knockout was required and Vangl2flox mice in which tissue 
specific deletion of the Vangl2 gene was produced in order to dissect the tissue-
specific requirement for Vangl2 signalling in the developing heart. 
 
 1.8 Aims of the project 
Mutation of the Vangl2 gene, a key component of the non-canonical Wnt/PCP 
signalling pathway, in the Lp mouse leads to a wide range of cardiac 
malformations. However, loss of Vangl2 from all the cell types within the 
developing heart means that the Lp mouse cannot be used to dissect the role of 
Vangl2 gene in the various cell type/s that form the heart. 
It was hypothesized that Vangl2 has a role in the establishment of PCP in the 
early stages of heart development and is crucial for cell organisation and 
movement in the developing outflow tract. Loss of Vangl2 will result is the 
mislocalizaton of other proteins within the cell and a range of clinically relevant 
cardiac malformations. 
To test these hypotheses, the main objectives of this project are: 
1. To perform conditional deletions of Vangl2 in specific tissue and cell types in 
an attempt to isolate the cardiac defects identified in the Lp mouse mutant. 
53 
 
 To establish whether the new Vangl2flox line that has been produced 
recapitulates the Lp phenotype. 
 To reveal the requirement for Vangl2 specifically in NCC and SHF, and to 
establish how loss of Vangl2 function in these cell types impacts on 
morphogenesis of the cardiac outflow tract. 
2. To elucidate the normal behaviours of SHF and/or NCC as they contribute to 
the outflow tract, and to establish how loss of Vangl2 affects the polarisation, 
directional movement and maturation of these cell types. 
 To localise Vangl2 at the sub-cellular level by attempting to co-localise it 
with other known proteins within the developing heart. 
 To deduce the exact role of Vangl2 in the early stages of cardiac 
development. 
3. To determine whether PCP pathway and upstream components (Wnt5a and 
Ror2) and downstream targets, Rac1 and ROCK acts in the same way as 
Vangl2 to regulate outflow tract development (in either NCC or SHF).  
 
Using Cre recombinase (Cre-lox) technology a floxed allele of Vangl2 
(Vangl2flox), Rac1 (Rac1flox) and dominant negative form of ROCK (ROCKDN) 
have been used to dissect the tissue-specific requirement for their respective 
signalling in the developing heart and achieve the objectives of the project. 
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Chapter 2 
Material and Methods 
 
2.1 Mouse  
All animals were maintained and killed according to the requirements of the 
Animals (Scientific Procedures) Act 1986 of the UK Government. 
 
 2.1.1 Mouse lines 
Different mouse lines were used for the experiments. The Loop-tail mouse colony 
was maintained by inbreeding heterozygous males with female wild type litter-
mates and mating were set up between heterozygous males and heterozygous 
female mice. Vangl2
floxneo
 mice were created in partnership with Ozgene 
(Australia). To generate Vangl2
flox 
mice, Vangl2
floxneo
 mice were crossed with 
FlpE (Henrich et al., 2000)
 
mice. To visualize specific cell lines and to follow 
their contribution to the heart development (lineage tracing), Cre recombinase 
technology was used with enhanced yellow fluorescent protein (eYFP) as a 
marker, resulting in embryos in which the eYFP gene was expressed in a tissue-
specific manner. Hence, Vangl2
flox 
mice were then inter-crossed with ROSA-Stop-
eYFP
 
mice (Srinivas et al., 2001). Table 2.1 summarises the list on mice lines 
used for the experiments. Cre driver lines (table 2.2) were all intercrossed with 
the mouse lines to for gene deletion and knockdown. 
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Table 2.1: Different mouse lines used in the study. 
Mouse lines 
Vangl2
floxneo
 
Neo knockin created by Ozgene 
(Australia) 
FlpE (Henrich et al., 2000) 
FlpE knockin by inserting an FLPe-
encoding cassette and as a deleter strain 
ROSA-Stop-eYFP (Srinivas et al., 
2001) 
EYFP knockin into the ROSA26 locus, 
preceded by a loxP-flanked stop sequence 
ROCKDN (Kobayashi et al., 
2004) 
Cytomegalovirus (CMV) gene promoter 
was fused to chloramphenicol 
acetyltransferase (CAT) gene cassette, 
both ends of which were flanked 
by loxP sites. A DNA fragment encoding 
a dominant-negative mutant for ROCK 
was inserted into this site. 
Rac1flox (Walmsley et al., 2003) 
Knockin with loxP site inserted between 
exons 3 and 4 
 
Table 2.2: Details of Cre lines used in the study. 
Cre-line Cre-containing cells 
PGK (Lallemand et al., 1998),  
Sox2 (Hayashi et al., 2002) 
PGKcre and Sox2cre transgene generated 
by cloning PGK-1 promoter and Sox2 
promotor upstream of cre gene for 
Somatic and Germ Cells 
Isl1 (Yang et al., 2006) 
Cre knockin into the 
endogenous Isl1 locus, replacing the 
endogenous Isl1 ATG for Second Heart 
Field cells 
Wnt1 (Danielian et al., 1998) 
Cre recombinase under the control of 
Wnt1 enhancer for Neural Crest Cells 
Mlc2v (Chen et al., 1998) 
Cre knockin into the endogenous Mlc2v 
locus at XhoI site for Myocardium 
Tie2 (Kisanuki et al., 2001) 
Cre recombinase under the control of 
Tie2 enhancer for Endothelium 
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Mice having eYFP sequence have a stop codon before it, this stop codon also has 
loxP sites on its either sides. When this stop codon is present it doesn’t let the 
fluorescent protein to express but Cre recognizes loxP sites and removes stop 
codon and fluorescent protein is expressed. It depends on which Cre is used, 
because on Cre expressing cells would have this expression. It is beneficial for 
lineage tracing of different cells types. 
 
 2.1.2 Timed mating 
Mating were set up by putting Vangl2
flox/+
;Cre+ male and Vangl2
flox/flox
;YFP 
female mice together overnight followed by separation after successful mating. 
Successful mating was determined by the presence of a copulation plug. Plugged 
females were then separated and the day was considered as embryonic day 0.5 
(E0.5). This allows for timing of mating so that gestational ages can be estimated. 
 
2.1.3 Dissection 
At the desired developmental stages (E9.5-E15.5), pregnant females were 
sacrificed by putting them in carbon dioxide gas chamber, followed by cervical 
dislocation. Embryos were dissected out and placed in Dulbecco’s Modified 
Eagle Medium (DMEM) (Gibco) or ice cold phosphate buffered saline (PBS). 
Embryos were washed in phosphate buffered saline (PBS) and were 
photographed using a stereo microscope attached to a digital camera (Leica 
Microscope with an attached camera). The left hind-limb of each embryo was 
removed for genotyping.  Embryos were then fixed in 4% Paraformaldehyde 
(PFA) (at 4ºC) overnight, or several nights depending on age at which they were 
dissected (Table 4).  
 
2.2 Genotyping  
In order to identify mutant embryos, DNA from embryos of all new litters was 
extracted and genotyped by polymerase chain reaction (PCR) to visualise and 
amplify target genomic regions. 
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2.2.1 DNA extraction 
 
A hind limb from each embryo and ear clip from the adult mice were taken and 
digested in 200μl Proteinase K Buffer (0.1M EDTA pH 8.0, 0.2M Tris-HCl pH 
8.5, 1% SDS, 1mg/ml Proteinase K).  The digest was incubated at 52-55°C for 3 
hours – overnight, until the tissue was digested for DNA extraction. After being 
cooled to room temperature, 100μl of 5M potassium acetate was added to the 
digested samples and the tubes were vigorously shaken to mix the contents, 
generating a thick white protein precipitate. The tubes were left for 15 minutes on 
ice and then were centrifuged (13,000 rpm, 10 mins, 4°C) to pellet the protein 
precipitate.  The resulting supernatant was transferred to a fresh tube and 1000μl 
of 100% ice cold ethanol was added.  The contents were mixed and placed at -
20°C overnight or -80°C for 20 minutes.  The tubes were centrifuged (13,000 rpm, 
10 mins, 4°C) to pellet the precipitated DNA and the supernatant carefully 
discarded as not to disturb the DNA.  The DNA pellet was washed in 200μl of 
70% ethanol and then centrifuged (13,000 rpm, 5mins, 4°C), the supernatant 
discarded and the DNA left to air-dry for 5 minutes before re-suspending the 
DNA in 50μl of ddH20 and stored at -20°C until required. 
 
 
2.2.2 PCR 
 
Subsequent to genomic DNA extraction, mouse and embryo genotypes were 
determined by PCR using conditions optimised for each primer set specific to 
different genes.  All amplification reactions were conducted using the 
PROMEGA Go-Taq polymerase kit and PTC-200 (Sensoquest labcycler).  
Specific primers which adhere to and amplify the particular regions of interest are 
described in Table 2.3. 
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Table 2.3: Genotyping PCR Primers  
Gene Primer Name Primer Sequence 
Vangl2 
Neo 
Common for CGATCCACAGATGGGGCCAG 
Common rev CCACTGACATCTTGCCCACG 
Neo rev CCACTCCCACTGTCCTTTCC 
Vangl2 
Flox  
 
WT_F CCGCTGGCTTTCCTGCTGCTG 
Common 
Reverse 
TCCTCGCCATCCCACCCTCG 
Null/Delete F TTGACCTCAGTGCAGCGCCC 
Cre 
Cre/F GCATTACCGGTCGATGCAACGAGTGATGAG 
Cre/R GAGTGAACGAACCTGGTCGAAATCAGTGCG 
Loop-
tail 
CrpF AGA ATC TGA CTT ACC CAT GGT 
CrpR GAG GGA GAA GAA TTA TGT CTG 
 
Wnt5a 
GWnt5a_wtF GAGGAGAAGCGCAGTCAATC 
GWnt5a_mutF GCCAGAGGCCACTTGTGTAG 
GWnt5a_com CATCTCAACAAGGGCCTCAT 
Ror2 
 
 
GR0r2_ext CTGATGTTCATCCACATACATGTGGTG 
GRor2_neo ATCGCCTTCTATCGCCTTCTTGACGAG 
GRor2_wild CCTACTATAGACTCTGATCCTTCTGCC 
 
Rac1 
Rac1 Primer1 ATTTTGTGCCAAGGACAGTGACAAGCT 
Rac1 Primer2 GAAGGAGAAGAAGCTGACTCCCATC 
Rac1 Primer3 CAGCCACAGGCAATGACAGATGTTC 
RockDN 
GRhoAF ACTCATCTCAGAAGAGGATCTG 
GRhoKR TTCATTCAGTTCTTTCTGATATTTG 
 
The DNA, primers, and other reagents necessary for DNA amplification (see 
below), were combined to a final volume of 20μl and subjected to rounds of 
heating and cooling to amplify a specific region of DNA (Table 2.4). 
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Table 2.4: Genotyping PCR conditions 
(ul) Vangl2 
Neo 
New  
Vangl2 
Flox 
Cre 
 
Lp Wnt5a Ror2 Rac1 ROCKDN 
Genomic 
DNA 
2 2 2 2 2 2 2 2 
Primer 
(10uM) 
1+1+1 
comF+R
+Neo 
1+1 (WT + 
ComR) OR 
1+1 (Null + 
ComR) 
2 +2 2+2 1+1+1 2+2+2 1+1+1 1+1 
10mM 
dNTP 
0.4 0.2 0.2 0.2 0.2 0.3 0.2 0.2 
5x Go Taq 
Buffer 
4 - 4 - 4 4  4 
5x Go Taq 
Flexi Buf 
- 4 - 4 - - 4 - 
MgCl2 (25 
mM) 
- 0.8 - 3.2 - - 2 - 
Taq 
(Promega) 
0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
ddH2O  10.4 10.9 9.7 6.5 10.7 7.6 8.7 11.7 
Total 
reaction 
20 20 20 20 20 20 20 20 
PCR 
condition 
95:3m 
95:30s 
62:30s 
72:30s 
72:5m 
4:∞ 
95 C  2 
min, 95 C  
30 sec, 67.5 
C  30 sec 
Decrease 
temperature 
by 0.5 C 
every cycle. 
72 C  30 
sec 
Goto step 2 
for 15 more 
cycles. 95 
C  30 sec, 
60 C  30 
sec, 72 C  
30 sec Goto 
step 6 for 
19 more 
cycles. 72 
C  10 min, 
4 C 
Forever. 
94:2m 
94:15s 
58:30s 
72:1m 
72:5m 
4: ∞ 
94:4m 
94:1m 
58:1m 
72:1m 
72:10m 
4:∞ 
94:3m 
94:30s 
60:1m 
72:1m 
72:10m 
4:∞ 
95:10m 
95:1m 
63:1m 
73:1m 
73:10m 
4:∞ 
94:4m 
94:30s 
62:30s 
72:30s 
72:10m 
4:∞ 
94:4m 
94:1m 
58:1m 
72:1m 
72:10m 
4:∞ 
Cycles 33  33 30 35 30 33 35 
Gel 2% 2% 2% 5% 2% 1% 2% 2% 
Size Flox420 
Neo350W
t280 
560bp wt 
701bp Flox 
203bp 
Delete 
~400bp 140bplp/l
p 
150bp+/+ 
400bp 
Mutant 
484bp 
WT 
1300bp + 
1000bp - 
Rac1 
flox 333bp 
Rac1+ 300bp 
Rac1 del 
175bp 
482bp 
Mut 
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2.2.3 Gel electrophoresis 
The PCR products were separated by gel electrophoresis. The percentage of 
agarose used is specified in Table 3. The agarose gel consisted of agarose (NBS 
Biologicals) in 100ml 1 X TAE (40mM Tris-acetate, 1mM EDTA (pH8.3)) buffer 
plus one drop ethidium bromide (2.5mg/ml). A 100bp ladder (PROMEGA) (5μl 
DNA ladder and 1μl loading dye) was loaded to use as a size marker and 10μl of 
PCR product for each sample was loaded.  The gel underwent electrophoresis for 
approximately 30 minutes at 100 volts.  Visualization of the gel then took place 
under the UV illuminator (UVP Geldoc IT) and a photograph taken for records 
using UVP software.  
 
2.3 Histology 
 
2.3.1 Processing 
After fixation, the embryos were washed in PBS to remove traces of PFA and 
then dehydrated by placing in 50% ethanol, on an orbital rotator, at room 
temperature, and then twice in 70% ethanol, on an orbital rotator, at room 
temperature - the length of time was dependent on developmental stage of the 
embryos (Table 4).  After these dehydration steps the embryos could be stored at 
room temperature in 70% ethanol until use. 
 
2.3.2 Embedding  
 
2.3.2.1 Wax embedding 
Before the transgenic embryos were embedded they were put through a series of 
dehydration steps, at room temperature, to allow full penetration of the wax.  For 
embedding, the embryos were dehydrated in 95% ethanol, two times in 100% 
ethanol and two times in Histoclear (VWR). These steps were carried out by 
placing the embryos in glass vials on an orbital rotator. Final steps consisted of 
treating the embryos with 50% Histoclear-paraffin wax (VWR)  and three or four 
times with wax alone; temperature of wax being 65ºC.  The time of incubating at 
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each step is dependent on the age of embryo (table 2.5). Finally embryos were 
embedded in paraffin wax in the desired orientation. 
 
Table 2.5: Embedding Protocol 
 
  E9.5 E10.5 E13.5 E14.5 E15.5 
4% PFA 1 night 1 night 2 nights 
2-3 
nights 
2-3 
nights 
 at 4ºC           
50% EtOH 30 mins 30 mins 2 hours 3 hours 3 hours 
           
70% EtOH x2 30 mins 30 mins 2 hours 3 hours 3 hours 
 30 mins 30 mins 2 hours 3 hours 3 hours 
Can store embryos in 70% EtOH at room temperature 
95% EtOH 30 mins 30 mins 2 hours 3 hours 3 hours 
           
100% EtOH x2 30 mins 30 mins 2 hours 3 hours 3 hours 
 30 mins 1 hour O/N O/N O/N 
Histoclear x2 10 mins 15 mins 20 mins 20 mins 30 mins 
 10 mins 15 mins 20 mins 20 mins 30 mins 
Histoclear / Wax 15 mins 20 mins 30 mins 1 hour 1 hour 
Heat 60-65ºC           
Wax x3 / 4 20 mins 30 mins 1 hour 1 hour 1 hour 
Heat 60-65ºC 20 mins 30 mins 1 hour 1 hour 1 hour 
  20 mins 30 mins 1 hour 1 hour 1 hour 
           1 hour 
       (O/N = Overnight) 
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2.3.2.2 Cryo-embedding 
Dissected embryos were washed in PBS and kept on ice. The embryos were then 
passed through 7.5% sucrose (in PBS), (until they sank) and then in 15% sucrose 
(in PBS), (until they sank), on ice. Sucrose prevents ice crystal formation in the 
embryo. Lastly embryos were embedded in OCT (Cell Path) in plastic moulds 
and frozen on dry ice. Once embedded, embryos were stored at -80
o
C until 
required. 
 
2.3.3 Sectioning  
2.3.3.1 Wax sectioning 
Wax embedded embryos were serially sectioned in the transverse plane at 8 
micrometers using a Leica RM2235 rotary microtome. The angle of the blade was 
set at 5
o
. The sections were transferred onto Histobond adhesive glass slides 
(Marienfield) and were allowed to dry overnight at 37ºC. 
 
2.3.3.2 Cryo-sectioning 
Cryo-embedded sections were cut on a Microm GmbH (Type HM 560MV) 
cryostat. The temperature of the specimen was set at -19
o
C and the temperature of 
the blade was set at -21°C, the angle of the blade was 11
o
 and the sections were 
taken at 10μm thickness. Sections were transferred on to Histobond adhesive 
glass slides and air dried. Slides were stored, wrapped in foil, at -80°C. 
 
2.3.4 Haematoxylin and Eosin staining 
Wax embedded tissue sections taken from transgenic embryos were analysed 
using haematoxylin and eosin (H&E) staining.  This type of staining results in 
nuclei appearing blue/black; cytoplasm, varying shades of pink; muscle fibres, 
pink/red; red blood cells, orange/red and fibrin, deep pink.   
The dried slides were stained using Haematoxylin (which stains the nuclei) and 
Eosin (which stains the cytoplasm) to observe the morphology of the heart. The 
slides were placed in histoclear (2x 10 minutes) to remove wax from the sections 
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and then dehydrated through a series of ethanol steps; of 100% (x2), 90%, 70% 
and 50% (% ethanol in ddH20) and ddH20, for 2 minutes each.  The slides were 
then placed in Harris haematoxylin solution (Raymond A. Lamb) for 10 minutes. 
They were then placed under running tap water until tissues turned a purple-blue 
colour and then dipped five times in acid alcohol (1% HCl in 70% ethanol), 
which removed some of the haematoxylin, until sections turned red. They were 
then placed under running tap water again until the sections turned back to 
purple-blue. After these washing steps they were placed in 1% aqueous eosin 
(Raymond A. Lamb) for 5 minutes, then rinsed quickly in tap water. The slides 
were then dehydrated through a series of ethanol steps of 50%, 70%, 90% and 
100% (x2) ethanol for 2 minutes each. Lastly, slides were placed in histoclear (2x 
10 minutes) before mounting them using histomount (National Diagnostics) and 
placing glass coverslips (VWR) on top.  
 
2.3.5 Elastin staining 
Slides were placed in histoclear (2 x 10 minutes) to remove wax from the sections 
and then dehydrated through a series of ethanol; of 100% (x2), 90%, 70% and 
50% (% ethanol in ddH20) and ddH20, for 2 minutes each.  After 5 minutes 
equilibration in PBS, slides were placed in Miller’s elastin stain (Raymond A. 
Lamb) for 1 hour. To remove excess of stain, slides were dipped in water and 
then kept in 3% ferric chloride for 10 minutes to aid binding of stain to elastin 
fibres. Slides were counterstained with eosin for 5 minutes. After gentle rinsing 
under ddH20 to remove excess eosin, slides were dehydrated in 100% ethanol and 
incubated in histoclear for two 10 minute cycles and mounted with histomount 
and dried overnight. 
 
2.3.6 Photographs 
After staining, slides were photographed using Ziess Axioplan microscope and 
associated software. 
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2.4 Slide Immunohistochemistry 
2.4.1 Immunohistochemistry DAB 
Slides were de-waxed with histoclear for 10 minutes (x2) and rehydrated through 
a series of ethanol washes (100% for 5 minutes two times, 90%, 70% and 50% 
ethanol for 2 minutes each) and equilibrate for 5 minutes in PBS. Antigen 
retrieval was done by putting the slides in citrate buffer in the microwave on high 
power for 10 minutes then allowed to cool at room temperature for 5 minutes, 
before transfer into cool ddH20 for 10 minutes at room temperature. Slides were 
placed in 0.6% H202 (VWR) for 5 minutes to block endogenous peroxidase 
activity and bleach the slide clearing the background. Following a rinse in ddH20, 
the sections were washed 3 times for 5 minutes in TBS-Tx (TBS containing 0.1% 
Triton X-100) (Amresco), and were blocked in TBS-Tx containing 10% FCS 
(fetal calf serum) for 30 minutes. The slides were laid out in a humid chamber 
and 100l of primary antibody added to each at the concentrations (table 2.5). 
Parafilm coverslips were placed over the slides to prevent evaporation and to 
ensure complete coverage. Slides were left overnight at 4C. Next day the slides 
were washed 3 times for 5 minutes in TBS-Tx to remove any unbound antibody. 
They were transferred back into the humid chamber and 100 l of the appropriate 
biotinylated secondary antibody (diluted in TBS-Tx containing 2% FCS) were 
added (Table 6). The slides, covered with parafilm coverslips, were left for 90 
minutes at room temperature, and were then washed three times in TBS-Tx for 5 
minutes each. Avidin-biotin complex conjugated to horseradish peroxidase (AB 
Complex: Vector labs) was made up according to the manufacturer’s instructions 
and added to the slides for 30 minutes at room temperature. The slides were 
rinsed 3 times in TBS-Tx for 5 minutes each, and were then placed on aluminium 
foil. Diaminobenzidine solution (DAB: Sigma), made according to the 
manufacturer’s instructions, was added for up to 20 minutes until brown staining 
was observed, then the slides were placed in PBS to stop the reaction. Slides were 
rinsed in ddH2O and counterstained in 0.5 % methyl green (Sigma) for 10 
minutes. Excess stain was removed in ddH2O, and the sections were dehydrated 
in three 100% butanol washes. After 2 times for 10 minutes treatments in 
histoclear, slides were mounted with histomount and glass coverslips and left 
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over night for drying. After staining, slides were photographed using Ziess 
Axioplan microscope and associated software. 
To ensure that no non-specific staining had occurred, slides as negative control 
were made, which were not incubated with primary antibody but secondary 
antibody was applied as normal and handled under the same conditions as other 
slides. 
2.4.2 Immunofluorescence  
2.4.2.1 Immunofluorescence on wax sections 
Slides were de-waxed with histoclear for 10 minutes (x2) and rehydrated through 
a series of ethanol washes (100% for 5 minutes two times, 90%, 70% and 50% 
ethanol for 2 minutes each) and equilibrate for 5 minutes in PBS. Antigen 
retrieval was done by putting the slides in citrate buffer in the microwave on high 
power for 10 minutes then allowed to cool at room temperature for 5 minutes, 
before transfer into cool ddH20 for 10 minutes at room temperature. Following a 
rinse in ddH20, the sections were given 2 times 5 minutes washes in PBS. The 
sections were placed in PBS/0.5% Triton-X100 for 10 min, which make cells 
permeable, allowing the antibody access to the proteins within the cell. Two 
washes were then carried out in PBS, each for 5 minutes. Sections were then 
placed for 30 min in PBS/10% FCS to block any non-specific sites and then 
primary antibody was added. The primary antibody was diluted in PBS/2% FCS 
(the dilutions are antibody specific, Table 5). Of this, 100ul was pipetted on to 
each slide and covered with a parafilm coverslip and the slides were placed in a 
humidified chamber (tray with lid and wet blue roll) and incubated overnight at 
4
o
C. On the second day, the parafilm coverslips were carefully removed and 
slides were washed twice in PBS for 5 minutes each to remove the extra primary 
antibody and then put in PBS/10% FCS for 10 min as a second block step. The 
secondary antibody was diluted in PBS/2% FCS (Table 6) and pipetted onto the 
slides and left for 1-2 hours covered in foil to ensure complete darkness. To 
remove excess secondary antibody, two PBS washes were given for 5mins each 
and then slides were mounted in Vectashield with DAPI (Vector), which stains 
the nuclei, and observed under the Axio imager fluorescent microscope when the 
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vectashield was set. The slides were stored at 4
o
C, in complete darkness to 
preserve the fluorescence. 
To ensure that no non-specific staining had occurred, slides as negative control 
were made, which were not incubated with primary antibody but secondary 
antibody was applied as normal and handled under the same conditions as other 
slides. 
2.4.2.2 Immunofluorescence on cryosections 
Sections were equilibrated at room temperature, and fixed in 4% PFA (Sigma) for 
10 minutes and then washed in PBS twice for 5minutes. For 10 minutes, the 
sections were placed in PBS/0.5% Triton-X100, which make cells permeable, 
allowing the antibody access to the proteins within the cell. Two washes were 
then carried out in PBS, each for 5 minutes. Sections were then blocked by 
placing in PBS/10% Fetal Calf Serum (FCS) for 30 minutes, after which the 
primary antibody was added. Primary antibody was diluted in PBS/2% FCS (the 
dilutions are antibody specific, table 2.6). Of this, 100ul was pipetted on to each 
slide and covered with a parafilm coverslip and the slides were placed in a 
humidified chamber (tray with lid and wet blue roll) and incubated overnight at 
4
o
C. On the second day, the parafilm coverslips were carefully removed and 
slides were washed twice in PBS for 5minutes each to remove the excess primary 
antibody and then put in PBS/10% FCS for 10 minutes as a second blocking step. 
The secondary antibody was diluted in PBS/2% FCS (Table 2.7) and pipetted 
onto the slides and left for 1-2 hours covered in foil to ensure complete darkness. 
To remove excess secondary antibody, two PBS washes were given for 5mins 
each and then slides were mounted in Vectashield with DAPI, which stains the 
nuclei and observed under the Axio imager fluorescent microscope when the 
vectashield was set. The slides were stored at 4
o
C, in complete darkness to 
preserve the fluorescence. 
To ensure that no non-specific staining had occurred, slides as negative control 
were made, which were not incubated with primary antibody but secondary 
antibody was applied as normal and handled under the same conditions as other 
slides. 
67 
 
    Table 2.6: Primary Antibodies for Immunohistochemistry 
Primary Antibody Dilution 
Vangl2 (in rabbit) 1/200 
Chicken polyclonal anti-GFP Ab  
Abcam (13970) 
1/100 
Isl1 (in mouse) 
(Hybridoma Cell Bank) 
1/5 
Purified Mouse anti-N-Cadherin IgG1 
BD Biosciences (Cat: 610920) 
1/50 
Purified Mouse anti-E-Cadherin IgG2a 
BD Biosciences (Cat: 610181) 
1/50 
Purified Mouse anti- β-Catenin IgG1 
BD Biosciences (Cat: 610154) 
1/50 
Rabbit Polyclonal anti-PKCζ (C-20) 
Santa Cruz Biotechnology (sc-216) 
1/200 
Rabbit anti-Laminin 
Sigma-Aldrich (L9393) 
1/25 
Mouse monoclonal anti- Firbonectin IgG1 (EP5) 
Santa Cruz Biotechnology (SC 8422) 
1/50 
Monoclonal anti-Vinculin, produced in mouse 
(Clone hVIN-1, ascites fluid) 
Sigma (V9131) 
1/100 
Monoclonal anti-γ-Tubulin, produced in mouse 
Sigma (T6557) 
1/200 
Purified monoclonal Mouse anti-GM130 
BD Biosciences (Cat: 610822) 
1/100 
Rabbit polyclonal anti-Dishevelled 2  
Enzo Lifesciences (BML DA4270) 
1.50 
Celsr1 1/400 
MF20 Undiluted (Hybridoma) 
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Primary Antibody Dilution 
Mouse monoclonal anti-actin, α Smooth Muscle 
Sigma-Aldrich (A5228) 
1/300 
Rat monoclonal anti-Endomucin IgG2a 
Santa Cruz (SC 65495) 
1/50 
 
    
         Table 2.7: Secondary Antibodies for Immunohistochemistry 
Secondary Antibody Dilution 
594 Donkey Anti-rabbit IgG (H+L) 
(ALEXA FLUOR) 
1 in 200 
488 Goat Anti-chicken IgG (H+L) 
(ALEXA FLUOR) 
1 in 200 
488 Donkey Anti-mouse IgG (H+L) 
(ALEXA FLUOR) 
1 in 200 
488 Goat Anti-mouse IgG1 (γ1) 
(ALEXA FLUOR) 
1 in 200 
488 Donkey Anti-rabbit IgG (H+L) 
(ALEXA FLUOR) 
1 in 200 
594 Donkey Anti-mouse IgG (H+L) 
(ALEXA FLUOR) 
1 in 200 
568 Goat Anti-rat IgG (H+L) 
(ALEXA FLUOR) 
1 in 200 
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2.5 Recombination efficiency of Cre line 
2.5.1 RNA extraction 
Frozen tissue samples (not fixed) from embryos were homogenized by passing 
through fine needles in 1ml TRIzol reagent (Life Tecnologies), which is used to 
break the cells. Homogenized sample was incubated at room temperature for 5 
minutes and then mixed with 200µl chloroform (Sigma), which dissolves the fat 
and layers out everything. Tube was vigorously shaken for 15 seconds and then 
incubated at room temperature for 2-3 minutes. Samples were then centrifuged at 
12,000rpm at 4°C for 15 minutes; separating the solution into lower red phenol-
chloroform organic phase, an interphase with white precipitated DNA, and a 
colourless upper aqueous phase. The aqueous phase was transferred to a new tube 
and precipitated with 500µl isopropanol (for cleaning and removing trizol and 
chloroform) and incubated for 10minutes at room temperature before centrifuging 
at 12000 rpm for 10 minutes at 4°C. The supernatant was discarded after 
centrifugation and the RNA pellet was washed with 75% DEPC-ethanol at 7500 
rpm for 5 minutes at 4°C. After brief air drying, the RNA pellet was dissolved in 
RNase-free DEPC-H2O and stored -80°C until use. Concentration of RNA was 
check using Nanodrop (ND 800 Labtech International). 
 
2.5.2 cDNA synthesis 
RNA synthesised was treated with DNAase before using it to make cDNA, to 
remove all traces of DNA. For 1µg RNA, 2µl buffer and 2µl DNAase buffer 
(Ambion) was used with ddH20 to make a solution mix of total 20µl. This mix 
was incubated at 37°C for 10 minutes. Then 2µl EDTA was added to the mix to 
remove Ca
2+
 ions which stops DNAase from working. The mix was incubated at 
65°C for 5 minutes. EDTA deactivates DNAase and 65°C denatures whatever 
traces of DNAase are left. RNA procured after this was DNA free and was used 
to synthesise cDNA. 
 
Applied Bioscience High Capacity cDNA Kit was used for cDNA synthesis. The 
RNA (DNAase treated), random primers, and other reagents necessary for cDNA 
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synthesis (see below), were combined to a final volume of 40μl and subjected to 
rounds of heating and cooling (table 2.8) 
 
 
 
 
 
                                   Table 2.8: cDNA synthesis conditions 
Amount in (ul) 
RNA 20 
Random 
Primer 
(10uM) 
4 
10mM dNTP 1.6 
Buffer 4 
Reverse 
Transcriptase 
2 
RNAase 
Inhibitor 
2 
DEPC H2O  6.4 
Total 
reaction 
40 
Condition 25:10m 
37:120
m 
85:5m 
4:∞ 
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2.5.3 RT-PCR 
The generated cDNA from 1µg of total RNA was used for RT-PCR (Reverse 
transcriptase PCR) for gene amplification. All amplification reactions were 
conducted using the PROMEGA Go-Taq polymerase kit and PTC-200 
(Sensoquest labcycler).  Specific primers which adhere to and amplify the 
particular regions of interest are described in table 2.9. 
 
   Table 2.9: RT-PCR primers 
Gene Primer Name Primer Sequence 
Vangl2 
Forward 
primer 
TGAGGGCCTCTTCATCTCC 
Reverse 
primer 
ACCAATAACTCCACGGG 
Beta Actin 
Actb-fw CCCGCGAGCACAGCTTCTTTG 
Actb-rev CGACCAGCGCAGCGATATCGT 
         
 
The cDNA, primers, and other reagents necessary for cDNA amplification (table 
2.9), were combined to a final volume of 20μl and subjected to rounds of heating 
and cooling to amplify a specific region of cDNA (Table 2.10). 
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                                        Table 2.10: RT-PCR conditions 
(ul) Vangl2 β-Actin 
cDNA 5 2 
Primer(10uM) 0.1 + 0.1 0.5 + 0.5 
10mM dNTP 0.2 0.5 
5x Go Taq 
Buffer 
4 4 
Taq (Promega) 0.1 0.2 
ddH2O 10.5 12.3 
Total reaction 20 20 
PCR condition 
94:2m 
94:1m 
58:1m 
72:1m 
72:10m 
4: ∞ 
94:2m 
94:30s 
58:40s 
72:40s 
72:10m 
4: ∞ 
Cycles 33 35 
Gel 2% 2% 
Size 535bp 90bp 
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2.6 Protein analysis 
2.6.1 Western blotting 
Frozen tissue samples (not fixed) from embryos were lysed with 500µl 1X 
laemmli buffer (2% SDS, 5% BME (Betamercaptoethanol), 10% Glycerol, 
0.05%w/v  Bromophenol blue, 0.0625M Tris HCL pH 6.8; made solution without 
BME and added BME just before use), by homogenizing passing through fine 
needles. Samples were heated at 95°C for 5 minutes to break open the protein 
tertiary structure and then centrifuged at full speed for 5 minutes. Finally samples 
were cooled at room temperature for 5 minutes and were ready to use. At this 
point samples can be stored at -20°C. 
Once the samples were ready, they were run on premade gel (Bio-Rad) at 90V for 
initial few minutes till the samples cross the stacking gel passing into resolving 
gel. Then the gel was run at 180V for 30-35 minutes in the running buffer 
(2.5mM Tris pH 8, 19mM Glycine, 0.01% SDS). While the samples are running 
on the gel, membrane preparation was done by treating membrane and four 
blotting papers with methanol for 30 seconds and then in distilled water for 5 
minutes. After that the membrane and four blotting papers along with 2 sponges 
were transferred to ice cold transfer buffer (48Mm Tris pH 8, 39mM Glycine, 
0.04% SDS, 20% Methanol) for 20 minutes. Once the gel was fully run and the 
dye front of the samples reached the bottom of the gel, the gel was taken out and 
it was sandwiched with the membrane (sponge/2 blotting paper/gel/membrane/2 
blotting paper/sponge) and run at 100V for 1 hour at 4°C with transfer buffer. The 
gel was positioned towards the negative side and membrane towards positive. 
After the bands (of protein ladder) have completely transferred on the membrane, 
the membrane was stained with Ponceau stain to check for presence of protein 
bands in the samples. The membrane was put in methanol for 30 seconds, then in 
Ponceau stain for 5 minutes and then in 5% Acetic acid (x2) to remove the 
background staining so that band become visible. Then the membrane was rinsed 
in TBST (TBS, 0.1% Tween 20; TBS – 2.423%w/v Trizma Hydrochloride, 
8.006%w/v Sodium Chloride at pH 7.6) a few times to remove Ponceau. The 
membrane was then blocked in 5%milk/TBST at room temperature for 1 hour on 
a shaker, after which primary antibody (Vangl2; table 2.10) was added and 
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incubated overnight on a roller at 4°C. The next day, membrane was washed in 
5%milk/TBST for 10 minutes (x4) to remove excess primary antibody and then 
incubated with secondary antibody (table 2.10) for 1 hour at room temperature. 
Membrane was then washed in 5%milk-TBST for 10 minutes (x4) and then in 
TBST for 10 minutes (x4) to remove excess antibody. During the washes, the 
developer was turned on 30 minutes before use and chemilluminescence substrate 
was prepared (1 ml A + 1 ml B). Membrane was then incubated with the substrate 
in the dark room for 5 minutes and developed using developing films. 
The same membrane was stripped and then reprobed to check if equal amount of 
protein was loaded for control and mutant. Membrane was washed in stripping 
buffer (1.5%w/v Glycine, 0.1%w/v SDS, 1% Tween 20, with pH set at 2.2) two 
times for 10 minutes each. Then two times in PBS for 10 minutes each and finally 
in TBST for 2 x 5 minutes washes. After these washes membrane was again 
blocked in 5%milk/TBST at room temperature for 1 hour on a shaker, and then 
primary antibody (alpha-actin, GAPDH; table 2.10) was added and incubated 
overnight on a roller at 4°C. The next day, membrane was washed in 
5%milk/TBST for 10 minutes (x4) to remove excess primary antibody and then 
incubated with secondary antibody (table 2.10) for 1 hour at room temperature. 
Membrane was then washed again in 5%milk-TBST for 10 minutes (x4) and then 
in TBST for 10 minutes (x4) to remove excess antibody. During the washes, the 
developer was turned on 30 minutes before use and chemilluminescence substrate 
was prepared (1 ml A + 1 ml B). Membrane was then incubated with the substrate 
in the dark room for 5 minutes and developed using developing films. 
 
Table 2.10: Antibodies for western blotting 
Primary Antibodies 
(in 5%milk/TBST) 
Secondary Antibodies 
(in 5%milk/TBST) 
Antibody Dilution Antibody Dilution 
Vangl2 1/2500 
Polyclonal swine anti-rabbit 
immunoglobulins/HRP 
1/2500 
GAPDH 1/25000 
Polyclonal swine anti-rabbit 
immunoglobulins/HRP 
1/10000 
Alpha-Actin 1/1000 
Polyclonal goat anti-mouse 
immunoglobulins/HRP 
1/3000 
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Chapter 3 
Characterization of Vangl2
flox
 mouse and establishing the tissue that requires 
Vangl2 for normal heart development 
 
3.1 Introduction 
To understand the role Vangl2 plays in embryonic development a lot of work has 
been done on loop-tail mice (Lp), which is a naturally occurring mutant and has 
Vangl2 mutated in all body cells (Strong and Hollander, 1949). Lp/Lp mice suffer 
from neural tube defects, along with cardiac defects (Henderson et al., 2001). 
However, because Vangl2 expression is disrupted in all body cells of Lp mice, it 
is not possible to tell unequivocally which cell types require Vangl2 and are 
crucial during heart development. Looking at the cardiac defects present in Lp 
mice, primarily the outflow tract is affected. The main cell types involved in 
development of the outflow tract are NCC (Hutson and Kirby, 2007) and cells 
derived from the SHF (Buckingham et al., 2005). Therefore, my main focus was 
to genetically dissect the role of Vangl2 specifically in NCC and SHF cells, for 
which a new Vangl2
flox 
line was used. 
The classical approach to study the function of a gene using mouse models is to 
analyse the effect of loss of function by deleting the expression of the gene in 
every cell or a particular cell type. This approach was applied to look at the role 
the PCP gene Vangl2 is playing during heart development. A gene can be targeted 
specifically using gene targeting technology in embryonic stem (ES) cells (Müller, 
1999; Prosser and Rastan, 2003). Using this approach, a DNA construct 
containing the gene of interest (or a portion of the gene) and a marker, such as a 
neomycin (neoR) cassette, is transfected into ES cells (Prosser and Rastan, 2003). 
The latter allows selection of cells successfully transfected with the targeted 
construct. However, the presence of the neoR resistance expression cassette can 
actually affect the level of expression and hence the function of the gene of 
interest and create a hypomorph (Meyers et al., 1998; Kist et al., 2007). Any 
mutation or change in the genetic makeup can lead to a change in gene expression. 
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Hermann J. Muller classified such mutations as amorph and hypomorph. He 
termed hypomorphic mutants as ‘lesser-normal’; therefore when gene function is 
reduced but not absent compared with the normal wild type level. In contrast, 
amorph is when the mutation results in complete loss of functional expression of 
the gene (Muller, 1932). For example, Fgf8neo and Pax9neo homozygotes have 
defects because of reduction in functional gene expression due to presence of the 
neo cassette (Meyers et al., 1998; Kist et al., 2007). It has also been reported that 
the neo cassette has cryptic splice sites which can be responsible for interfering 
with the gene expression (Jacks et al., 1994; Carmeliet et al., 1996). During 
normal gene expression, the mRNA is transcribed from the endogenous DNA 
sequence, and subsequently the functional protein is translated. Introns are 
removed through a process of splicing, allowing the correct exon to be joined 
together. However, the presence of cryptic splice sites within the neoR cassette 
can interfere with this process as it can cause aberrant splicing, hence altering the 
gene sequence and hence gene expression. 
To decipher the role of Vangl2 in specific cell types, a floxed line was produced 
which would remove exon 4 from the sequence of Vangl2 gene. Exon 4 encodes 
the trans-membrane domains of Vangl2 and removing this exon results in a frame 
shift and stop codon which result in the formation of a non-functional and 
truncated protein. The gene sequence was altered by a process of recombination, 
mediated by the site-specific DNA recombinase sequences, Cre and FLP. The 
targeted region of the gene was engineered to be flanked by loxP and FRT sites, 
and these sequences are identified by Cre or FLP, respectively (Meyers et al., 
1998). LoxP sites are inserted on either side of the gene of interest (or exons 
within a gene). The Cre enzyme recognizes these sequences and recombines the 
DNA between those two points, leaving one loxP site. Similarly, the neoR 
cassette can be removed by inserting FRT sites on either side and using FLP to 
identify those sites and allowing recombination between the two FRT sites, hence 
removing the neoR cassette.   
The first aim of this chapter was to establish whether the new Vangl2
flox
 line that 
had been produced recapitulated the Lp phenotype, which is a functional null 
mutant of Vangl2. Having established that the Vangl2
flox
 line behaved as expected, 
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we wanted to reveal the requirement for the Vangl2 specifically in SHF and NCC, 
and to establish how loss of Vangl2 function in these cell types impacts on 
morphogenesis of the cardiac outflow tract. 
 
3.2 Results  
3.2.1 Construction of Vangl2
floxneo
 mice  
Vangl2
floxneo
 mice were created by Ozgene (Australia) for the Henderson lab by 
inserting loxP sites on either side of exon 4 of the Vangl2 gene (containing the 
transmembrane domains, required for Vangl2 activity) and neoR cassette, by 
homologous recombination in ES cells (figure 3.1). NeoR cassette allows 
selection of cells successfully transfected with the targeted construct, and was 
flanked by FRT sites so it could be deleted.   
 
 
Figure 3.1: Vangl2
floxneo
 construct 
Exon 4 of Vangl2 gene (containing the transmembrane domains, required for 
Vangl2 activity) flanked by loxP sites on both side and neoR cassette downstream 
to it with FRT sites on either sites for recombination.  
 
 
3.2.1.1 Vangl2
floxneo
 is hypomorphic allele of Vangl2 
Previous studies have shown that the neoR cassette can be responsible for 
creating a hypomorph (Meyers et al., 1998; Kist et al., 2007), so it was checked if 
the presence of neo cassette in our construct was also giving a similar result, 
creating a hypomorph with reduced level of functional expression of Vangl2. 
To confirm this, crosses were set up between Vangl2
floxneo/+ 
parents (figure 3.2b) 
and 2 litters were collected at embryonic day (E) 14.5. Mendelian ratios of 
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expected genotypes were obtained from total 12 embryos (25% Vangl2
+/+
, 50% 
Vangl2
floxneo/+
, 25% Vangl2
floxneo/floxneo
) (figure 3.2c). To compare the Vangl2
floxneo
 
phenotype with Lp phenotype, crosses were also set up between Lp/+ parents and 
2 litters were dissected out at E14.5, which also showed Mendelian percentage of 
embryo genotypes from total 16 embryos (25% Lp+/+, 50% Lp/+, 25% Lp/Lp). 
Phenotypic analysis showed open neural tube, suggesting mutation and loss of 
Vangl2 function, however genotypes were confirmed using specific primers for 
both crosses. 
 
 
 
 
 
Figure 3.2: Vangl2
floxneo
 cross 
Cross between Vangl2
floxneo/+ 
parents with neoR present on one allele and other 
allele being wild type, giving Vangl2
floxneo/floxneo
. 
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The presence of the neoR cassette on both of the alleles; Vangl2
floxneo/floxneo
; 
homozygous embryos, resulted in the neural tube defect (NTD) craniorachischisis 
(figure 3.3f arrows showing open brain and spinal cord, and arrowhead showing 
looped tail because of delay in closure of posterior neuropore (Copp et al., 1994)) 
(2/12 embryos; table 3.1). This is identical to the NTD defects seen in Lp/Lp 
embryos (figure 3.3e, g) (4/16 embryos; table 3.1). One Lp/Lp embryo also 
showed gastroschisis, which is very unusual (figure 3.3g with arrow pointing at 
open body line resulting in protrusion of abdominal contents). Gastrochisis was 
not seen in Vangl2
floxneo/floxneo
 embryos. But presence of neoR cassette on both 
alleles not only gives craniorachischisis but a variable external phenotype was 
also observed; where in 1 embryo the neural tube was open only at the posterior 
trunk, known as spina bifida (figure 3.3h arrows showing closed brain and spinal 
cord, and arrowhead showing failure in closure of posterior trunk region). In 
heterozygous embryos, the presence of neoR cassette on one allele 
(Vangl2
floxneo/+
), had no effect as these embryos were phenotypically normal 
(figure 3.3d) (6/12 embryos; table 3.1). In Lp mice the heterozygous embryos and 
adult mice (Lp/+) had a looped tail (figure 3.3c) (8/16 embryos; table 3.1), 
however this phenotype was not seen in our Vangl2
floxneo/+
embryos (figure 3.3d 
arrowhead showing normal tail) or adult mice. As delayed closure of posterior 
neuropore in Lp/+ leads to looped tail (Copp et al., 1994), the results suggest that 
there is no delay in neural tube closure when neoR cassette is present on only one 
allele in Vangl2
floxneo/+
. Table 3.1 summarizes the external phenotypic defects 
observed in Lp/Lp and Vangl2
floxneo/floxneo 
embryos. 
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Table 3.1: External phenotypic defects seen in Lp/Lp and Vangl2
floxneo/floxneo 
mutants at E14.5 
Genotype 
Number 
of 
embryos 
Looped 
tail 
Craniorachischisis 
Spina 
bifida 
Gastroschisis 
Lp/+ 8/16 8 0 0 0 
Lp/Lp 4/16 4 4 0 1 
Vangl2
floxneo/+
 6/12 0 0 0 0 
Vangl2
floxneo/floxneo
 3/12 3 2 1 0 
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Figure 3.3: External phenotypic defects in Lp and Vangl2
floxneo
 hypomorphic 
embryos at E14.5  
Whole mount embryos from Lp/+ x Lp/+ cross and Vangl2
floxneo/+
x Vangl2
floxneo/+ 
litter. a, b) +/+ embryos for both the crosses with normal external phenotype. c, 
d) Lp/+ embryo showing a looped tail (arrowhead) and Vangl2
floxneo/+
embryo 
with normal external phenotype (c; arrowhead showing no loop in tail). e, f) 
Lp/Lp (e) and Vangl2
floxeo/floxneo 
(f) phenotype with craniorachischisis (arrows 
pointing at open neural tube and arrowhead showing looped tail). g, h) Lp/Lp 
embryo with gastrochisis (g; arrow pointing at protruding liver) and 
Vangl2
floxneo/floxneo 
embryo showing external phenotypic defect, spina bifida (h; 
arrows showing closed neural tube and arrowhead showing at opening at the 
posterior region). Scale – 2000µm. 
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3.2.1.2 Cardiac defects in Lp and Vangl2
floxneo
 embryos 
Lp and Vangl2
floxneo
 embryos were embedded in wax and transverse sections were 
taken (figure 4i shows the plane of section through the embryo) and hematoxylin 
and eosin (H&E) staining was carried out to look at the morphology of the heart. 
Heart sections of Lp/Lp embryos showed spectrum of cardiac defects (table in 
figure 3.4) which has been previously reported (Henderson et al., 2001). Lp/Lp 
embryos had double outlet right ventricle (figure 3.4c), aortic arch defect 
retroesophageal subclavian artery (figure 3.4e) and ventricular septal defect 
(figure 3.4g). Vangl2
floxneo/floxneo 
homozyogote embryos after analysis of the heart 
sections also showed the same cardiac defect as Lp/Lp (table in figure 3.4). They 
had double outlet right ventricle (figure 3.4d) with the aorta incorrectly connected 
to the right ventricle instead of left ventricle; retroesophageal subclavian artery 
(figure 3.4e), with subclavian artery forms a ring around the oesophagus which 
would result in its constriction; and ventricular septal defect (figure 3.4h), which 
would result in mixing of oxygenated and deoxygenated blood. The 
Vangl2
floxneo/floxneo 
embryo which did not show craniorachischisis and had only 
spina bifida present also had double outlet right ventricle (figure 3.4h), which 
suggests that cardiac defects are not secondary to craniorachischisis. Presence of 
a neoR cassette on only one allele (Vangl2
floxneo/+
) resulted in normal external 
phenotype and a normal heart (figure 3.4b) meaning that the Vangl2 gene is not 
haploinsufficient.  
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Figure 3.4: Cardiovascular defects in Lp and Vangl2
floxneo 
hypomorphic 
embryos at E14.5  
Transverse sections of heart from Lp/+ x Lp/+ and Vangl2
floxneo/+
 x Vangl2
floxneo/+
 
litter. a,b) Transverse section through heart of Lp/+ (a) and Vangl2
floxneo/+ 
(b) 
embryo showing normal heart development. c-h) Lp/Lp and Vangl2
floxneo/floxneo 
embryo with double outlet right ventricle (c,d; arrow pointing at aorta coming 
from right ventricle instead of left ventricle as seen in Lp/+ and 
Vangl2
floxneo/+
embryo), retroesophageal subclavian artery (e,f; arrow), and 
ventricular septal defect (g,h; circle). i) Plane of the section. Table shows 
different defects seen in Lp/Lp and Vangl2
floxneo/floxneo 
embryos. RA-right atria, 
LA-left atria, RV-right ventricle, LV-left ventricle, A-aorta, PT-pulmonary trunk, 
RRESA-retroesophageal subclavian artery, DORV-double outlet right ventricle, 
VSD-ventricular septal defect, E-esophagus, IVS-interventricular septum. Scale - 
20µm. 
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The similarities and differences between Lp and Vangl2
floxneo
 embryos are 
summarized in table 3.2, which is suggestive that Vangl2
floxneo
 is a hypomorph.  
 
Table 3.2: Comparison between Lp and Vangl2
floxneo
 phenotype. 
Similarities/Differences Lp Vangl2
floxneo
 
External 
Phenotype 
Tail 
Lp/+ have a 
looped/kinked tail 
Vangl2
floxneo/+ 
have a 
normal tail 
Neural 
Tube 
Lp/Lp have neural tube 
completely open (CRN) 
Vangl2
floxneo/floxneo 
have 
neural tube open but in 
variation, from 
completely open (CRN) 
to just in the posterior 
region (Spina bifida) 
Cardiac Defects 
Lp/Lp have 
cardiovascular defects 
(double outlet right 
ventricle, ventricular 
septal defect, aortic 
arch defects) 
Vangl2
floxneo/floxneo 
have 
cardiovascular defects 
(double outlet right 
ventricle, ventricular 
septal defect, aortic arch 
defects) 
 
 
3.2.2 Construction of Vangl2
flox
 line (removal of neoR cassette) 
After establishing that Vangl2
floxneo
 is likely to be a hypomorphic allele of Vangl2, 
it was essential to remove neoR cassette from the construct and generate 
Vangl2
flox
 line for further experiments to eliminate any effect presence of neoR 
could cause. NeoR construct was flanked by FRT sites and was removed by 
causing recombination at the FRT sites by crossing  Vangl2
floxneo
 mice with FLPe 
mice (Henrich et al., 2000) to give rise to Vangl2
flox
 mice (figure 3.5). 
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Figure 3.5: Vangl2
flox
 line 
Cross between FLPe mice and Vangl2
floxneo
 to remove neoR cassette from the 
construct by recombination at FRT sites, giving the new Vangl2
flox
 line. 
 
 
The Vangl2
flox
 mice produced were then inter-crossed with mice carrying a floxed 
enhanced yellow fluorescent protein sequence (ROSA-Stop-eYFP) (Srinivas et al., 
2001)  so that when different Cre lines are crossed with the Vangl2flox line, the 
Cre, as well as removing exon 4 of Vangl2 would also result in the expression of 
this enhanced yellow fluorescent protein (eYFP). Once Vangl2
flox
 line had eYFP 
sequence in it, it was crossed with different Cre lines to drive Cre expression in 
different cell types to produce a Vangl2
flox/+
;Cre males, which would have 
Vangl2 expression on one allele. These Vangl2
flox/+
;Cre males were crossed with 
Vangl2
flox/flox 
females for the further experiments (Figure 3.6). Recombination due 
to the activity of the enzyme Cre deletes exon 4, creates a frame shift and a stop 
codon that truncates the protein at amino acid 78. 
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Figure 3.6: Crosses to delete Vangl2 from different tissues 
All Vangl2
flox
 mice used for the study were incorporated with eYFP sequence, by 
inter-crossing with mice carrying a floxed enhanced yellow fluorescent protein 
sequence (ROSA-Stop-eYFP) a) Cross between Vangl2
flox/flox
 and a Cre line 
(which can be any tissue specific Cre or universally expressing Cre) to get 
Vangl2
flox/+
;Cre mice. b) Cross between Vangl2
flox/flox
 and Vangl2
flox/+
;Cre mice 
to produce mice which had Vangl2 deletion on both alleles and eYFP protein 
expression by Cre drived recombination. 
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3.2.3 Vangl2
flox
 line recapitulates Lp phenotype (using PGK-Cre and Sox2-
Cre) 
The next question was whether a global knockout of Vangl2 using the Vangl2
flox
 
allele recapitulated the Lp/Lp phenotype. To test this a globally expressing Cre, 
PGK-Cre was used (Lallemand et al., 1998). PGK-Cre was crossed into our 
Vangl2
flox
 line, which would remove Vangl2 in all cells that are expressing Cre, 
that is all cells in this case.  
Vangl2
flox/+
;PGK-Cre mice were crossed with Vangl2
flox/flox 
mice (shown in figure 
3.7) and embryos were collected at E14.5. These embryos were then compared 
with Lp embryos for their external as well as internal phenotype. Embryos were 
genotyped using Vangl2
flox
 primers and Cre primers. Of these embryos, 
Vangl2
flox/flox
;PGK-Cre were expected to recapitulate Lp/Lp phenotype. 
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Figure 3.7: Vangl2
flox
 cross with PGK-Cre 
Vangl2
flox/+
;PGK-Cre x Vangl2
flox/flox 
cross to have full deletion of exon 4 of 
Vangl2 gene. Exon 4 has loxP sites on either sides (shown in red), which gets 
removed with the expression of Cre. Resulting genotype would be devoid of exon 
4 and have eYFP expression in all the cells which express Cre (in this case all 
body cells, as PGK-Cre is a universally expressing Cre). 
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A total of 6 mutants (Vangl2
flox/flox
;PGK-Cre) from 3 litters (total 24 embryos) 
were used for the phenotype analysis. These 6 mutant embryos had the same 
neural tube defect as Lp/Lp mice; where the complete neural tube was open 
(craniorachischisis), although the neural tube was closed rostral to the mid-
brain:hindbrain boundary, just like in Lp (Copp et al., 1994). Vangl2
flox/flox
;PGK-
Cre also had looped tail as seen in Lp/Lp embryos, although Vangl2
flox/+
;PGK-
Cre embryos didn’t have looped tail. Figure 3.8 shows a control embryo with a 
normal phenotype, with closed neural tube (figure 3.8a) compared to 
Vangl2
flox/flox
;PGK-Cre embryos with craniorachischisis (arrows in figure 3.8b,c,d) 
and looped tail (arrow head in figure 3.8b,c,d), as seen in Lp/Lp (figure 3.3e). 
This phenotype had 100% penetrance and was observed in all mutant embryos 
with equal amount of severity. Table 3.3 summarizes the external phenotypic 
defects observed in Lp/Lp and Vangl2
flox/flox
;PGK-Cre embryos. 
 
Table 3.3: External phenotypic defects seen in Lp/Lp and Vangl2
flox/flox
;PGK-
Cre mutants at E14.5 
Genotype 
Number 
of 
embryos 
Looped 
tail 
Craniorachischisis 
Spina 
bifida 
Gastroschisis 
Lp/+ 8/16 8 0 0 0 
Lp/Lp 4/16 4 4 0 1 
Vangl2
flox/+
; 
PGK-Cre 
6/24 0 0 0 0 
Vangl2
flox/flox
; 
PGK-Cre 
6/24 6 6 0 0 
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Figure 3.8: Neural Tube defects in Vangl2
flox/flox
;PGK-Cre embryos at E14.5  
Whole embryos from Vangl2
flox/+
;PGK-Cre x Vangl2
flox/flox
 litter. a) 
Vangl2
flox/+
;PGK-Cre embryo with normal external phenotype. b, c, d) 
Vangl2
flox/flox
;PGK-Cre embryo showing external phenotypic defect, 
craniorachischisis (arrows showing open neural tube and arrowhead pointing at 
looped tail). Scale - 2000µm. 
 
 
 
Once the external phenotype was established, the Vangl2
flox/+
;PGK-Cre and 
Vangl2
flox/flox
;PGK-Cre embryos were fixed and wax embedded. Transverse 
sections were taken (figure 10a showing the plane of section) and H&E stained to 
look at heart morphology. When only one allele was floxed (Vangl2
flox/+
;PGK-
Cre) there was normal heart development (Figure 10b), as in Lp/+ embryos. On 
the other hand, when both alleles were floxed (Vangl2
flox/flox
;PGK-Cre) and had 
Vangl2 truncated in all body cells, heart defects were observed. These included 
double outlet right ventricle (figure 3.9c arrow), ventricular septal defect (figure 
3.9e circle) and aortic arch defect retroesophageal subclavian artery (figure 3.9g 
arrow).   
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Figure 3.9: Cardiovascular defects in Vangl2
flox/flox
;PGK-Cre embryos at 
E14.5  
Transverse sections of heart from Vangl2
flox/+
;PGK-Cre x Vangl2
flox/flox
 litter. The 
table shows different defects seen in Vangl2
flox/flox
;PGK-Cre embryos. a) Plane of 
the section. b) Transverse section through heart of Vangl2
flox/+
;PGK-Cre embryo 
showing normal heart development. c) Heart section from Vangl2
flox/flox
;PGK-Cre 
embryos showing double outlet right ventricle. d) Section of Vangl2
flox/+
;PGK-
Cre embryo showing interventricular septum. e) Section of Vangl2
flox/flox
;PGK-
Cre embryo showing ventricular septal defect. f,g) Normal left sided aortic arch 
in Vangl2
flox/+
;PGK-Cre embryo and retroesophageal subclavian artery in 
Vangl2
flox/flox
;PGK-Cre (g). RA-right atria, LA-left atria, RV-right ventricle, LV-
left ventricle, A-aorta, PT-pulmonary trunk, DORV-double outlet right ventricle, 
VSD-ventricular septal defect, IVS-interventricular septum, RRESA- 
retroesophageal subclavian artery. Scale - 20µm. 
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Table 3.4 is used as a summary to look at the phenotype of Vangl2
flox/flox
;PGK-
Cre and compare it with Lp/Lp and Vangl2
floxneo/floxneo
 phenotype. The table shows 
that there was 100% penetrance of heart defects along with external phenotypic 
defect suggesting that PGK-Cre gives a complete knockout of Vangl2 and 
resembles the defective phenotype seen in Lp mice (Henderson et al., 2001). 
 
 
Table 3.4: Comparison between Lp, Vangl2
floxneo
 and Vangl2
flox
;PGK-Cre 
phenotype. 
Phenotypes Lp/Lp Vangl2
neo/neo
 
Vangl2
flox/flox
; 
PGK-Cre 
External 
Phenotype 
Tail 
Lp/+ -  
looped/ 
kinked tail 
Lp/Lp -  
looped/ 
kinked tail 
Vangl2
floxneo/+ 
-  
normal tail 
Vangl2
floxneo/floxneo 
-  looped/ kinked 
tail 
Vangl2
flox/+
;PGK-
Cre -  normal tail 
Vangl2
flox/flox
;PGK-
Cre -  looped/ 
kinked tail 
Neural 
Tube 
Lp/Lp - open 
neural tube 
(CRN) 
Vangl2
floxneo/floxneo
 
- open neural 
tube, but in 
variation(CRN to 
Spina bifida) 
Vangl2
flox/flox
;PGK-
Cre - open neural 
tube (CRN) 
Cardiac Defects 
Lp/Lp - 
cardiovascula
r defects 
(double outlet 
right 
ventricle, 
ventricular 
septal defect, 
aortic arch 
defects) 
Vangl2
floxneo/floxneo
 
- cardiovascular 
defects (double 
outlet right 
ventricle, 
ventricular septal 
defect, aortic arch 
defects) 
Vangl2
flox/flox
;PGK-
Cre - 
cardiovascular 
defects (double 
outlet right 
ventricle, 
ventricular septal 
defect, aortic arch 
defects) 
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3.2.3.1 PGK-Cre is not expressed in all body cells 
Looking at the phenotype, we got full recapitulation of Lp phenotype in our 
Vangl2
flox
 line using PGK-Cre. To confirm that there was full loss of Vangl2 in 
our Vangl2
flox/flox
;PGK-Cre mutant embryos, western blotting was carried out 
using protein samples from whole embryos at E14.5. PGK-Cre is a globally 
expressing Cre and is used to produce global knockouts (ref), which would be 
expected to delete Vangl2 from all cells. However there was a Vangl2 band in the 
Vangl2
flox/flox
;PGK-Cre sample, as in Vangl2
flox/+
;PGK-Cre control (figure 3.10a). 
This was checked with 3 different control and mutant samples. To confirm that 
equivalent levels of proteins were loaded, the same membrane was reprobed for 
β-actin and similar levels of protein was observed in control and mutant (figure 
3.10a). Thus, although the levels of Vangl2 appeared slightly reduced, it was still 
present. To understand and explain this, the expression of PGK-Cre in sections 
was looked at using anti-GFP antibody. Heart sections from 3 controls and 3 
mutants were taken at E9.5 and using immunohistochemistry techniques, were 
immunostained for anti-GFP antibody, which recognizes the eYFP protein in the 
sections. Ideally a universally expressing Cre like PGK-Cre should have eYFP 
labelled on all cells, but there were regions where staining wasn’t present in both 
Vangl2
flox/+
;PGK-Cre control and Vangl2
flox/flox
;PGK-Cre mutant embryo sections 
(figure 3.10b,c asterisk), suggesting that eYFP isn’t expressed in these cells. 
These results suggest that PGK-Cre isn’t driving expression in all body cells. 
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Figure 3.10: Vangl2 expression not completely lost in the presence of PGK-
Cre 
a) Western blot showing a faint Vangl2 band in Vangl2
flox/flox
;PGK-Cre mutant 
embryo at E14.5, with similar levels of β-actin protein. b,c) Immunostaining 
using GFP-DAB on E9.5 embryos, brown cells showing cells expressing eYFP. 
Vangl2
flox/+
;PGK-Cre embryo (b) showing regions which are not expressing 
eYFP (blue, asterisk), similar expression in Vangl2
flox/flox
;PGK-Cre embryo (c) 
with blue region (asterisk). Scale - 100µm. 
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3.2.3.2 Sox2-Cre as the new universal Cre line 
Sox2-Cre is another universally expressing Cre with efficient recombination and 
effective removing of a gene (Hayashi et al., 2002). Therefore Sox2-Cre mice 
were intercrossed with Vangl2
flox
 line (cross shown in figure 3.11). Embryos were 
collected at E15.5 for western blotting and at E9.5 for immunohistochemistry. 
Vangl2
flox/flox
;Sox2-Cre were taken as mutants and Vangl2
flox/+
;Sox2-Cre as 
controls and were detected by PCR. 
96 
 
 
Figure 3.11: Vangl2
flox
 cross with Sox2-Cre 
Vangl2
flox/+
;Sox2-Cre x Vangl2
flox/flox
 cross to have full deletion of exon 4 of 
Vangl2 gene. Resulting genotype would be devoid of exon 4 and have eYFP 
expression in all the cells which express Cre (in this case all body cells, as Sox2-
Cre is a universally expressing Cre). 
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Similar experiment using anti-GFP antibody was done on 3 Vangl2
flox/+
;Sox2-Cre 
and 3 Vangl2
flox/flox
;Sox2-Cre embryos as was done on embryos with PGK-Cre 
present. More widespread expression of eYFP was observed, with labelling 
detected the brown colour of DAB (figure 3.12a). It should be noted that in the 
regions where eYFP expression was not observed with in Vangl2
flo+
;PGK-Cre 
embryos (figure 3.10b,c) also had uniform staining (shown with arrows in figure 
3.12a). RT PCR of cDNA and western blot of the protein sample from 3 different 
control and mutant embryos were done to check for presence of Vangl2 transcript 
and protein respectively. RT-PCR showed complete loss of Vangl2 at the RNA 
level, as no Vangl2 band was observed in Vangl2
flox/flox
;Sox2-Cre as compared to 
a clear band in Vangl2
flox/+
;Sox2-Cre lane (figure 3.12b). β-actin was used to 
check the levels of cDNA for RT PCR, which showed same levels in both control 
and mutant. There was significant loss of Vangl2 at the protein level as well 
detected by western blot (figure 3.12c). Membrane was reprobed to check the 
levels of protein added, by checking GAPDH protein, which did not show 
equivalent level of protein in control and mutant (figure 3.12c), however using 
densitometry analysis the levels were equalised and still showed significant 
reduction of Vangl2 in Vangl2
flox/flox
;Sox2-Cre. This confirms that expression of 
Vangl2 was reduced and recombination directed by Sox2-Cre was more efficient 
as compared to PGK-Cre.  
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Figure 3.12: Vangl2 expression lost in the presence of Sox2-Cre 
a) Immunostaining using GFP-DAB, brown cells showing cells expressing Cre. 
Vangl2
flox/+
;Sox2-Cre embryo and in Vangl2
flox/flox
;Sox2-Cre embryo (arrows 
pointing at region where Cre expression was not observed in Vangl2
flox
;PGK-Cre 
embryos) at E9.5. b) RT PCR showing complete loss of Vangl2 band in 
Vangl2
flox/flox
;Sox2-Cre embryo at RNA level at E15.5. c) Western blot showing 
significant reduction in Vangl2 protein level in Vangl2
flox/flox
;Sox2-Cre embryo at 
E15.5. Scale - 100µm. 
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To check the loss of Vangl2 from the embryo co-expression of Vangl2 with anti-
GFP antibody was checked using immunofluorescence. Anti-GFP antibody which 
detects eYFP protein in Cre expressing cells was used along with Vangl2 
antibody. Secondary antibodies having fluorescence probes were used. Figure 
3.13a,b shows the position of outflow tract in Vangl2
flox/+
;Sox2-Cre and 
Vangl2
flox/flox
;Sox2-Cre sections. Vangl2
flox/+
;Sox2-Cre embryos showed eYFP 
expression (in green, figure 3.13c) throughout the embryo in uniform manner 
along with Vangl2 expression (in red, figure 3.13e). This was in contrast with 
Vangl2
flox/flox
;Sox2-Cre section, where eYFP expression (in green, figure 3.13d) 
was similar to controls, but no staining was observed for Vangl2 (figure 3.13f) at 
the same exposure as for the control section. This was repeated on 3 different 
controls and mutants with similar expression pattern and therefore adds on to our 
confirmation that Vangl2 was deleted by Sox2-Cre mediated recombination. 
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Figure 3.13: Vangl2 expression completely lost in the presence of Sox2-Cre 
Different panels for Immunofluorescence for co-expression of Cre (GFP antibody) 
and Vangl2 in Vangl2
flox/+
;Sox2-Cre and Vangl2
flox/flox
;Sox2-Cre embryo. a,b) 
DAPI marking nucleus of cells showing outflow tract in Vangl2
flox/+
;Sox2-Cre (a) 
and Vangl2
flox/flox
;Sox2-Cre (b) section. c,d) Anti-GFP antibody labeling eYFP in 
Vangl2
flox/+
;Sox2-Cre (c) and Vangl2
flox/flox
;Sox2-Cre (d) showing similar 
expression throughout the section. e,f) Vangl2 expression in Vangl2
flox/+
;Sox2-
Cre (e) and Vangl2
flox/flox
;Sox2-Cre (f) where no Vangl2 expression is seen. g,h) 
Coexpression of eYFP and Vangl2 in Vangl2
flox/+
;Sox2-Cre (g) with yellow 
regions (arrows, neural tube and outflow tract) where both are expressed and 
Vangl2
flox/flox
;Sox2-Cre(h) where no coexpression is seen (arrows). Scale - 200µm. 
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3.2.3.3 Vangl2
flox
;Sox2-Cre recapitulates Lp and Vangl2
flox
;PGK-Cre 
phenotype  
After establishing that recombination using Sox2-Cre is more efficient and 
effective, the embryonic phenotype of Vangl2
flox/flox
;Sox2-Cre embryos was 
analysed at E15.5 and compared with phenotype of Vangl2
flox/flox
;PGK-Cre 
mutants to check if it was  same or more severe phenotype. Also recapitulation of 
Lp phenotype was checked. 
Embryos were dissected at E15.5 and were genotyped. Six mutant embryos 
(Vangl2
flox/flox
;Sox2-Cre) were obtained and showed open neural tube 
(craniorachischisis) as seen in Vangl2
flox/flox
;PGK-Cre and Lp/Lp embryos, while 
Vangl2
flox/+
;Sox2-Cre had a normal external phenotype. Figure 3.14 shows 
Vangl2
flox/+
;Sox2-Cre embryo with closed neural tube and no looped-tail and 
Vangl2
flox/flox
;Sox2-Cre embryos with craniorachischisis (arrows) and looped-tail 
(arrowhead).  Table 3.5 summarizes the external phenotypic defects observed in 
Lp/Lp and Vangl2
flox/flox
;Sox2-Cre embryos. 
 
Table 3.5: External phenotypic defects seen in Lp/Lp and Vangl2
flox/flox
;Sox2-
Cre mutants at E15.5 
Genotype 
Number 
of 
embryos 
Looped 
tail 
Craniorachischisis 
Spina 
bifida 
Gastroschisis 
Lp/+ 8/16 8 0 0 0 
Lp/Lp 4/16 4 4 0 1 
Vangl2
flox/+
; 
Sox2-Cre 
6/24 0 0 0 0 
Vangl2
flox/flox
; 
Sox2-Cre 
6/24 6 6 0 0 
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Figure 3.14: Neural Tube defects in Vangl2
flox/flox
;Sox2-Cre embryos at E15.5  
Whole embryos from Vangl2
flox/+
;Sox2-Cre x Vangl2
flox/flox
 litter. a) 
Vangl2
flox/+
;Sox2-Cre embryo with normal external phenotype. b, c) 
Vangl2
flox/flox
;Sox2-Cre embryo showing external phenotypic defect, 
craniorachischisis (arrows showing open neural tube and arrowhead pointing at 
looped tail). Scale - 2000µm. 
 
 
 
Transverse heart sections of wax embedded embryos were taken (figure 3.15a, f) 
and stained with H&E to analyse the heart morphology. Vangl2
flox/+
;Sox2-Cre had 
a normal heart phenotype (figure 3.15b), whereas all 6 Vangl2
flox/flox
;Sox2-Cre 
mutant embryos showed double outlet right ventricle (figure3.15c, d) and 
ventricular septal defect (figure3.15e). Of these 2 mutants also had 
retroesophageal subclavian artery (figure 3.15g) which are the same defects as 
seen in Vangl2
flox/flox
;PGK-Cre and Lp/Lp embryos. 
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Figure 3.15: Cardiovascular defects in Vangl2
flox/flox
;Sox2-Cre embryos at 
E15.5  
Transverse sections of heart from Vangl2
flox/+
;Sox2-Cre x Vangl2
flox/flox
 litter. 
Table shows different defects seen in Vangl2
flox/flox
;Sox2-Cre embryos. a) Plane of 
the section. b) Transverse section through heart of Vangl2
flox/+
;Sox2-Cre embryo 
showing normal heart development. c) Heart section from Vangl2
flox/flox
;Sox2-Cre 
embryos showing double outlet right ventricle. d) Heart section of 
Vangl2
flox/+
;Sox2-Cre embryo showing interventricular septum. e) Heart section 
from Vangl2
flox/flox
;Sox2-Cre embryos showing ventricular septal defect. f) Heart 
section of Vangl2
flox/+
;Sox2-Cre embryo showing normal left sided aortic arch. g) 
Heart section from Vangl2
flox/flox
;Sox2-Cre embryos showing retroesophageal 
subclavian artery. RA-right atria, LA-left atria, RV-right ventricle, LV-left 
ventricle, A-aorta, PT-pulmonary trunk, DORV-double outlet right ventricle, 
VSD-ventricular septal defect, IVS-interventricular septum, RRESA- 
retroesophageal subclavian artery. Scale - 20µm. 
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3.2.4 Vangl2
flox
 allele fails to complement Lp allele 
When two different genes in their recessive form give the same phenotype, but 
when crossed together to be present in the same genome give a wild-type 
phenotype, the effect is called ‘complementation’. For complementation to occur, 
the mutations have to be in different genes. The wild type allele of each gene will 
compensate for the loss of the other gene and resulting in the wild-type phenotype. 
If the mutation is in same gene, complementation will not occur; therefore if 
mutant phenotype is observed in the crossed strains it means that they are allelic 
in nature. Reduced protein stability and expression in Lp/Lp has been reported 
suggesting Lp as a null allele (Montcouquiol et al., 2006; Torban et al., 2007). 
However, another study showed dominant negative effect of Lp mutation by 
comparing severity of Vangl2 knockouts with Vangl2 knockout mouse 
intercrossed with Lp mutants (Yin et al., 2012). 
To establish if Lp is a null allele and Vangl2
flox
 and Lp are allelic in nature, 
crosses were set up between Lp/+ and Vangl2
flox/+
;PGK-Cre (and 
Vangl2
flox/+
;Sox2-Cre)(cross shown in figure 19). Possible genotypes of the 
offsprings are shown in the figure, and if presence of Lp and Vangl2
flox
;Cre 
(PGK-Cre/Sox2-Cre) in one embryo produces a wild-type phenotype it would 
mean that these two complement each other and are not allelic but give the same 
phenotype in recessive condition. However, if presence of Lp and Vangl2
flox
;Cre 
produces a mutant phenotype which is same as phenotype they produce in the 
individual recessive forms it would mean that these two fail to complement and 
are allelic in nature. Therefore, Vangl2 deletion from one allele by Cre 
recombination producing Lp phenotype would mean that Lp is a null/loss of 
function mutation.  
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Figure 3.16: Lp cross with Vangl2
flox/+
;Cre (PGK-Cre/Sox2-Cre) 
Vangl2
flox/+
;Cre (PGK-Cre/Sox2-Cre) x Lp/+ cross to check complementation 
between these two alleles. Different possible genotypes from the cross are also 
shown. 
 
 
Embryos were collected at E14.5 and genotyped using Lp primers and Vangl2
flox
 
primers. Vangl2
flox
;Lp;PGK-Cre and Vangl2
flox
;Lp;Sox2-Cre embryos had 
craniorachischisis (figure 3.18a,b) (n=4), as observed in Lp/Lp (figure 3.3e) and 
Vangl2 knockouts (figure 3.8b, 3.14b). To look at the heart morphology, embryos 
were embedded in wax and transerve sections through heart were taken. Heart 
sections after H&E staining revealed outflow tract defect and aortic arch defects. 
Vangl2
flox
;Lp;PGK-Cre and Vangl2
flox
;Lp;Sox2-Cre embryo had double outlet 
right ventricle (figure 3.18c,e) and retroesophageal subclavian artery (figure 
3.18d,f), which are seen in Lp/Lp embryos (figure 3.4c,e) as well as knockout 
embryos of Vangl2 using PGK-Cre (figure 3.9c,g) and Sox2-Cre (figure 3.15c,g). 
Table 3.6 summarizes the external phenotypic defects and cardiac defects 
observed Vangl2
flox
;Lp;PGK-Cre and Vangl2
flox
;Lp;Sox2-Cre embryos, along 
with different genotype combinations from Lp and Vangl2
flox
 allele and their 
external phenotype shown in figure 3.17. 
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Table 3.6: External phenotypic defects and cardiac defects seen in 
Vangl2
flox
;Lp;PGK-Cre and Vangl2
flox
;Lp;Sox2-Cre embryos at E14.5 
Genotype 
Number 
of 
embryos 
Looped 
tail 
Craniorachischisis DORV VSD RRESA 
+/+ 4/13 0 0 0 0 0 
Lp/+ 3/13 3 0 0 0 0 
Vangl2
flox/+
 3/13 0 0 0 0 0 
Vangl2
flox
; 
Lp 
4/13 4 4 4 4 4 
 
 
Figure 3.17: Different genotype combinations from Lp and Vangl2
flox
 allele 
Different genotype combinations from Lp and Vangl2
flox
 allele and external 
phenotype obtained with those allele combinations. 
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Figure 3.18: Neural Tube and Cardiovascular defects in Vangl2
flox
;Lp;Cre 
embryos at E14.5  
a,b) Whole mount embryos from Vangl2
flox/+
;Cre x Lp/+ litter. 
Vangl2
flox
;Lp;PGK-Cre embryo (a) and Vangl2
flox
;Lp;Sox2-Cre embryo (b) 
showing external phenotypic defect, craniorachischisis (arrows showing open 
neural tube and arrowhead pointing at looped tail). Scale - 2000µm. c-f) 
Transverse sections of heart from Vangl2
flox
;Lp;PGK-Cre embryo showing 
double outlet right ventricle (c) and retroesophageal subclavian artery (d), and 
Vangl2
flox
;Lp;Sox2-Cre embryo showing double outlet right ventricle (e) and 
retroesophageal subclavian artery (f). Scale - 20µm. RA-right atria, LA-left atria, 
RV-right ventricle, LV-left ventricle, A-aorta, DORV-double outlet right 
ventricle, E-esophagus, RRESA- retroesophageal subclavian artery.  
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Thus, Lp and Vangl2
flox
 are allelic and both appear to act as loss of function/null 
mutations. Our results confirm that the Vangl2
flox
 allele, when knocked out 
globally, recapitulated Lp phenotype and subsequently was a useful tool for 
genetically dissecting the role of Vangl2 in specific cell types. 
 
 
3.2.5 Vangl2 is not required in NCC for heart development 
Studies have suggested that several extra-cardiac cell populations contribute in 
the development of heart and its remodelling. Neural crest cells (NCC) are 
essential for outflow tract development and are required for its septation and 
alignment (Anderson et al., 2012; Kirby et al., 1983; Phillips et al., 2013). Their 
ablation and functional disruption leads to a number of cardiovascular defects 
reflecting the various functions NCC perform during the process of cardiac 
development (Creazzo et al., 1998). 
The heart defects seen in Lp mice, like outflow defect and arch artery defects, are 
an indication that possibly NCC are also regulated by Vangl2 and loss of Vangl2 
may cause abnormal behaviour of NCC leading to these defects. Although 
migration of NCC in Lp/Lp embryos is shown to be normal (Henderson et al., 
2001), it is essential to look at the role of Vangl2 in NCC because the latter are 
playing a key role in outflow tract development. 
To delete Vangl2 specifically in NCC, Wnt1-Cre was used (Danielian et al., 
1998). As Wnt1 is expressed in NCC very early and is turned off as the cells 
migrate away from the neural tube, Wnt1-Cre is frequently used for lineage 
tracing of NCC (Danielian et al., 1998; Hutson and Kirby, 2007). Our aim was to 
determine if Vangl2 is required in NCC, and if any heart defects are observed in 
its absence from this cell type. 
Crosses were set up between Vangl2
flox/+
;Wnt1-Cre and Vangl2
flox/flox
 mice (figure 
3.19a) and embryos were collected at E14.5. Embryos were obtained with 
genotypes in accordance with expected Mendelian ratios. Vangl2
flox/flox
;Wnt1-Cre 
were considered the mutants (n=8). Externally, these embryos were 
indistinguishable from the control littermates. Figure 3.19b shows 
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Vangl2
flox/+
;Wnt1-Cre embryo (control) along with Vangl2
flox/flox
;Wnt1-Cre 
embryos (mutant) (figure 3.19c). Table 3.7 summarizes the external phenotypic 
defects observed in Vangl2
flox/flox
;Wnt1-Cre embryos. 
 
 
Table 3.7: External phenotypic defects seen in Vangl2
flox/flox
;Wnt1-Cre 
mutants at E14.5 
Genotype 
Number 
of 
embryos 
Looped 
tail 
Craniorachischisis 
Spina 
bifida 
Gastroschisis 
Vangl2
flox/+
; 
Wnt1-Cre 
8/30 0 0 0 0 
Vangl2
flox/flox
; 
Wnt1-Cre 
8/30 0 0 0 0 
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Figure 3.19: Vangl2
flox
 cross specifically within NCC, using Wnt1-Cre  
a) Vangl2
flox/+
;Wnt1-Cre x Vangl2
flox/flox
 cross to have deletion of Vangl2 gene 
specifically in NCC. b) Whole mount Vangl2
flox/+
;Wnt1-Cre embryo with normal 
external phenotype. c) Vangl2
flox/flox
;Wnt1-Cre embryo also showing normal 
external phenotypic. Scale - 2000µm. 
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After establishing that loss of Vangl2 in NCC does not cause any external 
phenotypic defect, it was checked if any cardiac defects were present in the 
mutants. To look at the heart phenotype, embryos were embedded in wax and 
transverse sections through heart were taken (figure 3.20a), which were stained 
with H&E. The heart phenotype of controls as well as mutant embryos was 
normal with no outflow tract defect. Figure 3.20 shows heart section of 
Vangl2
flox/+
;Wnt1-Cre (figure 3.20b) embryo with normal heart development with 
aorta coming out from left ventricle and complete interventricular septum fused 
with the outflow tract and atrio-ventricular cushions. Similarly, heart section of 
Vangl2
flox/flox
;Wnt1-Cre emrbyo also showed normal heart development (figure 
3.20c) with no double outlet right ventricle, ventricular septal defect or aortic arch 
defect as seen in Lp/Lp and global knock out of Vangl2. Ablation of NCC not 
only results in cardiovascular phenotype but non-cardiovascular phenotype is also 
reported, including hypoplasia or aplasia of the thymus (Bockman and Kirby, 
1984), and formation of dorsal root ganglia (Epstein et al., 2000). Results show 
that there is no hypoplasia or aplasia of thymus or abnormality in formation of 
dorsal root ganglia in Vangl2
flox/flox
;Wnt1-Cre mutant embryos (figure 3.20f) 
when compared to Vangl2
flox/+
;Wnt1-Cre control embryos (figure 3.20e). 
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Figure 3.20: Cardiac phenotype and non-cardiac structures in 
Vangl2
flox
;Wnt1-Cre embryos at E14.5  
Transverse sections of embryos from Vangl2
flox/+
;Wnt1-Cre x Vangl2
flox/flox
 litter. 
a) Plane of the section. b) Transverse section through heart of Vangl2
flox/+
;Wnt1-
Cre embryo showing normal heart development. c) Heart section from 
Vangl2
flox/flox
;Wnt1-Cre embryo also showing normal heart. d) Plane of the 
section. e,f) Transverse section shows normal thymus and dorsal root ganglia 
formation (arrow) in Vangl2
flox/+
;Wnt1-Cre control embryos (e) as well as in 
Vangl2
flox/flox
;Wnt1-Cre mutant embryo (f). RA-right atria, LA-left atria, RV-right 
ventricle, LV-left ventricle, A-aorta, PT-pulmonary trunk, T-Thymus. Scale - 
20µm.  
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To confirm whether there was deletion of Vangl2 in NCC by Wnt1-Cre 
recombination and to confirm whether Vangl2 is expressed in NCC, 
immunofluorescence was carried out to check for loss of Vangl2 expression in 
mutants and colocalization of NCC and Vangl2 in controls. Anti-GFP antibody 
was used to label cells expressing eYFP protein in the presence of Cre, Wnt1-Cre 
in this case, therefore labelling all NCC. Vangl2 antibody was used along with 
anti-GFP antibody to look at the expression of Vangl2 protein in NCC in 3 
controls and 3 mutants. Embryos were collected at E9.5 while the heart is 
developing and cells are migrating into the outflow tract. Figure 3.21 shows 
Vangl2
flox/+
;Wnt1-Cre heart section (figrue 3.21a) with eYFP expression (shown 
in green) and Vangl2 expression (shown in red). It appeared that NCC are not 
expression Vangl2 and co-expression cannot be seen (figure 3.21a). Heart 
sections of Vangl2
flox/flox
;Wnt1-Cre (figure 3.21b) had eYFP and Vangl2 
expression as observed in the control. This shows that Vangl2 is not expressed in 
NCC, which justifies the lack of outflow tract defect in Vangl2
flox/flox
;Wnt1-Cre 
mutants.  
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Figure 3.21: Vangl2 expression in NCC 
a,b) Immunofluorescence for co-expression of Wnt1-Cre (GFP antibody) and 
Vangl2 in Vangl2
flox/+
;Wnt1-Cre E9.5 embryo (a) and Vangl2
flox/flox
;Wnt1-Cre 
embryo(b) where no co-expression is seen. OFT-outflow tract. Scale - 100µm. 
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To rule out any subtle defects because of loss of Vangl2 from NCC and confirm 
that mutants were healthy and didn’t have any heart defects or late onset defects, 
two litters were taken at post natal day (P) 28. These 4 weeks old mice were 
genotyped and mutants (n=4) were viable, healthy and indistinguishable from 
their control littermates. Their hearts were dissected out to compare the heart 
morphology of controls and mutants, which showed normal looking heart (figure 
3.22a,b). Hearts were embedding in wax and sectioned transversally, then stained 
with H&E. Both the control (figure 3.22c) and mutant (figure 3.22d) showed 
normal outlets of aorta and pulmonary trunk from left ventricle and right ventricle 
respectively. 
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Figure 3.22: Adult heart of Vangl2
flox
;Wnt1-Cre mice at P28 
a) Whole heart of Vangl2
flox/+
;Wnt1-Cre adult mice (P28). b) Whole heart of 
Vangl2
flox/flox
;Wnt1-Cre mutant adult mice (P28). Scale - 2000µm. c,d) Section of 
Vangl2
flox/+
;Wnt1-Cre heart (c) and Vangl2
flox/flox
;Wnt1-Cre heart (d). RA-right 
atria, RV-right ventricle, LV-left ventricle, A-aorta, PT-pulmonary trunk. Scale - 
20µm. 
 
 
Thus, the reason for no cardiac outflow tract or extra-cardiac abnormalities in 
Vangl2
flox/flox
;Wnt1-Cre mutants that Vangl2 is not expressed in NCC. Hence, 
Vangl2 is not required in NCC for normal cardiac outflow tract development. 
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3.2.6 Vangl2 is indispensable in SHF cells for heart development 
The cardiac defects seen in Lp embryos and our Vangl2
flox
 global knock out 
embryos (using PGK-Cre and Sox2-Cre) are double outlet right ventricle, 
ventricular septal defect and aortic arch defects and of these double outlet right 
ventricle in particular would require disturbance in alignment of aorta and 
pulmonary trunk to left and right ventricle respectively. In this particular region 
SHF cells are playing a key role in extension and alignment. These observations 
led us to think that Vangl2 may be playing a key role in SHF cells and disruption 
in its expression is resulting in the defects.  
To delete Vangl2 specifically in SHF cells, Isl1-Cre was used (Yang et al., 2006) 
which is a tissue specific Cre line targeting SHF cells. Crosses were set up 
between Vangl2
flox/+
;Isl1-Cre and Vangl2
flox/flox
 mice (figure 3.23a) and embryos 
were collected at E14.5. Embryos were genotyped to identify mutants and 
controls, as none of the embryos showed any external phenotypic defect. Of these 
Vangl2
flox/flox
;Isl1-Cre were considered as mutants embryos. Figure 3.23 shows 
Vangl2
flox/+
;Isl1-Cre control embryo (figure 3.23b) along with Vangl2
flox/flox
;Isl1-
Cre mutant embryo (figure 3.23c) (n=11) showing normal external phenotype of 
all embryos. Table 3.8 summarizes the external phenotypic defects observed in 
Vangl2
flox/flox
;Isl1-Cre embryos. 
 
Table 3.8: External phenotypic defects seen in Vangl2
flox/flox
;Isl1-Cre mutants 
at E14.5 
Genotype 
Number 
of 
embryos 
Looped 
tail 
Craniorachischisis 
Spina 
bifida 
Gastroschisis 
Vangl2
flox/+
; 
Isl1-Cre 
8/30 0 0 0 0 
Vangl2
flox/flox
; 
Isl1-Cre 
8/30 0 0 0 0 
 
118 
 
 
 
 
Figure 3.23: Vangl2
flox
 cross specifically within SHF cells, using Isl1-Cre  
a) Vangl2
flox/+
;Isl1-Cre x Vangl2
flox/flox
 cross to have deletion of Vangl2 gene 
specifically in SHF cells. b) Whole embryo Vangl2
flox/+
;Isl1-Cre at E14.5 with 
normal external phenotype. c) Vangl2
flox/flox
;Isl1-Cre embryo at E14.5 also 
showing normal external phenotypic. Scale - 2000µm. 
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To look at the heart morphology of the embryos, they were embedded in wax and 
then sectioned transversally (figure 3.24a) and stained with H&E. 
Vangl2
flox/+
;Isl1-Cre showed a normal heart phenotype (figure 3.24b), however 
heart sections of Vangl2
flox/flox
;Isl1-Cre mutant embryos revealed they had double 
outlet right ventricle (figure 3.24c) and ventricular septal defect (figure 3.24d). 
These defects are same as seen in Lp mice and there was 100% penetrance of this 
phenotype in the mutants (table in figure 3.24). Although SHF cells enter the 
inflow tract as well as are responsible for formation of parts of atria, inflow 
defects like atrial septal defects were not observed in the mutants, along with no 
aortic arch defect, retroesophageal subclavian artery as seen in Lp/Lp (figure 
3.4e). 
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Figure 3.24: Cardiovascular defects in Vangl2
flox/flox
;Isl1-Cre embryos at 
E14.5  
Transverse sections through heart of embryos from Vangl2
flox/+
;Isl1-Cre x 
Vangl2
flox/flox
 litter. a) Plane of the section. b) Transverse section through heart of 
Vangl2
flox/+
;Isl1-Cre embryo showing normal heart development. c,d) Heart 
section from Vangl2
flox/flox
;Isl1-Cre embryo showing double outlet right ventricle 
(c) and ventricular septal defect (d). Table shows different defects seen in 
Vangl2
flox/flox
;Isl1-Cre embryos. Table RA-right atria, LA-left atria, RV-right 
ventricle, LV-left ventricle, A-aorta, DORV-double outlet right ventricle, VSD-
ventricular septal defect, IVS-interventricular septum, RRESA- retroesophageal 
subclavian artery. Scale - 20µm. 
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Looking at our results it can be said that Vangl2 is playing a key role in regulating 
SHF and its disruption specifically in SHF is leading to cardiac defects. However, 
to confirm that Vangl2 was actually knocked out in these cells and had no Vangl2 
expression, immunofluorescence labelling was done. Three controls and 3 mutant 
embryos were collected at a younger development stage, E9.5, when SHF cells 
are moving into the outflow tract. Embryos were embedding in wax and 
transverse sections were taken, which were immunofluorescently labelled using 
anti-GFP antibody to label eYFP protein in cells expressing Cre, along with 
Vangl2 antibody. Figure 3.25 shows Vangl2
flox/+
;Isl1-Cre control embryo (figure 
3.25a) with eYFP positive cells (SHF cells) in green while Vangl2 expression is 
seen in red. Regions which are yellow show the co-localization of SHF cells and 
Vangl2 (figure 3.25a arrows). It can be seen that in the outflow tract there is clear 
co-localization between SHF cells and Vangl2, showing that Vangl2 is expressed 
in these cells. When similar staining was done on Vangl2
flox/flox
;Isl1-Cre mutant 
embryos (figure 3.25b) it was seen that there was no co-localization between Cre 
positive cells (SHF) and Vangl2, that is Vangl2 is not being expressed in SHF 
cells. Figure 3.25b shows that in the outflow tract there is green staining showing 
the presence of SHF, but there isn’t any Vangl2 staining (shown in red, arrows). 
However in the same section Vangl2 staining can be seen in the neural tube and 
left ventricle where SHF cells are not present (figure 3.25c, arrows), confirming 
conditional knock out of Vangl2.  
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Figure 3.25: Vangl2 expression lost in SHF cells in the presence of Isl1-Cre 
Different panels for Immunofluorescence for co-expression of Isl1-Cre (GFP 
antibody) and Vangl2 in Vangl2
flox/+
;Isl1-Cre and Vangl2
flox/flox
;Isl1-Cre embryo. 
a,b,c) DAPI marking nucleus of cells, showing outflow tract in Vangl2
flox/+
;Isl1-
Cre (a) and Vangl2
flox/flox
;Isl1-Cre (b,c) section. d,e,f) GFP staining in 
Vangl2
flox/+
;Isl1-Cre (d) and Vangl2
flox/flox
;Isl1-Cre (e,f) showing similar 
expression of cells derived from SHF magnified in outflow tract (e) and whole 
section (f). g,h,i) Vangl2 staining in Vangl2
flox/+
;Isl1-Cre (g) and 
Vangl2
flox/flox
;Isl1-Cre (h,i) where no Vangl2 expression is  seen in SHF cells 
magnified in outflow tract (h) and whole section (i). j,k,l) Coexpression of GFP 
and Vangl2 in Vangl2
flox/+
;Isl1-Cre (j) with yellow regions (arrows) where both 
are expressed and Vangl2
flox/flox
;Isl1-Cre (k,l) where no coexpression is seen 
(arrows in k showing outflow tract) and Vangl2 expression is seen in areas where 
SHF cells are not present (arrows in l showing neural tube, pharyngeal region and 
left ventricle).OFT-outflow tract. Scale - 100µm. 
123 
 
Thus, it is evident that deletion of Vangl2 in SHF cells leads to double outlet right 
ventricle and ventricular septal defect as seen in Lp mice, but not retroesophageal 
subclavian artery, which confirms that Vangl2 is regulating SHF cells in the 
outflow region of the heart and its absence leads to the defects observed. 
 
3.2.6.1 Vangl2
flox/flox
;Isl1-Cre mutants are able to survive 
We were also interested in looking if these mutants would survive with these 
heart defects. Litters were taken and culled at P28 (4 weeks old mice). 
Interestingly the litter size was normal, but had a few mice which were quite 
small in size. The mice were ear clipped and genotyped and it was confirmed that 
the mice which were smaller in size were Vangl2
flox/flox
;Isl1-Cre. Figure 3.26 
shows the comparison of a Vangl2
flox/+
;Isl1-Cre control mice and 
Vangl2
flox/flox
;Isl1-Cre mutant mice in size and weight. 
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Figure 3.26: Adult mice from Vangl2
flox
;Isl1-Cre litter at P28  
Table shows the number of mutants got from 3 litters, 5/25 pups were 
Vangl2
flox/flox
;Isl1-Cre, however 2 pups were dead at birth so couldn’t be analysed. 
Adult mice shown with Vangl2
flox/+
;Isl1-Cre as normal size and 
Vangl2
flox/flox
;Isl1-Cre smaller in size and graph shows the difference in the 
weight of controls and mutants, with controls with normal weight and mutants 
lighter in weight. 
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To look if these mice had heart defects, the heart was dissected out. Figure 3.27 
shows that in Vangl2
flox/+
;Isl1-Cre mice the heart phenotype was normal and in 
figure 3.27a we can see that aorta and pulmonary trunk are coming out of left and 
right ventricles respectively. Whereas in Vangl2
flox/flox
;Isl1-Cre it looked like both 
aorta and pulmonary trunk are coming out from the right ventricle (figure 3.27c). 
To confirm this, these adult hearts were embedded in wax, sectioned and stained 
with H&E. Sections confirmed that Vangl2
flox/+
;Isl1-Cre  heart section had aorta 
and pulmonary trunk coming out from left and right ventricle respective (figure 
3.27b), and Vangl2
flox/flox
;Isl1-Cre adult mice had double outlet right ventricle 
with both aorta and pulmonary trunk coming out from the right ventricle (figure 
3.27d). 
 
Figure 3.27: Heart phenotype of Vangl2
flox
;Isl1-Cre adult mice  
a) Whole heart of Vangl2
flox/+
;Isl1-Cre control adult mice (P28). c) Whole heart 
of Vangl2
flox/flox
;Isl1-Cre mutant adult mice (P28). Scale - 1000µm. c,d) Section 
of Vangl2
flox/+
;Isl1-Cre heart (c) and Vangl2
flox/flox
;Isl11-Cre heart (d) showing 
double outlet right ventricle. RA-right atria, LA-left atria, RV-right ventricle, LV-
left ventricle, A-aorta, PT-pulmonary trunk, DORV-double outlet right ventricle. 
Scale - 20µm. 
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Thus, Vangl2 is expressed in SHF cells and is playing an essential role as its 
deletion in SHF cells (Vangl2
flox/flox
;Isl1-Cre) leads to double outlet right ventricle 
and ventricular septal defect. Hence, Vangl2 is required in SHF cells for normal 
cardiac outflow tract development. 
 
3.2.7 Vangl2 is required in undifferentiated precursor SHF cells 
Undifferentiated SHF cells differentiate into myocardium and endothelial cells in 
the heart. Isl1-Cre labels all SHF cells; therefore, Vangl2 was deleted specifically 
in ventricular myocardium by using Mlc2v-Cre (Chen et al., 1998). Vangl2
flox/flox 
mice were crossed with Vangl2
flox/+
;Mlc2v-Cre mice and embryos were collected 
at E14.5. Vangl2
flox/flox
;Mlc2v-Cre (n=7) were used as mutants after genotyping. 
They showed no external defects and were indistinguishable from their control 
littermates (figure 3.28a,b). Embryos were embedded in wax, sectioned 
transversally and H&E stained. Heart sections showed that there was no outflow 
defects in the mutants (figure 3.28c,d), indicating Vangl2 is not regulating 
differentiated SHF cells. Table 3.9 summarizes that there were no incidences of 
external or cardiac outflow tract defects when Vangl2 was deleted from 
ventricular myocardium. 
 
 
Table 3.9: External phenotypic and cardiac defects in Vangl2
flox/flox
;Mlc2v-
Cre mutants at E14.5 
Genotype 
Number 
of 
embryos 
External 
defects 
Outflow 
defects 
Vangl2
flox/+
;Mlc2v-Cre 9/35 0 0 
Vangl2
flox/flox
;Mlc2v-Cre 7/35 0 0 
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Figure 3.28: External and heart phenotype of Vangl2
flox
;Mlc2v-Cre embryos 
at E14.5  
a,b) Whole embryo at E14.5 with normal external phenotype of 
Vangl2
flox/+
;Mlc2v-Cre control embryo (a) and Vangl2
flox/flox
;Mlc2v-Cre mutant 
embryo (c). Scale - 2000µm. c) Transverse section through heart of 
Vangl2
flox/+
;Mlc2v-Cre control embryo showing normal heart development with 
aorta exiting left ventricle. d) Transverse section through heart of 
Vangl2
flox/flox
;Mlc2v-Cre mutant embryo also showing no outflow tract defect. 
RA-right atria, LA-left atria, RV-right ventricle, LV-left ventricle, A-aorta. Scale 
- 20µm.  
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To check the importance of Vangl2 in endothelial cells, Tie2-Cre was used 
(Kisanuki et al., 2001). Vangl2
flox/flox 
mice were crossed with Vangl2
flox/+
;Tie-Cre 
mice. Embryos were collected at E14.5 and genotyped. Vangl2
flox/flox
;Tie2-Cre 
(n=4) mutant embryos had no external defects (figure 3.29b). However, 2 
Vangl2
flox/flox
;Tie2-Cre had craniorachischisis exhibiting full recombination, were 
excluded from the analysis. The 4 Vangl2
flox/flox
;Tie2-Cre mutants(with no 
external defects) were further used to look at the heart morphology. Embryos 
were embedded in wax, sectioned transversally and H&E stained. Heart sections 
of both control and mutants showed normal outflow tract with aorta exiting left 
ventricle (figure 3.29c,d). Table 3.10 summarizes that there were no incidences of 
external or cardiac outflow tract defects when Vangl2 was deleted from 
endothelial cells.  
 
 
 
Table 3.10: External phenotypic and cardiac defects in Vangl2
flox/flox
;Tie2-Cre 
mutants at E14.5 
Genotype 
Number 
of 
embryos 
External 
defects 
Outflow 
defects 
Vangl2
flox/+
;Tie2-Cre 6/25 0 0 
Vangl2
flox/flox
;Tie2-Cre 4/25 0 0 
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Figure 3.29: External and heart phenotype of Vangl2
flox
;Tie2-Cre embryos at 
E14.5  
a,b) Whole embryo at E14.5 with normal external phenotype of Vangl2
flox/+
;Tie2-
Cre control embryo (a) and Vangl2
flox/flox
;Tie2-Cre mutant embryo (c). Scale - 
2000µm. c) Transverse section through heart of Vangl2
flox/+
;Tie2-Cre control 
embryo showing normal heart development with aorta exiting left ventricle. d) 
Transverse section through heart of Vangl2
flox/flox
;Tie2-Cre mutant embryo also 
showing no outflow tract defect. RA-right atria, LA-left atria, RV-right ventricle, 
LV-left ventricle, A-aorta. Scale - 20µm.  
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Deletion of Vangl2 from myocardium derived from SHF cells and endothelial 
cells showed normal outflow tract development. Thus, defects like double outlet 
right ventricle and ventricular septal defect in Vangl2
flox/flox
;Isl1-Cre suggests the 
importance of Vangl2 in undifferentiated precursor SHF cells. Hence, Vangl2 is 
required only in undifferentiated precursor SHF cells for normal cardiac outflow 
tract development. 
3.3 Discussion 
Lp mice are a naturally occurring Vangl2 mutant and have been characterized 
with numerous developmental defects (Strong and Hollander, 1949; Henderson et 
al., 2001; Montcouquiol et al., 2003; Torban et al., 2008). Vangl2 is essential for 
normal heart development; however despite a thorough description of the cardiac 
defects in the Lp/Lp mutant (Henderson et al., 2001), it is still to be established 
which cell type requires Vangl2 signalling during outflow tract development and 
the role that Vangl2 plays in these cells. The cardiac defects, double outlet right 
ventricle and ventricular septal defect, which are seen in Lp/Lp mutants, can be 
associated with CNCC or SHF abnormalities, given their role during outflow tract 
morphogenesis (Buckingham et al., 2005; Hutson and Kirby, 2007). However it 
has been suggested previously that migration and differentiation of CNCC is 
normal in Lp/Lp and there is normal development of neural crest derived 
structures including cranial ganglia, dorsal root ganglia and thymus (Henderson et 
al., 2001). SHF cells ablation also results in alignment defects of the outflow tract 
(Buckingham et al., 2005), therefore it is possible that Vangl2 might also act in 
this cell type. An abnormality in heart looping during developmental stages can 
compromise remodelling and positioning of great vessels (aorta and pulmonary 
trunk) and ventricles leading to outflow tract defects like double outlet right 
ventricle and ventricular septal defect in Lp/Lp embryos (Henderson et al., 2001). 
Therefore Lp mutants have a range of defects that overlap with those seen when 
either the contribution of neural crest cells, or the addition of second heart field 
cells to the heart being disrupted. To unravel which cell type out of NCC and 
SHF is responsible for this phenotype, Vangl2
flox
 mice were produced to delete 
Vangl2 gene in particular cell types to dissect the tissue-specific requirement for 
Vangl2 signalling in the developing heart.  
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The two aims of the chapter were to establish whether the Vangl2
flox
 line 
recapitulates the Lp phenotype and to reveal the requirement for the Vangl2 gene 
specifically in NCC and cells derived from SHF. Initially, Vangl2
flox
 line had 
neoR cassette present in the construct, but as it was established that Vangl2
neo
 is a 
hypomorphic allele of Vangl2 and that neoR disrupts the function of Vangl2 gene.   
The results show that in the presence of neoR, the external phenotype produced 
and the heart defects were similar to those seen in the Lp/Lp mutant. However, 
there were some variations with respect to external phenotype and lung 
morphology. Presence of neoR cassette on both alleles not only gives 
craniorachischisis but a variable external phenotype was also observed; where 
neural tube was open only at the tail region (known as spina bifida). This 
observation shows that Vangl2 function is only reduced to certain extent giving a 
variable phenotype. Even in the absence of craniorachischisis, double outlet right 
ventricle was present in Vangl2
floxneo/floxneo 
embryo, which shows that heart defects 
produced are not secondary to craniorachischisis. Therefore, it can be stated that 
in the Vangl2
neo
 mice produced, neoR disrupts the function of Vangl2 and that 
Vangl2
neo
 is a hypomorphic allele of Vangl2, although it is yet to be studied to 
what extent the function is disrupted. Recently another hypomorph, Vangl2R259L 
has been reported to have a mild NTD phenotype (no craniorachischisis, just a 
looped or kinky tail in 47% and spina bifida in 12% homozygous mutant embryos 
(Guyot et al., 2011)). This mutant also lacked other PCP phenotypes including 
outflow tract defects in the heart, failure of eyelid closure, severe ear polarity 
defects, and imperforate vagina in affected females as seen in homozygous Lp 
mutants (Henderson et al., 2001). This milder functional defect suggests that 
dosage is an important modulator of the severity of the PCP defective phenotypes 
(Guyot et al., 2011). Therefore, because of the different natures of different 
hypomorphs, the extent of gene level of expression should be established. 
These results add further evidence to the current literature that the presence of a 
neoR cassette can disrupt the gene function resulting in a hypomorphic mutation. 
Although it is not certain if the Vangl2 function is disrupted because of the neoR 
cassette causing abnormal and divergent splicing or affecting through some other 
mechanism. Looking together at the genetic and molecular results, it is confirmed 
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that the external phenotype and heart phenotype of embryos with neoR cassette 
are similar to Lp but not as severe. Hence, neoR was removed for further 
experiments so that a universal or tissue specific Cre could be used to completely 
knockout Vangl2 in all body cells or specific tissues respectively. 
To establish the efficiency of our Vangl2
flox
 line, PGK-Cre was used to delete 
Vangl2 from all body cells to establish whether it recapitulates the Lp phenotype. 
Vangl2 deletion with PGK-Cre resulted in embryos with neural tube defects same 
as in Lp/Lp mutants, and also heart defects including double outlet right ventricle, 
retroesophageal subclavian artery and ventricular septal defect were observed. 
However, our results from western blotting showed a Vangl2 band in the 
Vangl2
flox/flox
;PGK-Cre mutant, suggesting that PGK-Cre may not be expressed in 
all body cells. However, it must be quite widely expressed as its recombination 
gives the full Lp/Lp phenotype. It has been reported that PGK-Cre expression is 
not uniform (McBurney et al., 1994). A study used X-gal staining to recognize 
PGK-LacZ transgene observed that at different embryonic developmental stages 
the intensity of staining varied and expression was widespread but was not 
uniform (McBurney et al., 1994). Therefore it seems that it is the PGK-Cre which 
isn’t expressed ‘universally’ and not that our Vangl2flox line isn’t suitable for our 
purpose. 
Therefore, another universally expressing Cre, Sox2-Cre was used. Looking at 
the RNA expression level, protein level and embryo phenotype it is established 
that Vangl2
flox/flox
;Sox2-Cre results in successful recombination and marked 
deletion of Vangl2. We saw the same external phenotypic and cardiac 
abnormalities in Vangl2
flox/flox
;Sox2-Cre mutants as in Vangl2
flox/flox
;PGK-Cre and 
Lp/Lp mutants. This suggests that for our purpose PGK-Cre is acceptable to use 
as it clearly deleted expression in the relevant heart forming regions, however on 
the basis of the results, it is clear that Sox2-Cre mediated recombination is more 
effective compared to PGK-Cre recombination. 
The nature of the Lp mutation is not clear, if it is null mutation or dominant 
negative. Loss of Vangl2 protein from samples isolated from Lp/Lp brain indicate 
Lp is a null mutation (Montcouquiol et al., 2006), however another study has 
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shown Lp intercrossed with Vangl2 knockout mice line had severe defects in the 
inner ear than Vangl2 knockout homozygotes and the mutant protein produced 
altered the distribution of Vangl1 and Pk2 along with Vangl2, suggestive 
dominant negative nature of Lp mutation during inner ear development (Yin et al., 
2012). A similar analysis is done keeping heart development as reference and Lp 
were intercrossed with Vangl2 knockouts (with PGK-Cre and Sox-Cre) and 
results show that external and heart phenotype was same in Lp/Lp, 
Vangl2
flox/flox
;PGK-Cre, Vangl2
flox/flox
;Sox2-Cre, Vangl2
flox
;Lp;PGK-Cre and 
Vangl2
flox
;Lp;Sox2-Cre embryos. Thus, Lp and Vangl2
flox 
are allelic and both 
appear to act as loss of function/null mutations during heart development.  
To check which cell type requires Vangl2, tissue specific Cre lines were used and 
as SHF and NCC are important for normal heart development and we hypothesis 
that Vangl2 plays a key role in their movement and polarization through non-
canonical Wnt PCP pathway. When Vangl2 was deleted only in NCC, no external 
or heart defects were observed, confirming that Vangl2 is not required in NCC, 
which are contributing to the development of the heart. Although there is 
evidence that planar cell polarity is required for NCC migration and function in 
Xenopus, zebrafish and chick (De Calisto et al., 2005; Carmona-Fontaine et al., 
2008a; Matthews et al., 2008; Shnitsar and Borchers, 2008; Sisson and 
Topczewski, 2009; Banerjee et al., 2011; Topczewski et al., 2011; Theveneau et 
al., 2013; Ulmer et al., 2013; Mayor and Theveneau, 2014), a similar role in 
mammals is still to be established. However there are reports of loss of PCP 
components in NCC leading to cardiac defects in mice (Thomas et al., 2010; 
Phillips et al., 2013), the results here show that Vangl2 is not regulating NCC. 
Defects in NCC can lead to a range of outflow tract anomalies like common 
arterial trunk and double outlet right ventricle, of which double outlet right 
ventricle is a characteristic feature of Lp cardiac phenotype, but they also exhibit 
common arterial trunk (Henderson et al., 2001; Anderson et al., 2012).  
When Vangl2 was specifically deleted only in SHF cells, embryos showed heart 
defects but the external phenotype was normal. Similar heart defects were 
observed as seen in Lp/Lp mutants but with normal external phenotype, which 
adds to the conclusion that heart defects are primary and not secondary to the 
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neural tube defects. Because the heart defects seen in Lp mice were recapitulated 
when Vangl2 was specifically deleted in SHF, it can be said that Lp mice is a 
SHF mutant with respect to heart development. Although, the aortic arch 
abnormality, retroesophageal subclavian artery seen in Lp, Vangl2
flox/flox
;PGK-Cre 
and Vangl2
flox/flox
;Sox2-Cre mutants, may be secondary to the neural tube defects 
or abnormalities in body form, as they are only observed in the presence of 
craniorachischisis. SHF cells can be present in undifferentiated precursor state or 
in differentiated state. Deletion of Vangl2 in differentiated myocardium and 
endothelial cells showed that Vangl2 is not required in differentiated SHF cells, 
but only regulates and plays an important role in proginetor SHF cells. 
SHF cells play a role in outflow tract alignment with the ventricles, and if these 
cells behave abnormally, their function is hampered which might lead to 
alignment of outflow tract being disturbed leading to double outlet right ventricle.  
No inflow defects were seen in Vangl2
flox/flox
;Isl1-Cre mutants, therefore from the 
results, it can be concluded that Vangl2 is indispensable in SHF for outflow tract 
development and is acting as a key regulator of SHF cells. Another PCP protein, 
Dvl2 has also been shown to regulate SHF cells for outflow tract development 
(Sinha et al., 2012), indicating importance of PCP in SHF. It can also be stated 
that SHF do not contribute to the neural tube defects but are responsible for heart 
morphogenesis. Co-localization of Vangl2 with SHF cells was done. It was 
observed that there is co-localization between Vangl2 and SHF in the cells of the 
dorsal pericardial wall, distal outflow tract, and the differentiated myocardium of 
the right ventricle of the heart concluding that these cells express Vangl2 in 
respective regions of heart and validates the histological results observed showing 
heart defects in Vangl2 SHF mutants. This set of results established the key role 
Vangl2 plays in SHF which led us to characterize these cells and their behaviour 
in presence as well as absence of Vangl2. The mechanism and the reason behind 
these changes in cellular behaviour need to be established, which will form the 
basis of next chapter. 
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Chapter 4 
Characterization of SHF phenotype – Loss of Vangl2 disrupts polarity in 
SHF cells 
 
 
4.1 Introduction 
The requirement for the PCP gene Vangl2 specifically in SHF and how the loss of 
Vangl2 function in these cells impacts on the morphogenesis of the cardiac 
outflow tract was established in the previous chapter. This chapter seeks to 
establish how loss of Vangl2 affects the polarisation, organisation, and maturation 
of SHF derived cells. 
During heart development, SHF reside in the anterior pharynx and move together 
into the poles (both venous/inflow and arterial/outflow) of the heart after 
formation of the linear heart tube (Kelly et al., 2001; Snarr et al., 2007) (figure 
4.1a). These cells do not migrate individually but as a sheet of cells moving 
together (Van Den Berg et al., 2009), which is similar to the movement of 
epithelial cells in other organs (Guillot and Lecuit, 2013). Figure 4.1c (red arrows) 
illustrates SHF cells in the heart at both outflow and inflow tracts on a sagittal 
section through an embryo at E9.5 (figure 4.1b), while figure 4.1e (red arrows) 
shows SHF cells only in the outflow tract on a transverse section (figure 4.1d) at 
E9.5. Similarly to Lp/Lp mutants, Vangl2
flox/flox
;Isl1-Cre mutants had the 
alignment defect, double outlet right ventricle, therefore the outflow region was 
focussed upon to study the pattern and behaviour of SHF  in this region. Hence 
figure 4.1e was taken as reference section for all the analysis and experiments to 
understand cellular behaviour in the outflow tract. 
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Figure 4.1: Movement of SHF into the developing heart at E9.5 
a) E9.5 embyro with arrows showing the direction in which SHF cells move into 
the developing heart through the outflow and inflow. b) Plane of sagittal section 
shown in (c). d) Plane of transverse section shown in (e). 
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SHF remain in their precursor state for a longer duration as compared to FHF, 
with prolonged expression of Isl1, whereas in the FHF Isl1 is expressed only 
transiently (Cai et al., 2003). Previous work in Lp/Lp mutants in the Henderson 
lab by Dr Jun Hong Rhee, showed that there is disorganisation of Isl1 positive 
cells in the distal outflow tract instead of normal uniform distribution in the 
outflow tract wall. The expression of Isl1 at E9.5 in SHF indicates they are still in 
precursor state in the distal outflow tract and work on Lp/Lp suggests that there 
could be a movement defect/delay. Therefore, it was important to understand the 
movement of SHF cells in control embryos and see if it changes in mutants. As 
Vangl2 is a polarity protein and cell polarity plays an important role in directional 
movement of the cells and their organization, it was considered relevant to look at 
the polarity of SHF derived cells while they are entering the outflow tract. The 
possible reason for the disorganisation of SHF derived cells in the distal outflow 
tract in Lp/Lp mice could be the disruption in polarity of cells. 
Epithelial cells are compartmentalised into apical and basal sides, also known as 
apical-basolateral polarity (ABP). This division between the compartments is 
regulated by presence of adherens junctions (AJ) and tight junctions (TJ), which 
are present at the border of apical and basolateral domain (Kaplan et al., 2009). 
The basal side of a cell is where it is attached to the basement membrane and its 
attachment to the adjoining cells is at the lateral side (Figue 4.2). The AJ, apart 
from dividing the cell into two compartments, are also responsible for cell-cell 
adhesion and migration by improving cell coordination during collective 
migration and promote cell motility by transducing signals that actively 
participate in controlling directed cell migration and providing polarity cues 
(Etienne-Manneville, 2012). SHF cells instead of migrating as an individual cells, 
move as a sheet of cells exhibiting epithelial nature (Van Den Berg et al., 2009) 
and cell polarity regulates both collective and individual cell movements during 
developmental stages (Muñoz-Soriano et al., 2012). Apart from ABP, epithelial 
cells also exhibit planar cell polarity (PCP), which involves asymmetric 
localization of core PCP components like Vangl2. The functional link between 
ABP and PCP, and their requirement for normal embryonic development is well 
established (Djiane et al., 2005). 
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Figure 4.2: Apical-Basolateral Polarity in epithelial cells 
Cells exhibiting apical-basolateral polarity with adherens junctions and tight 
junctions dividing the cell into apical and basal compartments. TJ-tight junction, 
AJ- adherens junction. 
 
 
E-cadherin, N-cadherin and β-catenin are components of AJ (Tepass, 2002; 
Hartsock and Nelson, 2008). Cadherins are the heart of these junctions; they are 
present on membrane and recruit β-catenin onto their intracellular regions. β-
catenin forms an association with α-catenin that binds to actin filaments (James 
Nelson, 2008). This complex organises and regulates actin cytoskeleton and plays 
important role in cell-cell adhesion and movement (James Nelson, 2008). Another 
protein, vinculin, is also associated with AJ along with establishment of focal 
adhesion and its loss prevents cell adhesion by formation of fewer focal adhesions 
and a decrease in spreading of cells (Goldmann and Ingber, 2002).  
Apart from AJ, there are TJ present just above the AJ (figure 4.2). Recent studies 
have revealed the importance of the PAR-PKCζ complex in cell polarity (Joberty 
et al., 2000; Lin et al., 2000; Ohno, 2001). In mammalian epithelial cells PAR-3, 
PAR-6, and PKCζ colocalize and form a complex in the apical most part of the 
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cell where TJ are formed. This ternary complex co-localizes with TJ protein ZO-1 
(Suzuki et al., 2001). Point mutation in PKCζ (PKCζ-kn, dominant negative form 
of PKCζ which lacks kinase activity) leads to mislocalization of PAR3 and PAR6 
along with TJ proteins Z0-1, occludin and claudin-1 (Ohno, 2001). Also there is 
mislocalization of apical and basolateral membrane proteins because of loss of 
PCKζ activity. These studies confirm that PCKζ is required for the establishment 
of epithelial cell polarity.  
To look at the ABP of SHF, AJ and TJ markers were examined and also markers 
which were specific to each compartment. This was done by looking at 
components of AJ (E-cadherin, N-cadherin and β-catenin), different polarised cell 
organelles like microtubule organising centre (MTOC) (Magdalena et al., 2003) 
which is specific to the apical domain (MTOCs shown as pink dots in figure 4.2), 
laminin and fibronectin which are extracellular markers present at the basal side 
of the cell, and polarity marker PKCζ which is present in TJ and is also 
responsible for the formation of AJ (Colosimo et al., 2010). Fibronectin is an 
extracellular matrix molecule that is involved in cell-matrix adhesion and 
migration and has been implicated to play a role in the localization, composition 
and functioning of AJ (Lefort et al., 2011). Laminin is also involved in adhesion 
and cell migration and is present in basal lamina, which is one of the layers of 
basement membrane (Timpl et al., 1979).  
Apart from ABP, cells also exhibit PCP. Vangl2 is a part of PCP complex, along 
with other polarity proteins, like Dvl2 and Celsr1, which work in coordination 
with Vangl2. Therefore all these markers were shortlisted to look at the polarity 
of SHF. 
Finally, this chapter focuses on the SHF derivatives. SHF can give rise to three 
major cell lineages of the heart: cardiomyocytes, smooth muscle cells and also 
endothelial cells (Moretti et al., 2006). Different markers, specific for each 
derivative, were used to analyse if there is any difference in their expression in 
control and mutant embryos. 
As SHF are important for normal heart development and deletion of Vangl2 
specifically in these cells leads to the outflow tract defect, double outlet right 
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ventricle, it was hypothesised that Vangl2 plays a key role in their organization, 
movement and polarization through non-canonical Wnt/PCP pathway. 
 
4.2 Results 
4.2.1 Transition of SHF from precursor state to differentiated cells in distal 
outflow tract 
 
Previous work on Lp mice suggested that there might be a defect in organisation 
of SHF as they enter the distal outflow tract from the dorsal pericardial wall, as 
there was disorganisation of Isl1 positive cells in the distal region in Lp/Lp 
mutants as compared to controls, along with a shortened outflow tract at E10.5 
(figure 4.3a-d red arrows) (Ramsbottom et al, 2014). Isl1 antibody labels all cells 
which are actively expressing Isl1. In SHF there is persistent expression of Isl1, 
which is subsequently down regulated as cells differentiate (Cai et al., 2003), 
meaning that Isl1 marks SHF in their precursor state. It was expected that similar 
phenotype would be seen in Vangl2
flox/flox
;Isl1-Cre mutants as in Lp/Lp, and to 
confirm this, a similar experiment was performed on Vangl2
flox/flox
;Isl1-Cre 
mutants at E10.5 similarly to Lp embryos, using an Isl1 antibody.  
Embryos were collected at E10.5 and were embedding in wax. Sections were 
taken in traverse orientation as shown in figure 4.1e. Isl1 antibody expression in 
Vangl2
flox/flox
;Isl1-Cre mutant embryos was similar to Lp/Lp mutant embryos, 
appearing disorganised in the distal outflow tract (figure 4.3g,h red arrows) as 
compared to control (figure 4.3e,f red arrows). Isl1 antibody expression was 
analysed on 3 control and 3 mutant embryos and similar results were seen. This 
supported the probable abnormality in SHF in the absence of Vangl2. It was also 
observed that the mutants had shortened outflow tract (figure 4.3g black double 
sided arrow) and the outflow tract wall was thicker (figure 4.3h black double 
sided arrow), as compared to controls (figure 4.3e,f black double sided arrow).  
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Figure 4.3: Disorganisation of Isl1 positive SHF cells in distal outflow tract at 
E10.5 
Isl1 antibody staining to mark SHF actively expressing Isl1. The box represents 
the magnified region. a,b) SHF expressing Isl1 (brown cells) in an organised 
manner in the distal outflow tract in Lp/+ embryo and higher magnification in b 
(red arrows). c,d) Disorganisation of Isl1 positive cells in distal outflow tract of 
Lp/Lp embryo with cells arranged is a disorganised manner in d (red arrows) 
(Images taken by Dr Hong Jun Rhee). e-h) Similar expression was seen in 
Vangl2
flox
;Isl1-Cre control and mutant embryos, with SHF cells expressing Isl1 in 
the distal outflow tract in Vangl2
flox/+
;Isl1-Cre embryo (e, f red arrows) and 
disorganised Isl1 positive cells in distal outflow tract of Vangl2
flox/flox
;Isl1-Cre 
embryo (g, h red arrows) with a shorter and thicker outflow tract as compared to 
control (black double sided arrows in e-h). Scale - 100µm. 
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SHF cells enter the outflow tract in the precursor state, but differentiate as they 
move proximally to form the outflow tract myocardium and ventricular 
myocardium. While Isl1 marks the SHF in precursor state, expression of myosin 
heavy chain (marked by MF20) marks the differentiated myocardium derived 
from SHF cells. Therefore, MF20 was used to mark differentiated SHF. 
Transverse sections of wax embedded E9.5 embryos when stained with MF20 
showed no expression in dorsal pericardial wall, and started with low expression 
in the distal outflow tract and became stronger towards the proximal outflow tract 
when all of the cells were fully differentiated in Vangl2
flox/+
;Isl1-Cre control 
embryo (figure 4.4e,f arrowheads) (n=3). MF20 expression overlapped with Isl1 
expression in the distal outflow tract, and this overlapping region was termed as 
Transition Zone, which marked the transition of undifferentiated SHF cells into 
differentiated cardiomyocytes (figure 4.5). In Vangl2
flox/flox
;Isl1-Cre mutant 
embryo there was no gradual increase in MF20 expression, but an abrupt 
appearance was observed (figure 4.4g,h arrowhead) (n=3). Hence, transition zone 
appeared to be shifted distally in Vangl2
flox/flox
;Isl1-Cre mutants. 
Dr Simon Ramsbottom looked at Isl1 expression in Vangl2
flox/flox
;Isl1-Cre mutant 
embryo and compared it with Vangl2
flox/+
;Isl1-Cre control embryo (n=3). It was 
observed that nuclear expression of Isl1 was lost more distally in the mutants as 
compared to controls (figure 4.4c,d arrows), indicating loss of precursor 
phenotype earlier in mutants as compared to controls (figure 4.4a,b arrows). 
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Figure 4.4: Loss of SHF precursor phenotype in distal outflow tract at E9.5 
Isl1 and MF20 labeling precursor and differentiated SHF respectively. The box 
represents the magnified region. a,b) MF20 expression marking cardiomyocytes 
in Vangl2
flox/+
;Isl1-Cre control embryo with gradual increase in expression to a 
more stronger expression from distal to proximal outflow tract (arrowheads in b). 
c,d) Abrupt appearance of strong MF20 expression in Vangl2
flox/flox
;Isl1-Cre 
mutant embryo more distally (arrowheads in d). e,f) Isl1 expression in 
Vangl2
flox/+
;Isl1-Cre control embryo showing nuclear expression of Isl1 in the 
distal outflow tract and expression going off as cells move proximally (arrows in 
f). g,h) Loss of nuclear expression of Isl1 in the distal outflow tract of 
Vangl2
flox/flox
;Isl1-Cre mutant embryo (arrows in h). Images were taken by Dr 
Simon Ramsbottom. Scale - 100µm. 
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Figure 4.5: Transition Zone (undifferentiated SHF cells into differentiated 
cardiomyocytes) 
Representation of Transition zone with SHF in progenitor state entering from 
dorsal pericardial wall into the distal outflow tract and differentiates into 
myocardium while moving proximally. OFT-outflow tract. 
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4.2.2 Expression of Vangl2 in the transition zone 
In the previous chapter it was established that there was co-localization between 
Vangl2 and Isl1-Cre expressing SHF using Vangl2 and GFP antibody (figure 
3.24). Vangl2 expression was seen in the undifferentiated precursor SHF in the 
distal outflow tract and in the differentiated myocardium of the proximal outflow 
tract and ventricles. To address the abnormality seen in SHF derived cells in the 
distal outflow tract, Vangl2 expression was examined in that region. Interestingly, 
Vangl2 expression in Vangl2
flox/+
;Isl1-Cre controls was not uniform in all the 
cells analysed in sections from 3 embryos at E9.5. Figure 4.6b-d shows that the 
expression of Vangl2 changes in SHF at different positions in the outflow tract. 
Vangl2 expression localized to cell membrane in the distal outflow tract as these 
precursor cells enter the outflow tract (figure 4.6b,c1-3 arrowheads) and changes 
to cytoplasmic as the cells move to the proximal outflow tract and reach the right 
ventricle and differentiate into myocardium (figure 4.5b,d1-3). SHF changes from 
epithelium while entering into heart, into myocardium as they reach right 
ventricle. Change in Vangl2 expression in the transition zone can be seen as 
representation in figure 4.5a. Localisation of Vangl2 at the cell membrane 
supports the idea that cells are polarised in the distal outflow tract. 
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Figure 4.6: Vangl2 expression in transition zone at E9.5 
a)  Representation of Transition zone with SHF cells in progenitor state entering 
from dorsal pericardial wall into the distal outflow tract and differentiates into 
myocardium while moving proximally. b) Representation of Vangl2 expression 
in the transition zone with being localised to cell membrane in the zone but 
becoming cytoplasmic in the differentiated SHF cells. c) Vangl2 antibody 
staining (in red) showing change in expression as SHF cells moves towards 
proximal outflow tract and right ventricle with membrane localized expression in 
the transition zone (d arrowheads, box in c representing the magnified region) and 
cytoplasmic expression after that (e, box in c representing the magnified region). 
OFT-outflow tract. Scale - 100µm. 
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4.2.3 SHF cell behavior in absence of Vangl2 
It was shown that during outflow tract development, SHF derived cells appear 
disorganised in the distal outflow tract in Vangl2
flox/flox
;Isl1-Cre mutants. To 
understand the reason behind this, it was important to look at cellular behaviour 
in this region. SHF cells move from the mesothelial dorsal pericardial wall into 
the distal outflow tract as a sheet of epithelial cells. Vangl2 expression during this 
is membrane localised (figure 4.6), indicating PCP might be acting at this point as 
in other epithelial structures. It is important for the cells to possess polarity which 
helps them in their adhesion and movement. As Vangl2 is a polarity protein, its 
loss could possibly affect cell polarity. Therefore, we hypothesised that loss of 
Vangl2 in SHF leads to disruption in cellular polarity. To confirm this, markers 
which are responsible for cell polarity along with indicators of polarity were 
looked at.  
 
4.2.3.1 Adherens Junctions disrupted in absence of Vangl2  
AJ help in cell-cell adhesion and also in giving apical-basal polarity to cells. AJ 
consist of the cadherin–catenin complex (Niessen, 2007). Therefore, expression 
of E-cadherin, N-cadherin and β-catenin was checked at to look at the position of 
AJ in the transition zone in distal outflow tract. E-cadherin is a classical epithelial 
markers and its presence in the outflow tract confirmed that tissue is the distal 
outflow tract is epithelium. Previous work has shown that mutation in PCP 
components, Scribble and Wnt11 causes mis-expression of N-cadherin and β-
catenin (Phillips et al., 2007; Nagy et al., 2010), which makes it more likely that 
AJ might be affected by the loss of Vangl2.  
E-cadherin, N-cadherin and β-catenin expression was investigated on 
Vangl2
flox/+
;Isl1-Cre controls and Vangl2
flox/flox
;Isl1-Cre mutants at E9.5 (n=3), 
while the SHF derived cells enter into the outflow tract. Embryos were wax 
embedded, sectioned transversally and labeled individually with N-cadherin, E-
cadherin and β-catenin antibodies. In the distal outflow tract, N-cadherin 
expression was seen in the cell membrane with strong apical staining in controls 
(figure 4.7a-h arrowheads). However in the mutants, this localization was lost and 
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uniform expression and distribution at the cell membrane was seen (figure 4.7i-p 
arrowheads). 
 
 
 
 
Figure 4.7: Loss of apical localization of N-cadherin expression in the 
transition zone at E9.5 
N-cadherin antibody staining on Vangl2;Isl1-Cre control and mutant sections. 
The boxed region marks the transition zone and is magnified. a-h) N-cadherin 
expression (in green) in Vangl2
flox/+
;Isl1-Cre controls (a,e) showing apical 
expression  (arrowheads in c,g). i-p) N-cadherin expression in Vangl2
flox/flox
;Isl1-
Cre mutants (l,m) with loss of apical expression but uniform expression around 
cells in the transition zone (arrowheads in k,o). A-apical, B-basal. Scale - 100µm. 
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Another cadherin, E-cadherin (epithelial cadherin), also showed abnormal 
expression in mutants in the distal outflow tract. It was observed that the 
expression of E-cadherin was localized at cell membrane in controls at the apical-
basal boundary of cells in the distal outflow tract (figure 4.8a-h arrowheads); 
however in mutants this expression was altered with some cells showing 
expression at the basolateral compartment (figure 4.8i-p arrowheads).   
 
 
 
Figure 4.8: Loss of apical-basal localization of E-Cadherin expression in the 
transition zone at E9.5 
E-cadherin antibody staining on Vangl2;Isl1-Cre control and mutant sections. 
The boxed region marks the transition zone and is magnified. a-h) E-cadherin 
expression (in green) in Vangl2
flox/+
;Isl1-Cre controls (a,e) showing apical –basal 
expression  (arrowheads in c,g). i-p) E-cadherin expression in Vangl2
flox/flox
;Isl1-
Cre mutants (l,m) with expression  at basolateral compartment of some cells in 
the transition zone (arrowheads in k,o). A-apical, B-basal. Scale - 100µm. 
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Distribution of β-catenin also looked abnormal and not uniform in the 
Vangl2
flox/flox
;Isl1-Cre mutants when compared to stage-matched controls. β-
catenin expression was seen on cell membranes in the distal outflow tract cells, 
marking the basolateral compartment in control embryos  (figure 4.9a-h 
arrowheads), whereas in mutants although the expression was present at the cell 
membrane, there was disorganisation of cellular architecture in the distal outflow 
tract (figure 4.9i-p arrowheads).  
 
 
 
Figure 4.9: Disorganised expression of β-catenin in the transition zone at 
E9.5 
β-catenin antibody staining on Vangl2 SHF controls and mutants sections. The 
boxed region marks the transition zone and is magnified. a-h) β-catenin 
expression (in green) in Vangl2
flox/+
;Isl1-Cre controls (a,e) showing membrane 
bound expression  (arrowheads in c,g). i-p) β-catenin expression in 
Vangl2
flox/flox
;Isl1-Cre mutants (l,m) disorganized expression in some cells in the 
transition zone (arrowheads in k,o). A-apical, B-basal. Scale - 100µm. 
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Expression of these markers was looked at another region than transition zone to 
check if the effect was isolated to the transition zone or not. Isl1 positive cells are 
present in the lateral and ventral regions of the pharynx, the dorsal wall of aortic 
sac and in distal outflow tract. As N-cadherin is not expressed in dorsal wall of 
aortic sac (figure 4.10a,e arrowhead), its expression in the proximal outflow tract 
was analysed. For E-cadherin and β-catenin dorsal wall of aortic sac was 
examined. It was observed that all these adhesion proteins are expressed in a 
comparable manner in controls and mutants in regions other than transition zone 
(figure 4.10). These regions have Vangl2 expression as well, therefore in 
Vangl2
flox/flox
;Isl1-Cre mutants Isl1 positive cells in these regions would have 
Vangl2 knocked down and comparable expression in controls and mutants shows 
specificity of defect to the transition zone only. This solidifies the argument of 
Vangl2 regulating SHF in the transition zone.  
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Figure 4.10: Comparable expression of N-cadherin, E-cadherin and β-
catenin in controls and mutants outside transition zone 
N-cadherin, E-cadherin and β-catenin antibody staining on Vangl2;Isl1-Cre 
control and mutant sections in other regions than transition zone. The box 
represents the magnified area. a-h) N-cadherin expression (in green) in 
Vangl2
flox/+
;Isl1-Cre control (a-d) showing apical expression  (arrowheads in c) 
and in Vangl2
flox/flox
;Isl1-Cre mutant (e-h) also with apical expression between 
cells in the proximal outflow tract (arrowheads in g). i-p) E-cadherin expression 
(in green) in Vangl2
flox/+
;Isl1-Cre control (i-l) showing apical–basal expression  
(arrowheads in k) and in Vangl2
flox/flox
;Isl1-Cre mutant (m-p) also with apical-
basal expression in cells in the dorsal wall of aortic sac (arrowheads in o). q-x) β-
catenin expression (in green) in Vangl2
flox/+
;Isl1-Cre control (q-t) showing 
membrane bound expression  (arrowheads in s) and in Vangl2
flox/flox
;Isl1-Cre 
mutant (u-x) also showing membrane bound expression in cells in the dorsal wall 
of aortic sac (arrowheads in w). Scale - 100µm. 
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Disrupted expression of N-cadherin and E-cadherin along with disorganization of 
β-catenin suggests disruption of AJ in the cells in distal outflow tract at E9.5. As 
AJ are present at the border of apical and basal compartments, this is suggestive 
of the imbalance between the apical and basal compartments of the cell, 
indication disruption in ABP. 
 
4.2.3.2 Tight Junctions disrupted in absence of Vangl2 
TJ are a characteristic feature of epithelial cells, and are present just above the AJ. 
They help in acting as a barrier for material transport and maintain the osmotic 
balance of cells, apart from dividing the apical and basal domains of the cell 
along with AJ. PKCζ is known to be compartmentally localized in epithelial cells, 
was chosen as the marker because of its dual function that it is present in TJ and 
is also responsible for the formation of AJ (Colosimo et al., 2010).  
Transverse sections of wax embedded embryos at E9.5 were taken and were 
examined for PKCζ expression. Figure 4.11a-h (arrowheads) shows 
Vangl2
flox/+
;Isl1-Cre control embryo showing PCKζ staining in the apical region 
of the cells in distal outflow tract wall, at the point of TJ, however this apical 
expression was lost when cells enter the outflow tract in Vangl2
flox/flox
;Isl1-Cre 
mutants (figure 4.11i-p arrowheads). It was observed that PCKζ was mislocalized 
only in transition zone, as there was apical localization of PCKζ expression at TJ 
of cells before entering the outflow tract in controls (figure 4.11c arrowhead) and 
in mutants (figure 4.11k,o arrowhead). This result indicates that absence of 
Vangl2 results in mislocalization of PCKζ expression, suggesting disruption of 
epithelial ABP and altered expression on these epithelial markers in 
Vangl2
flox/flox
;Isl1-Cre mutants also indicate at loss of epithelial nature of SHF 
cells in the absence of Vangl2. 
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Figure 4.11: Mislocalization of PKCζ expression in transition zone at E9.5 
PKCζ antibody staining on Vangl2;Isl1-Cre control and mutant sections. The 
boxed region marks the transition zone and is magnified. a-h) PKCζ expression 
(in red) in Vangl2
flox/+
;Isl1-Cre controls (a,e) showing apical localization at tight 
junctions  (arrowheads in c,g). i-p) PKCζ expression in Vangl2flox/flox;Isl1-Cre 
mutants (l,m) with mislocalized expression in cells in the transition zone 
(arrowheads in k,o). A-apical, B-basal. Scale - 100µm. 
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4.2.3.3 Mislocalisation of basal markers in Vangl2
flox/flox
;Isl1-Cre mutants 
Apical-basolateral polarity means that cell is divided into apical and basal zones 
which are different from each other with respect to the different proteins and 
determinants specific to each zone. Fibronectin and laminin are extra-cellular 
markers and were used as they both have roles in adhesion and cell movement 
and mark the basal side of the side. To check interaction of cells with extra-
cellular matrix, vinculin was used which assists in the focal adhesions of the cells.  
Polarised organelle like MTOC is specific to the apical side of the epithelial cells 
and was used as apical marker. All these markers were checked in transition zone 
to test if basal and apical determinants are restricted to their respective 
compartments. 
Three Vangl2
flox/+
;Isl1-Cre control and 3 Vangl2
flox/flox
;Isl1-Cre mutant embryos 
were collected at E9.5 and wax embedded. Transverse sections were taken and 
immunostained with marker specific antibodies. Laminin had basal expression in 
the control embryos associated with the basal compartment of the distal outflow 
tract wall cells in the transition zone (figure 4.12a-h arrowheads). However, in 
Vangl2
flox/flox
;Isl1-Cre mutants expression was irregular and not limited to basal 
side of the cells and completely surrounded some on the cells in the transition 
zone (figure 4.12i-o arrowheads).  
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Figure 4.12: Disruption of laminin basal expression in transition zone at E9.5 
Laminin antibody staining on Vangl2;Isl1-Cre control and mutant sections. The 
boxed region marks the transition zone and is magnified. a-h) Laminin expression 
(in red) in Vangl2
flox/+
;Isl1-Cre controls (a,e) showing uniform basal expression  
(arrowheads in c,g). i-p) Laminin expression in Vangl2
flox/flox
;Isl1-Cre mutants 
(l,m) with disrupted expression with not being limited to basal side of the cells in 
the transition zone (arrowheads in k,o). A-apical, B-basal. Scale - 100µm. 
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In contrast, laminin was comparable between Vangl2
flox/flox
;Isl1-Cre mutants and 
stage matched controls in the proximal outflow tract, where the cells had 
differentiated to cardiomyocytes (figure 4.13). This again indicates that the 
abnormalities were restricted to the distal outflow region.  
 
 
 
 
Figure 4.13: Basal expression of laminin in proximal outflow tract at E9.5 
a-c) Laminin expression (in green) in Vangl2
flox/+
;Isl1-Cre control showing basal 
expression between the basement membrane and the cells (arrowheads in c). d-f) 
Laminin expression in Vangl2
flox/flox
;Isl1-Cre mutants showing basal expression 
similar to control (f arrowheads). A-apical, B-basal. Scale - 100µm. 
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Similarly to laminin, fibronectin also has a basal expression between the 
basement membrane and the cells, which can be seen in controls (figure 4.14a-h 
arrowheads). However, in all the 3 Vangl2
flox/flox
;Isl1-Cre mutants, basal 
expression of fibronectin was disrupted in cells in the transition zone (figure 
4.14i-p arrowheads) and a more non-uniform and dispersed expression was seen.  
 
 
Figure 4.14: Disruption of fibronectin basal expression in transition zone at 
E9.5 
Fibronectin antibody staining on Vangl2;Isl1-Cre control and mutant sections. 
The boxed region marks the transition zone and is magnified. a-h) Fibronectin 
expression (in green) in Vangl2
flox/+
;Isl1-Cre controls (a,e) showing basal 
expression between the basement membrane and the cells (arrowheads in c,g). i-p) 
Fibronectin expression in Vangl2
flox/flox
;Isl1-Cre mutants (l,m) with disrupted, 
non-uniform and dispersed expression in cells in the transition zone (arrowheads 
in k,o). A-apical, B-basal. Scale - 100µm. 
159 
 
Vinculin, which marks the focal adhesions, was not affected in mutants (figure 
4.15i-p arrowheads) and was similar to the expression seen in controls (figure 
4.15a-h arrowheads). However, cells in the region looked disorganised, although 
cell-matrix adhesion appears to be normal in the absence of Vangl2 in SHF cells 
in the outflow tract.  
 
 
 
Figure 4.15: Disorganized expression of vinculin in transition zone at E9.5 
Vinculin antibody staining on Vangl2;Isl1-Cre control and mutant sections. The 
boxed region marks the transition zone and is magnified. a-h) Vinculin 
expression (in green) in Vangl2
flox/+
;Isl1-Cre controls (a,e) showing uniform 
membranous expression  (arrowheads in c,g). i-p) Vinculin expression in 
Vangl2
flox/flox
;Isl1-Cre mutants (l,m) showing disorganized cells in the transition 
zone (arrowheads in k,o). A-apical, B-basal. Scale - 100µm. 
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4.2.3.4 Mislocalisation of apical marker in Vangl2
flox/flox
;Isl1-Cre mutants 
To investigate whether there was any abnormality in apical determinants; the 
position of MTOCs was examined, which are present towards the apical side of 
epithelial cells. To establish loss of polarity as a result of Vangl2 mutation in SHF 
cells, two possibilities were proposed, one that either the cells will lose MTOCs 
as loss of AJ leads to loss of apical determinants of the cell (Kaplan et al., 2009) 
or MTOCs will not be restricted to apical compartment of the cell (figure 4.15a, 
black dots being MTOCs), both causing disturbance in polarity in SHF. In our 
experiments, γ-tubulin was used to label the MTOCs on 3 Vangl2flox/+;Isl1-Cre 
controls and 3 Vangl2
flox/flox
;Isl1-Cre mutant embryo sections at E9.5. Transition 
zone was analysed and γ-tubulin staining showed that in controls MTOCs were 
restricted to the apical compartment of the cells, while in mutants they were not 
restricted to the apical side of the cell. Figure 4.16 shows transverse sections of 
outflow tract as results showed that position of MTOCs was more apical in 
controls (figure 4.16b-i arrowheads) as compared to mutants (figure 4.16j-q 
arrowheads).  
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  Figure 4.16: Loss of apical localization of MTOCs in transition zone at E9.5 
Black dots showing MTOC pointing in apical direction in polarized cells and loss 
of polarity could lead to either loss of MTOCs or MTOCs being pointing at 
different direction. γ-tubulin antibody staining on Vangl2;Isl1-Cre control and 
mutant sections. The boxed region marks the transition zone and is magnified. a-
h) γ-tubulin (marking MTOCs) expression (in green) in Vangl2flox/+;Isl1-Cre 
controls (a,e) showing apical localization of MTOCs  (arrowheads in c,g). i-p) γ-
tubulin expression in Vangl2
flox/flox
;Isl1-Cre mutants (l,m) showing MTOCs being 
present at basal side of some cells in the transition zone (arrowheads in k,o). A-
apical, B-basal. Scale - 100µm. 
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To establish whether there was decrease in MTOC numbers, cell counting was 
done using Fiji software with total number of cells and total MTOCs. There was 
no evident decrease in number of MTOCs in the mutants as compared to controls 
when this quantitative analysis by cell counting was done (table and graph in 
figure 4.17). To solidify our finding about the loss of apical positioning of MTOC 
in Vangl2
flox/flox
;Isl1-Cre mutants, higher magnification images were taken to look 
at the position of MTOCs. To check the position of MTOC, 100 cells were 
labelled in controls and mutants. These cells were divided into apical and basal 
compartments and then position of MTOC was observed by measuring the angle 
from the centre of the cell using Fiji software. These sections showed evident 
difference in position of MTOCs (average angles of controls and mutants are 
mentioned in the table in figure 4.17). In controls they are present on apical side 
of the cells (figure 4.16c) and in mutants they were present all around the cells 
(figure 4.17f). These results of MTOC position in cells gives a strong evidence 
for the possible disruption is ABP in the absence of Vangl2 in SHF cells with 
MTOC being an apical determinant isn’t restricted to the apical compartment of 
the cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
163 
 
 
 
 
Figure 4.17: Quantification and position analysis of MTOCs 
Table showing quantification of MTOCs in Vangl2
flox/+
;Isl1-Cre controls (n=3) 
and Vangl2
flox/flox
;Isl1-Cre mutants (n=3) and average angle of of MTOC from the 
centre of the cell. Graph showing no signification difference in their numbers and 
representation of position of MTOC around the cell at apical/basal side. a-c)  
MTOCs (green dots) in Vangl2
flox/+
;Isl1Cre control (a) with magnified region 
showing MTOCs pointing towards the apical side of the cells (c). d-f)  MTOCs 
(green dots) in Vangl2
flox/flox
;Isl1-Cre mutant embryo section (d) with magnified 
region showing MTOCs pointing towards the basal side of the cells (f). MTOC-
microtubule organising centre, A-apical, B-basal. Scale - 100µm. 
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4.2.3.5 Loss of planar cell polarity in absence of Vangl2 
Our results confirm the loss of ABP in SHF derived cells in the distal outflow 
tract in the absence of Vangl2; however, epithelial cells apart from exhibiting 
ABP also exhibit PCP along the plane of epithelium and because Vangl2 is a core 
PCP protein it was hypothesised that its absence along with loss of ABP leads to 
loss of planar polarity as well.  
PCP signaling pathway is a multi-protein pathway and requires all the proteins 
involved to work in coordination (Henderson and Chaudhry, 2011). We checked 
if in absence of Vangl2 in SHF cells two other members of the PCP signaling 
pathway, Dvl2 and Celsr1, are recruited to the membrane. Our previous result 
about Vangl2 expression during heart development in SHF cells showed that 
Vangl2 expression is membrane bound in the dorsal pericardial wall and in the 
distal outflow tract in transition zone, but becomes cytoplasmic towards proximal 
outflow tract and after reaching the right ventricle of heart where SHF are 
differentiated into myocardium (section 4.2.2). Dvl2 and Celsr1 when observed in 
Vangl2
flox
 embryos had similar expression like Vangl2, with membrane 
localisation in the distal outflow tract and cytoplasmic expression in proximal 
outflow tract. Embryos were collected at E9.5 and sectioned transversally after 
wax embedding to analyze the transition zone (n=3).  
Figure 4.18 compares Dvl2 and Celsr1 expression in Vangl2
flox/+
;Isl1-Cre control 
embryo (figure 4.18a-e and 4.18i-l respectively) and Vangl2
flox/flox
;Isl1-Cre 
mutant embryo (figure 4.18e-h and 4.18m-p respectively). In control embryos 
both Dvl2 and Celsr1 expression was membrane localized in cells in the transition 
zone in distal outflow tract (figure 4.18c1 and k1 respectively; arrowheads), while 
this is not seen in the mutant embryos for both the proteins (figure 4.18g1 and o1 
respectively; arrowheads). However when looked in the differentiated 
myocardium in the proximal outflow tract, expression of both Dvl2 and Celsr1 
remained cytoplasmic in both controls and mutant embryo sections (figure 
4.18c2,g2 and k2,o2 respectively; arrowheads), which was comparable to Vangl2 
expression in the same region (figure 4.6). 
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Figure 4.18: Loss of polarity proteins, Dvl2 and Celsr1 in the absence of 
Vangl2 in transition zone at E9.5 
Dvl2 and Celsr1 antibody staining on Vangl2;Isl1-Cre control and mutant 
sections. The boxed region marks the transition zone and proximal outflow tract. 
a-d) Dvl2 expression (in red) in Vangl2
flox/+
;Isl1-Cre control embryo showing 
change in expression as SHF cells moves towards proximal outflow tract with 
membrane localized expression in the transition zone (c1 arrowheads) and 
cytoplasmic expression after that (c2 arrowheads). e-h) Loss of Dvl2 membrane 
localized expression in Vangl2
flox/flox
;Isl1-Cre mutant embryo in transition zone 
(g1 arrowheads) and cytoplasmic expression after that (g2 arrowheads). i-l) 
Celsr1 expression (in green) in Vangl2
flox/+
;Isl1-Cre control embryo showing 
change in expression as cells moves towards proximal outflow tract with 
membrane localized expression in the transition zone (k1 arrowheads) and 
cytoplasmic expression after that (k2 arrowheads). m-p) Loss of Celsr1 
membrane localized expression in Vangl2
flox/flox
;Isl1-Cre mutant embryo in 
transition zone (o1 arrowheads) and cytoplasmic expression after that (o2 
arrowheads). A-apical, B-basal, OFT-outflow tract. Scale - 100µm. 
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Results show that loss of Vangl2 leads to non-recruitment of Dvl2 and Celsr1 at 
the cell membrane in the transition zone, possibly leading to the PCP complex to 
be not formed and resulting in disruption of the whole signaling pathway. 
 
4.2.4 Abnormal differentiation of SHF in absence of Vangl2 
After looking at the polarity of SHF cells during heart morphogenesis, it is also 
essential to check if the derivatives of these cells are formed and functioning in 
the usual manner or have some abnormal behaviour in the absence of Vangl2. 
SHF cells can give rise to three major cell lineages of the heart: cardiomyocytes, 
smooth muscle cells and endothelial cells (Moretti et al., 2006). Transverse 
sections of 3 control and 3 mutant wax embedded embryos were taken and 
labelled with specific antibodies for these derivatives. 
Cardiomyocytes constitute the cardiac muscle cells (myocardium) and are 
labelled by MF20 antibody. At E10.5 our mutants showed that although 
formation of cardiomyocytes was normal as compared to controls, there was a 
difference in cell shape. Cells in the distal outflow tract marked by MF20 show 
extended membrane protrusions in Vangl2
flox/+
;Isl1-Cre controls (figure 4.19a-d 
arrowheads) but no protrusions are seen in the cells in Vangl2
flox/flox
;Isl1-Cre 
mutant embryos and had a rounded appearance (figure 4.19e-h arrowheads). 
Similar expression of MF20 has been reported Lp controls and mutants (Phillips 
et al., 2005), however in this case the analysis was done at E13.5 and termed as 
myocardialization defect leading to failure in movement of myocardial cells.   
Smooth muscle cell are the major component of the great arteries and blood 
vessels. Their expression was also looked at, at E10.5 and at later stages of 
development, E14.5 when the heart is fully developed, using αSMA antibody. At 
E10.5 there was αSMA expression in both controls and mutants (figure 4.19i-p) 
suggesting formation of smooth muscle cells at early developmental stages is 
normal, however it was observed in all 3 mutant embryos that the expression 
comes on more distally (figure 4.19o arrowheads) as compared to controls (figure 
4.19k arrowheads). In controls the expression starts in the transition zone, 
however in the mutants expression came on at the beginning of the distal outflow 
tract, suggestion early differentiation in the absence of Vangl2. 
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The other cell type which is derivative of SHF cells is endothelial cells, which 
form the interior surface of blood vessels in outflow tract. Endothelial cells were 
marked using endomucin antibody and its expression was unchanged in mutants 
with respect to controls (figure 4.19q-x) when checked at E9.5 in the transition 
zone, indicating that the overall organization of the endothelial tissue as cells 
move into the developing outflow tract is maintained. 
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Figure 4.19: Derivatives of SHF cells 
MF20, α-sma and endomucin antibody staining on Vangl2;Isl1-Cre control and 
mutant sections. The boxed region marks the transition zone and is magnified. a-
h) MF20 labelling the cardiomyocytes in the transition zone with extended 
protusions in Vangl2
flox/+
;Isl1-Cre control embryo section (c arrowhead) and 
rounded appearance with no protusions in Vangl2
flox/flox
;Isl1-Cre mutant embryo 
section (g arrowhead). i-p) αSMA labelling smooth muscle cells showing early 
expression in Vangl2
flox/flox
;Isl1-Cre mutant embryo section (o arrowheads) as 
compared to Vangl2
flox/+
;Isl1-Cre control embryo section (k arrowheads). q-x) 
Endomucin expression labelling the endothelial cells with no difference in 
Vangl2
flox/+
;Isl1-Cre  control (s arrowheads) and Vangl2
flox/flox
;Isl1-Cre mutant (w 
arrowheads). Scale - 100µm 
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When αSMA expression was looked at later stage of development, E14.5 when 
the heart is fully septated, there was lack of expression at the aortic root in all 3 
mutants (figure 4.20). Figure 4.20a,b show Vangl2
flox/+
;Isl1-Cre control embryo 
showing aortic root, at the level of the aortic valves with αSMA labelling smooth 
muscle cells in brown colour (using DAB), and in Vangl2
flox/flox
;Isl1-Cre mutants 
the expression is similar, however there is lack of staining in the outer region of 
the aortic arterial wall (figure 4.20c,d arrows). Smooth muscle cells were normal 
in aortic arch region in mutants (figure 4.20f) and were comparable to controls 
(figure 4.20e).  
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Figure 4.20: Smooth muscle cells expression at E14.5  
α-sma staining on Vangl2;Isl1-Cre control and mutant sections. The boxed region 
represents the magnified area. a,b)  Smooth Muscle Cells staining using DAB 
(marked in brown) at aortic root level  in Vangl2
flox/+
;Isl1-Cre control. c,d) 
Smooth Muscle Cells expression at aortic root level in Vangl2
flox/flox
;Isl1-Cre 
mutant with lack of staining in the outer region of the aortic arterial wall (d 
arrows). e,f) Smooth muscle expression at aortic arch level with similar 
expression in control (e) and mutant (f). ). RA-right atria, LA-left atria, RV-right 
ventricle, LV-left ventricle, A-aorta, AA-aortic arch. Scale - 20µm. 
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Smooth muscle cells give rise to elastin fibres in the arteries. These elastin fibres 
are present in extra-cellular matrix (Liu et al., 2004) and are produced from 
fibroblasts and smooth muscle cells (Kagan and Trackman, 1991; Bökenkamp et 
al., 2006), and is involved in smooth muscle cell proliferation (Karnik et al., 
2003). When observed in Vangl2;Isl1-Cre embryos at E14.5, there was a drastic 
decrease in elastin fibres, when layers of elastin fibres were counted (figure 4.21f 
graph) in the aortic root in mutants (figure 4.21c,d arrows) as compared to 
controls (figure 4.21a,b arrows) (n=3), suggesting the role of abnormal SHF in 
either origin of these elastin fibres. 
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Figure 4.21: Reduction of elastin fibres in absence of Vangl2 at E14.5 
Elastin staining on Vangl2;Isl1-Cre control and mutant sections. The boxed 
region represents the magnified area. a,b)  Elastin fibres at aortic root level  in 
Vangl2
flox/+
;Isl1-Cre control. c,d) Elastin fibres at aortic root level in 
Vangl2
flox/flox
;Isl1-Cre mutant showing decrease in fibres (d arrows). e) Plane of 
transverse section of embryo at E14.5. f) Graph showing quantification of elastin 
fibres with decrease in mutants as compared to controls. RA-right atria, LA-left 
atria, RV-right ventricle, LV-left ventricle, A-aorta. Scale - 20µm. 
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4.3 Discussion 
The project seeks to establish the role of the Vangl2 gene, a key component of the 
non-canonical Wnt/PCP signalling pathway, in regulating polarisation of SHF in 
the outflow tract of the developing heart. After establishing that our new 
Vangl2
flox 
line recapitulates Lp/Lp phenotype, we proved that Lp is a SHF mutant 
with respect to heart development. Lp/Lp mutants have outflow tract defect that 
was recapitulated in our Vangl2
flox/flox
;Isl1-Cre mutants, confirming that SHF cells 
require Vangl2 in their undifferentiated precursor form and absence of Vangl2 
leads to double outlet right ventricle. Our next aim was to elucidate the 
characteristic behaviour of SHF cells as they contribute to the outflow tract, and 
to establish how loss of Vangl2 changes their behaviour and affects polarisation 
and maturation of these cells.  
We showed that Vangl2 co-localises with Isl1 expressing cells while they 
contribute to the developing heart, and its sub-cellular localisation changes while 
SHF derived cells enter the distal outflow tract and move towards proximal 
outflow tract. At E9.5 these cells enter the outflow tract through dorsal pericardial 
wall and are in multipotent progenitor state, but after entering outflow tract there 
is a transition from their undifferentiated precursor state to differentiated state as 
they move more proximally. This zone where both undifferentiated and 
differentiated SHF cells are present and transition from one form to another 
occurs in the distal outflow tract was termed as ‘transition zone’. Interestingly, 
Vangl2 expression in this transition zone was localized to cell membrane whereas 
it becomes cytoplasmic as cells move more proximally and differentiate into 
myocardium. Mutation in Vangl2, which results in Lp phenotype leads to loss of 
membrane bound expression of Vangl2 (Torban et al., 2007), indicating 
membrane association of Vangl2 is important for its function. Hence Vangl2 
localisation to cell membrane in transition zone suggests it is functional in this 
region. This shows the polarized nature of the undifferentiated SHF in the 
transition zone, therefore transition zone became the key zone for the analysis. In 
the absence of Vangl2 (seen in Lp/Lp and Vangl2
flox/flox
;Isl1-Cre mutants) the 
SHF derived cells appear disorganised in the distal outflow tract instead of 
moving in uniformly, suggesting that the alignment defects in the outflow tract 
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seen later in gestation could be because the SHF are unable to successfully add on 
to the distal end of the outflow tract.                               
Vangl2 is a key component of multi-protein complex in PCP pathway and plays a 
role in cell polarity (Henderson et al., 2006). Loss of Vangl2 leads to disrupted 
polarity in tissues. In fly Vang/Stbm mutation leads to loss of polarity in 
ommatidia of the compound eye and hair of the wing and thorax making them 
point in various directions (Klein and Mlodzik, 2005). In mice as well there is 
loss in cell polarity when Vangl2 is mutated. Mutation in Vangl2 results in 
abnormal orientation of stereociliary bundles in cochleae in Lp/Lp embryos 
(Montcouquiol et al., 2003). There have been suggestions about there being a 
polarity defect in Lp/Lp mutants (Phillips et al., 2005), leading to the cardiac 
defects observed in Lp/Lp mutants. However, polarity of SHF hasn’t been 
reported before in the absence of Vangl2. As the cardiac outflow tract defect 
observed in Lp/Lp was recapitulated in Vangl2
flox/flox
;Isl1-Cre mutants, it was 
hypothesised that it was a polarity defect and that loss of Vangl2 leads to loss of 
polarity in SHF resulting in their abnormal behaviour. 
 
To look at polarity of cell it is essential to look at its complete behaviour, how it 
interacts with neighbouring cells, their adhesion and directional movement. 
Epithelial nature of SHF cells while they move in the outflow tract was 
established, and loss of polarity in the cells was confirmed by checking the 
polarized organelles in cell and the complexes which play a role in polarity. 
Epithelial cells have AJ and TJ which divide the cell in apical and basal 
compartment, imparting ABP. Our results show that both these junctions are 
impaired in Vangl2
flox/flox
;Isl1-Cre mutants. There have been reports on β-catenin 
localization assists in establishing cell polarity in some tissues and its loss leading 
to a disruption of AJ (Wu et al., 2010). Change in cadherins expression and 
evident disorganisation of cells in the transition zone indicated loss of epithelial 
nature of the SHF. To look at TJ, expression of PKCζ was seen. The PAR-PKCζ 
complex has an important role in cell polarity (Joberty et al., 2000; Lin et al., 
2000; Ohno, 2001). In mammals, epithelial cells have colozalization of PAR-3, 
PAR-6, and PKCζ, which forms a complex in the apical most part of the cell 
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where TJ are formed. Mutation of PKCζ results in the complex being not formed 
and hence loss of polarity (Ohno, 2001). Vangl2
flox/flox
;Isl1-Cre mutant also had 
the same fate as PKCζ expression was mislocalised in the transition zone, 
however it was localised apically in the cells before they enter the transition zone. 
Laminin and fibronectin expression which are normally localised basally to the 
cells was spread to the apical side and MTOCs which are present on the apical 
side of cells were present even at the basal side of some cells in the mutants. 
Reports suggest that polarized alignment of MTOC along with cytoskeleton is 
required for directional cell movement (Kupfer et al., 1982; Kupfer et al., 1983; 
Magdalena et al., 2003). Vangl2
flox/+
;Isl1-Cre controls showed MTOC mostly 
towards the apical side of cells as compared to mutants which had MTOCs not 
limited to apical side but had them towards the basal side of some cells. Therefore 
cell’s apical and basal domains were not separate and markers specific to each 
domain were no longer exclusive. This indicates that loss of Vangl2 from SHF 
cells leads them to behave abnormally owing to disrupted apical-basolateral 
domain mixing and loss of ABP (figure 4.22b). However, apart from disruption 
of ABP, another possibility is abnormal orientation of cells which makes these 
apical and basal determinants look misoriented (figure 4.22c). Mislocalisation of 
MTOCs could be because of the abnormal orientation of cells, but as laminin is 
an extra cellular marker, disruption in its basal expression is indicative of loss of 
ABP. Hence, it could be a combination of both the factors. 
176 
 
 
Figure 4.22: Comparison of ABP in control and mutants. 
Control shows proper demarcation between apical and basolateral domains (a), 
divided by adhesion junctions (AJ) and tight junctions (TJ). However, in mutants, 
when AJ and TJ are disrupted, the apical and basolateral domains lose their 
boundaries and don’t stick to it (b), and there is misorientation of cells leading to 
abnormal positioning of apical and basal determinants (c). 
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To look at PCP, two other members of PCP pathway, Dvl2 and Celsr1 were 
checked in the transition zone. In controls their expression in the transition zone 
was comparable to Vangl2 expression, with expression localized at cell 
membrane; however in the absence of Vangl2, their expression was also lost from 
the membrane, suggesting PCP complex is not formed in the absence of one of 
the core member. All this evidence is supporting our hypothesis that loss of 
Vangl2 in SHF leads to loss of their polarity. Together all the results suggests that 
in the absence of Vangl2, SHF lose their polarity and epithelial nature in the 
transition zone in distal outflow tract leading to disorganisation of cells, which in 
turn results in minimal extension of outflow tract (figure 4.23). During outflow 
tract formation, maximal extension is required for the proper alignment of the 
base of the aorta with the left ventricle during aorto-pulmonary septation 
(Sugishita et al., 2004). Therefore, disturbances in the SHF because of loss of 
Vangl2 leads to reduced extension of the outflow tract resulting in alignment 
abnormalities.  
 
 
Figure 4.23: Disorganisation of SHF cells 
In control SHF cells enter in an organised manner facilitating maximal extention 
and lengthening of the outflow tract, however in mutants there is disorganisation 
of cells, which leads to reduced extension of the outflow tract and ultimately 
resulting in alignment abnormalities. 
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SHF give rise to cardiomyocytes, smooth muscle cells and to endothelial cells 
(Moretti et al., 2006). The cardiomyocytes have myocardialization defect in 
Lp/Lp mutants where Lp/+ controls have extended protusions as lamellipodia and 
filopodia into the flanking cushion tissue showing the characteristics of motile 
polarized cells and Lp/Lp mutants has rounded cells and no extensions in E13.5 
embryos (Phillips et al., 2005). Similar behaviour was seen in Vangl2
flox/flox
;Isl1-
Cre mutants although at a younger stage as compared to Lp/Lp. At E10.5 
Vangl2
flox/+
;Isl1-Cre embryos showed extensions in the cells, however 
Vangl2
flox/flox
;Isl1-Cre had rounded cells with no protrusions or extensions 
indicating unpolarized nature of cells in the mutants. At E9.5 as well there was 
different in expression pattern as in controls there was a gradual increase of 
MF20 expression in the distal outflow tract and become strong as cells move 
more proximally showing gradual transition of precursor SHF into differentiated 
myocardium. However, high level expression was seen abruptly in 
Vangl2
flox/flox
;Isl1-Cre mutants. Smooth muscle cells also showed expression 
more distally in the Vangl2
flox/flox
;Isl1-Cre mutants as compared to controls. Isl1 
expression at E9.5 showed loss of nuclear expression more distally in the 
mutants. Hence, loss of Isl1 expression more distally, abrupt appearance of strong 
MF20 expression and early expression of smooth muscle cells indicates loss of 
precursor phenotype of SHF and early differentiation (figure 4.24).  
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Figure 4.24: Early differentiation of precursor SHF cells in mutants 
SHF cells enter the outflow tract in the precursor state and differentiate as they 
move proximally to form the outflow tract myocardium with a transition zone 
which there is transition from precursor to differentiated cells in control 
condition. In contrast, mutants show premature differentiation of SHF cells. 
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When looked at later stage, E14.5, smooth muscle cells expression appeared to be 
absent at the outer region of the aortic arterial wall at the aortic root along with 
loss of elastin fibres in mutants, which are derived from smooth muscle cells. 
Smooth muscle cells at the base of aorta and pulmonary trunk are derived from 
SHF cells while at the arch level are derived from NCC (Waldo et al., 2005b). 
Our results were in consistency with the Waldo model of different origins of 
smooth muscle cells as SHF specific Vangl2
flox/flox
;Isl1-Cre mutant showed 
normal expression of smooth muscle cells at the aortic arch, where the smooth 
muscle cells are derived from NCC. These results suggest that loss of Vangl2 
specifically from the SHF cells affects the maturation of these cells owing to the 
difference in smooth muscle cells expression and elastin levels in controls and 
mutants, confirming Vangl2 plays a key role in SHF cells. Together the results 
suggest that loss of Vangl2 leads to disruption of epithelialisation and polarisation 
of SHF cells and their premature differentiation in the distal outflow tract. This 
results in disorganisation of SHF cells while they entering the outflow tract 
leading to impairment in outflow tract lengthening process, which ultimately 
results in double outlet right ventricle in Vangl2
flox/flox
;Isl1-Cre mutants. 
Outflow tract defects are common in mice with mutations in PCP genes 
(Henderson et al., 2001; Hamblet et al., 2002; Curtin et al., 2003; Paudyal et al., 
2010), indicating their importance in SHF. I therefore decided to look at upstream 
and downstream targets of Vangl2 in the PCP pathway and establish whether they 
also play an important role in SHF for normal heart development. This forms the 
basis of the next chapter. 
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Chapter 5 
Upstream and Downstream of Vangl2 
5.1 Introduction 
The requirement of the PCP gene, Vangl2 specifically in SHF cells is established 
in the previous chapters. Loss of Vangl2 function in these cells impacts on 
morphogenesis of the cardiac outflow tract by failing to regulate polarisation and 
organisation of SHF cells into and within the developing outflow tract in the 
transition zone.  However, as other components of PCP pathway have been 
involved in cardiac outflow tract morphogenesis (Hamblet et al., 2002; Curtin et 
al., 2003; Phillips et al., 2007; Schleiffarth et al., 2007; Zhou et al., 2007b; 
Etheridge et al., 2008; Nagy et al., 2010; Paudyal et al., 2010; Yu et al., 2010), it 
was considered relevant to look at the signalling and transcription factors working 
upstream and downstream of Vangl2. 
 
5.1.1 Upstream of PCP signalling 
The Wnt family plays a role in different cell processes, and can be divided into 
two classes. The first Wnt class, which includes Wnt1, Wnt3a, Wnt8, activates 
the canonical β-catenin pathway and regulates cell proliferation and cell fate 
(Cadigan and Nusse, 1997; Sokol, 1999). The second class is the Wnt5a class, 
which includes Wnt5a and Wnt11, and activates non-canonical Wnt pathway and 
have been reported to regulate planar cell polarity and convergent extension 
movements in zebrafish and Xenopus (Moon et al., 1993; Heisenberg et al., 2000; 
Sokol, 2000; Tada and Smith, 2000; Wallingford et al., 2000). In mouse, Wnt5a 
interacts with Vangl2 during cochlear extension, neural tube closure, cilia 
orientation (Qian et al., 2007) and during limb elongation (Gao et al., 2011). This 
interaction of Wnt5a with Vangl2 is through Ror2 as it induces Ror2-Vangl2 
complex and regulates cell polarity (Gao et al., 2011). Ror2 is a receptor 
belonging to Ror family of receptor tyrosine kinases (RTKs) and has cysteine rich 
domains (CRD). Wnt5a binds extracellularly to the cysteine rich domain of Ror2 
(Oishi et al., 2003) and induces a complex formation between Ror2 and Vangl2. 
This complex between Ror2 and Vangl2 is formed through phosphorylation of 
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Vangl2 via tyrosine kinase (TK) domain present on Ror2 intracellularly and CKIδ 
(Casein Kinase 1) (Gao et al., 2011), which is shown to be a mandatory factor in 
PCP signalling in Drosophila (Klein et al., 2006; Strutt et al., 2006) (Figure 5.1). 
This complex is known to regulate cell polarity.  
 
 
 
Figure 5.1: Vangl2 phosphorylation by Ror2 and Wnt5a 
Wnt5a interacts with Ror2 through its cysteine rich domains (CRD) present extra-
cellularly and the tyrosine kinase (TK) domain present intra-cellularly interacts 
with Vangl2 and phophorylates it via casein kinase 1 (CKIδ). 
 
 
Wnt5a and Ror2 have a similar expression pattern and are expressed in the 
developing face, limbs, heart and lungs (Yamaguchi et al., 1999; DeChiara et al., 
2000; Takeuchi et al., 2000; Li et al., 2002). Mutations in both genes individually 
lead to respiratory dysfunction, cardiac defects and shortened-limb dwarfism 
known as Robinow Syndrome in humans (Van Bokhoven et al., 2000; Gao et al., 
2011). A similar phenotype is seen in Wnt5a and Ror2 mouse mutants 
(Yamaguchi et al., 1999; DeChiara et al., 2000; Takeuchi et al., 2000; Oishi et al., 
2003),  and similar expression pattern indicate a physical and functional 
interaction between Wnt5a and Ror2, which has been demonstrated before (Oishi 
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et al., 2003). Mutation in both Ror2 and Wnt5a also leads to cardiac defects 
(Oishi et al., 2003). Wnt5a null mice show 100% penetrance for outflow tract 
defects like common arterial trunk and also exhibit aortic arch defects in some 
nulls, while Ror2 null mice exhibit ventricular septal defects (Oishi et al., 2003; 
Schleiffarth et al., 2007). Similar external phenotype of Wnt5a null, Ror2 null and 
Lp/Lp mutants having shortened anterior-posterior body axis and shortened limbs 
suggests Vangl2, Ror2 and Wnt5a have similar roles and are present in the same 
signalling pathway. Their interaction with Vangl2 hasn’t been studied before in 
heart but because of their interaction with Vangl2 in other developmental 
processes (Gao et al., 2011), it may be that they play important roles in heart as 
well. 
 
5.1.2 Downstream of PCP signalling 
 
Vangl2 interact with PCP signalling molecules and activates Rac-JNK and Rho-
ROCK signalling cascades (Katoh, 2002; Torban et al., 2004; Katoh, 2005). 
ROCK and Rac1 are both downstream effectors of the PCP pathway, and have 
roles in cell adhesion, migration and polarity (Bosco et al., 2009; Amano et al., 
2010). PCP proteins present at the cell membrane activate downstream signalling 
via the small GTPases RhoA and Rac. This activation leads to activation of Rho 
kinases (ROCK) and c-jun terminal kinase (JNK) respectively, which helps in 
reorganization of the cell cytoskeleton and effects cell movements (figure 5.2).  
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Figure 5.2: ROCK and Rac1 as downstream targets of PCP signalling. 
PCP proteins activate RhoA and Rac, which leads to activation of ROCK leading 
to reorganization in cell cytoskeleton and polarized cell movement, and JNK 
which helps in transcription process. 
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ROCK is a serine/threonine protein kinase downstream of the GTPase Rho A 
(Amano et al., 2010). ROCKs phosphorylate over 20 substrate proteins primarily 
involved in regulating assembly of actin filaments within the cytoskeleton (Riento 
and Ridley, 2003). Through this mechanism it regulates a broad variety of 
physiological processes, including cell migration (Worthylake and Burridge, 
2003), proliferation (Sahai et al., 2001), transformation (EMT) (Zondag et al., 
2000), apoptosis (Sebbagh et al., 2001), morphology (Sordella et al., 2002) and 
establishing cell polarity (Amano et al., 2010).  ROCK is present in the form of 2 
isoforms (Rock 1 and 2), which are highly conserved serine/threonine kinases 
(Satoh et al., 2011) and have similar expression patterns and roles during 
embryonic development (Thumkeo et al., 2005). ROCK is key effector of RhoA 
signalling and ROCK1 is co-expressed with RhoA in the myocardial cushion 
interface and this co-expression is disrupted by the mutation of the Vangl2 gene 
(Brade et al., 2006). Knockout of ROCK1 and ROCK2 independently does not 
result in cardiac defects (Thumkeo et al., 2003; Thumkeo et al., 2005), however, 
disruption of ROCK signalling using the specific chemical inhibitor Y27632 in 
chick embryos results in a range of cardiac anomalies (Wei et al., 2001). It has 
been known that ROCK plays an important role in cell movement and 
development of their polarity (Raftopoulou and Hall, 2004) and loss of its 
function in Isl1 expressing cells prevents normal movement of SHF cells within 
the developing heart in mouse (Hildreth et al., 2009). This leads to defects like 
atrioventricular septal defects and hypoplastic venous valves in the inflow region 
of the heart (Hildreth et al., 2009). As SHF cells contribute to the outflow region 
as well in addition to inflow region of heart, ROCK activity was looked in the 
outflow tract.  
Rac1 is a member of the Rho family of small guanosine triphosphatases 
(GTPases), which are a subgroup of Ras-superfamily of GTPases. It regulates 
focal adhesion and reorganization of actin-cytoskeleton in cellular protrusions 
(Ridley, 2001) and plays a fundamental role in cellular processes like 
cytoskeleton organization, gene transcription, DNA synthesis, superoxide 
production, cell migration, cell proliferation and apoptosis (Bosco et al., 2009). 
All these roles of Rac1 has been investigated in cardiovascular development in 
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terms of cardiac progenitor populations (Tan et al., 2008; Bosco et al., 2009; 
D'Amico et al., 2009; Thomas et al., 2010). It regulates proliferation of vascular 
smooth muscle cell and their migration, cardiomyocyte hypertrophy, and 
realignment of endothelial cells (Sawada et al., 2010). Deletion of Rac1 
specifically in endothelial cells leads to embryonic lethality (Fiedler, 2009), and 
in neural crest cells mutant embryos have craniofacial abnormalities with cardiac 
defects like common arterial trunk and aberrant remodelling of pharyngeal arch 
arteries (Thomas et al., 2010). 
As ROCK and Rac1 are seen to play an important role in cell migration and cell 
survival or cell apoptosis, their role in cardiac development is very important and 
raises the possibility of their involvement in congenital heart defects related to 
migrating cardiac progenitor populations. Therefore, we aim to investigate the 
role of PCP pathway downstream targets, Rac1 and ROCK in SHF for heart 
development and relate them to the defects in the Vangl2;Isl1-Cre mutants. 
To genetically dissect the role of Rac1 and ROCK in SHF cells, expression of 
Rac1 and ROCK was specifically deleted/knocked down in cells derived from 
SHF. For tissue specific removal of Rac1, Rac1flox mice (Walmsley et al., 2003) 
were used, and for ROCK, a dominant negative form of ROCK was used, called 
ROCKDN (Kobayashi et al., 2004). ROCKDN protein has a point mutation in the 
RhoA binding site, therefore cannot bind to RhoA. It instead binds to endogenous 
ROCK1 and ROCK2 and inhibits the function of the kinase domain preventing 
functional activity of both ROCK isoforms (Kobayashi et al., 2004). There is a 
CAT gene cassette ahead of ROCKDN in the sequence which does not let it 
express, however this CAT cassette has lox P sites on its either sides and can be 
removed using Cre resulting in expression of ROCKDN. The SHF specific 
promoter, Isl1-Cre (Yang et al., 2006) was used to drive SHF specific 
deletion/knockdown (deletion in case of Rac1 and knockdown in case of 
ROCKDN).  
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5.2 Results 
5.2.1 Wnt5a and Ror2 regulating Vangl2 expression  
To look at cardiac defects in the absence of Wnt5a and Ror2, null mutants of each 
(Wnt5a
-/- 
and Ror2
-/-
) were analysed. Genetic interaction between Vangl2, Wnt5a 
and Ror2 was looked at using Lp mice, without using Cre lines. Finally, cellular 
behaviour was analysed in transition zone of the outflow tract of Wnt5a and Ror2 
null embryos for cell adhesion and polarity using specific markers. 
 
5.2.1.1 Wnt5a and Ror2 mutation leads to external and cardiac defects 
Wnt5a
+/-
 heterozygous mice, and separately Ror2
+/-
 heterozygous mice were 
crossed together to generate Wnt5a
-/-
 and Ror2
-/- 
embryos, which were collected at 
E14.5 to look at external and cardiac phenotype.  Wnt5a
-/-
 and Ror2
-/-
 embryos 
(n=4) showed external abnormalities and this phenotype was similar to the 
external phenotype seen in Lp/Lp mutant embryos (table), exhibiting shortened 
frontonasal processes (figure 5.3b,c,e,f,h,i bold white arrow), shortened body 
along P-D axis and shortened limbs (figure 5.3j red lines and graph). These range 
of external defects are summarized in table 5.1.  
  
Table 5.1: External defects in Lp/Lp, Wnt5a
-/-
 and Ror2
-/- 
at E14.5 
External 
defects 
Lp/Lp 
(n=4) 
Wnt5a
-/-
 
(n=4) 
Ror2
-/-
 
(n=4) 
CRN 4 (100%) 2 (50%) 2 (50%) 
Oedema 0 (0%) 2 (50%) 0 (0%) 
Shortened 
limbs 
4 (100%) 4 (100%) 4 (100%) 
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Figure 5.3: External defects in Lp/Lp, Wnt5a
-/-
 and Ror2
-/-
embryos at E14.5  
Whole embryos at E14.5 with external defects. a-c) Lp embryos with normal 
external phenotype of Lp/+ embryo (a), Lp/Lp embryos showing open neural tube 
(CRN) (b) and another Lp/Lp embryo showing open neural tube along with 
gastrochitisis (c), with shortened frotonasal processes (b,c bold white arrow).  d-f) 
Wnt5a
+/+ 
embryo with normal external phenotype (d) and Wnt5a
-/- 
embryo with 
oedema (e, arrow), open neural tube (f, arrow) with shortened frotonasal 
processes (e,f bold white arrow). g-i) Ror2
+/+
 embryo with normal external 
phenotype (g) and Ror2
-/-
 embryo open neural tube (i, arrow) with shortened 
frotonasal processes (h,i bold white arrow). j) Short limbs in Lp/Lp, Wnt5a
-/-
 and 
Ror2
-/-
 embryos as compared to Lp/+, Wnt5a
+/-
 and Ror2
+/- 
embryos (red lines) 
and graph showing limb length index of the embryos. Scale - 2000µm. 
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To check the presence of cardiac defects, embryos were embedded in wax and 
then transverse sections through heart (figure 5.4a) were stained with H&E. Both 
Wnt5a
-/-
 and Ror2
-/-
 embryos showed cardiac defects, which were also present in 
the outflow region as seen in Lp/Lp mutants. Table in figure 4 shows cardiac 
defects and their occurrence in Lp/Lp, Wnt5a
-/-
 and Ror2
-/-
 embryos. Lp/Lp 
mutants exhibit double outlet right ventricle, ventricular septal defect (figure 
5.4b,c) and aortic arch defect. Outflow defects were seen in Wnt5a
-/- 
embryos 
(n=4), having common arterial trunk (figure 4d) and ventricular septal defect 
(figure 5.4e) in all null embryos. However, 25% (1/4) Ror2
-/-
 embryos had double 
outlet right ventricle (figure 5.4f) and 50% (2/4) penetrance of ventricular septal 
defects (figure 5.4g). 
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Figure 5.4: Cardiac defects in Lp/Lp, Wnt5a
-/-
 and Ror2
-/-
embryos at E14.5 
a) Plane of the section with table showing different cardiac defects observed in 
Lp/Lp, Wnt5a
-/-
 and Ror2
-/-
 embryos. b,c) Transverse sections through heart of 
Lp/Lp mutant embryos showing double outlet right ventricle (b) and ventricular 
septal defect (c). d,e) Transverse sections through heart of Wnt5a
-/-
 embryos 
showing common arterial trunk (d) and ventricular septal defect (e). f,g) 
Transverse sections through heart of Ror
2-/-
 embryo showing double outlet right 
ventricle (f) and ventricular septal defect (g). RA-right atria, LA-left atria, RV-
right ventricle, LV-left ventricle, A-aorta, PT-pulmonary trunk, CAT-common 
arterial trunk, VSD-ventricular septal defect, DORV-double outlet right ventricle. 
Scale - 20µm. 
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5.2.1.2 Disruption of adherens junction in Wnt5a-/- and Ror2-/- embryos 
Wnt5a
-/- 
and Ror2
-/-
 embryos were collected at E9.5 stage to match the analysis of 
Vangl2
flox/flox
;Isl1-Cre mutants described in the previous chapter. At this point 
SHF cells are entering into the outflow tract and disruption in their organization 
and polarity at this stage leads to defects in the fully formed heart. Lp mice was 
established as SHF mutant with respect to heart development by genetically 
dissecting the role of Vangl2 in SHF cells using our Vangl2
flox/flox
;Isl1-Cre mice. 
Given the interaction of Wnt5a and Ror2 with Vangl2, it was hypothesised that 
their deletion would also lead to abnormalities in SHF cells within the outflow 
tract as seen in our Vangl2
flox/flox
;Isl1-Cre mutants. Therefore cellular organization 
was looked at using β-catenin, presence of epithelial nature and adherens junction 
was analysed by looking at apical localization of E-cadherin, presence of tight 
junctions through PKCζ and apical-basal polarity (ABP) in the cells by 
basolateral localization of laminin in Wnt5a
-/- 
and Ror2
-/-
 embryos (n=3). 
Adherens junctions (AJ) have a role in establishing cell polarity (Wu et al., 2010) 
and cadherin-catenin complex is an important component of AJ. In E9.5 
Vangl2
flox/flox
;Isl1-Cre mutant embryos, there was mislocalisation of E-cadherin 
apical expression in the distal outflow tract (figure 5.5 c,g arrow heads). Similar 
expression pattern was seen in Wnt5a
-/- 
and Ror2
-/-
 embryos. Figure 5.5 shows the 
expression of E-cadherin in the distal outflow tract in Wnt5a and Ror2 control 
and null embryos. The expression in the Wnt5a
+/+
 and Ror2
+/+
 embryos in the 
distal outflow tract (figure 5.5 k,s arrow heads) was seen at the apico-basal 
boundary, however there was mislocalisation of E-cadherin expression in Wnt5a
-/- 
(figure 5.5 o arrow heads) and Ror2
-/- 
(figure 5.5 w arrow heads) embryos as it 
was seen more towards basolateral compartment with no expression on apical 
side.  
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Figure 5.5: Loss of apical-basal localization of E-Cadherins expression in 
transition zone of Vangl2
flox/flox
;Isl1-Cre, Wnt5a
-/- 
and Ror2
-/- 
mutants at E9.5 
 
a-d) E-cadherin expression (in green) in Vangl2
flox/+
;Isl1-Cre control (a) showing 
apical –basal expression  (arrow heads in c). e-h) E-cadherin expression in 
Vangl2
flox/flox
;Isl1-Cre mutant (e) with expression  at basolateral compartment of 
some cells in the transition zone (arrow heads in g). i-l) E-cadherin expression in 
Wnt5a
+/- 
control (i) showing apical –basal expression  (arrow heads in k). m-p) E-
cadherin expression in Wnt5a
-/-
 mutant (m) with disruption of expression  in some 
cells in the transition zone (arrow heads in o). q-t) E-cadherin expression in 
Ror2
+/- 
control (q) showing apical –basal expression  (arrow heads in s). u-x) E-
cadherin expression in Ror2
-/-
 mutant (u) with disrupted expression  at cell 
boundary and expression at basolateral compartment of some cells in the 
transition zone (arrow heads in w). A-apical, B-basal. Scale - 100µm. 
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In Vangl2
flox/flox
;Isl1-Cre mutant embryos, expression of β-catenin showed 
disrupted cellular organization (figure 5.6 c,g arrow heads). β-catenin expression 
in Wnt5a and Ror2 embryos showed it was present localised at the membrane of 
distal outflow tract wall cells marking their basolateral compartment in Wnt5a
+/+
 
and Ror2
+/+ 
embryos (figure 5.6 k,s arrow heads). The expression was present in 
the cells in the distal outflow tract in both Wnt5a
-/-
 (figure 5.6 o arrow heads) and 
Ror2
-/-
 (figure 5.6 w arrow heads) embryos, but cells appeared to be disorganised 
as compared to their respective controls. However cellular organisation in Ror2
-/- 
embryo section appears less affected when compared to Wnt5a
-/- 
embryo. 
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Figure 5.6: Disorganized expression of β-catenin in transition zone of 
Vangl2
flox/flox
;Isl1-Cre, Wnt5a-/- and Ror2-/- mutants at E9.5 
a-d) β-catenin expression (in green) in Vangl2flox/+;Isl1-Cre control (a) showing 
membrane bound expression (arrow heads in c). e-h) β-catenin expression in 
Vangl2
flox/flox
;Isl1-Cre mutant (e) with disorganized expression in some cells in 
the transition zone (arrow heads in g). i-l) β-catenin expression in Wnt5a+/- 
control (i) showing membrane bound expression (arrow heads in k). m-p) β-
catenin expression in Wnt5a
-/-
 mutant (m) with disorganized expression in some 
cells in the transition zone (arrow heads in o). q-t) β-catenin expression in Ror2+/- 
control (q) showing membrane bound expression (arrow heads in s). u-x) β-
catenin expression in Ror2
-/-
 mutant (u) with some cells in disorganized manner 
in the transition zone (arrow heads in w). A-apical, B-basal. Scale - 100µm. 
195 
 
Expression of these markers was looked at another region than transition zone in 
the distal outflow tract to check if it is a universal effect or just in the transition 
zone. E-cadherin and β-catenin expression was looked at dorsal wall of aortic sac 
as observed in Vangl2;Isl1-Cre embryos, and confirm disruption of expression 
only in the transition zone. It was observed that these adhesion proteins are 
expressed in a comparable manner in controls and mutants in regions other than 
transition zone (figure 5.7 a2-h2 arrow heads) and show different expression 
pattern in transition zone only.  
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Figure 5.7: Comparable expression of E-cadherin and β-catenin in controls 
and mutants outside transition zone 
a-d) E-cadherin expression (in green) in Wnt5a
+/-
 control (a) and Ror2
+/-
 control 
(c) showing apical–basal expression (arrow heads in a2,c2) and in Wnt5a-/- 
mutant (b) and Ror2
-/-
 mutant (d) also with apical-basal expression in cells in the 
dorsal wall of aortic sac (arrow heads in b2,d2). e-h) β-catenin expression (in 
green) in Wnt5a
+/-
 control (e) and Ror2
+/-
 control (g) showing membrane bound 
expression (arrow heads in e2,g2) and in Wnt5a
-/-
 mutant (f) and Ror2
-/-
 mutant (h) 
also showing membrane bound expression in cells in the dorsal wall of aortic sac 
(arrow heads in f2,h2). Scale - 100µm. 
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Similar expression pattern of these markers was observed in Vangl2
flox/flox
;Isl1-
Cre mutants at E9.5 in the distal outflow tract, indicating disruption of AJ and 
loss of epithelial nature of the cells in the transition zone in Wnt5a
-/-
 and Ror2
-/-
 
embryos, like in Vangl2
flox/flox
;Isl1-Cre mutants. This similar phenotype in the 
absence of Vangl2, Wnt5a and Ror2 suggested relation between them indicating 
disruption in one may lead of similar disruption in cell behaviour. 
 
5.2.1.3 Disruption of tight junctions in Wnt5a
-/-
 and Ror2
-/- 
embryos 
Another epithelial marker, PKCζ expression was looked at, which is present 
enriched in apical compartment of the cells at the point of tight junctions (TJ). In 
Vangl2
flox/flox
;Isl1-Cre mutant embryos loss of apical enrichment of PKCζ 
expression in the distal outflow tract from cells was observed at E9.5 (figure 5.8 
c,g arrow heads) indicating disruption in TJ. Figure 5.8 shows PKCζ expression 
localized at TJ (at the apical side of the cells) in Wnt5a
+/+
 embryo (figure 5.8 k 
arrow heads) and Ror2
+/+
 embryo (figure 5.8 s arrow heads). This expression can 
be seen in cells before entering the outflow tract and while in distal outflow tract. 
However, in Wnt5a
-/- embryos PKCζ expression was mislocalised with no apical 
localization in cells in the dorsal pericardial wall and in the distal outflow tract 
(figure 5.8 o arrow heads). In Ror2
-/-
 embryos, cells before entering outflow tract 
had this apical localization, while the cells in the distal outflow tract in the 
transition zone had mislocalised PKCζ expression with no apical localization 
(figure 5.8 w arrow heads) similar to Vangl2
flox/flox
;Isl1-Cre phenotype. 
Mislocalization of PKCζ expression in TJ  have role in polarity of cells and 
similar expression leading to disrupted cellular polarity was also seen in our 
Vangl2
flox/flox
;Isl1-Cre mutants indicating a strong link between these genes. 
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Figure 5.8: Mislocalization of PKCζ expression in transition zone of 
Vangl2
flox/flox
;Isl1-Cre, Wnt5a
-/- 
and Ror2
-/- 
mutants at E9.5 
 
a-d) PKCζ expression (in red) in Vangl2flox/+;Isl1-Cre control (a) showing apical 
localization at tight junctions (arrow heads in c). e-h PKCζ expression in 
Vangl2
flox/flox
;Isl1-Cre mutant (e) with mislocalized expression in cells in the 
transition zone but apically localized expression in dorsal pericardial wall (arrow 
heads in g). i-l) PKCζ expression in Wnt5a+/- control (i) showing apical 
localization at tight junctions (arrow heads in k). m-p) PKCζ expression in 
Wnt5a
-/-
 mutant (m) with mislocalized expression in cells in the transition zone 
and in dorsal pericardial wall (arrow heads in o). q-t) PKCζ expression in Ror2+/- 
control (q) showing apical localization at tight junctions (arrow heads in s). u-x) 
PKCζ expression in Ror2-/- mutant (u) with mislocalized expression in cells in the 
transition zone but apically localized expression in dorsal pericardial wall (arrow 
heads in w). A-apical, B-basal. Scale - 100µm. 
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5.2.1.4 Loss of apical-basolateral polarity in Wnt5a
-/- 
and Ror2
-/- 
embryos 
The extra-cellular marker laminin is found extra-cellularly at the basal side of the 
cell giving a clear representation of which is the apical side and which is the basal 
side. Laminin expression was disrupted in E9.5 Vangl2
flox/flox
;Isl1-Cre mutant 
embryos in the transition zone in the distal outflow tract (figure 8c,d arrows) 
indicating abnormal compartmentalisation of cell into apical and basal sides in 
this region. Similar expression was seen in Wnt5a and Ror2 embryos. There was 
uniform basal expression in Wnt5a
+/+ 
(figure 8e arrows) and Ror2
+/+
  (figure 8g 
arrows) embryos, however abnormal expression pattern was observed  in Wnt5a
-/-
 
(figure 8f arrows) and Ror2
-/-
 (figure 8h arrows) embryos with laminin expression 
being irregular and not limited to the basal side of the cell. This similar pattern of 
disruption in ABP in cells in the transition zone showed mutation in Vangl2, 
Wnt5a or Ror2 leads to similar phenotype, indicating their role in the same 
pathway and genetic relation between them.  
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Figure 5.9: Disruption of laminin basal expression in transition zone of 
Vangl2
flox/flox
;Isl1-Cre, Wnt5a
-/- 
and Ror2
-/- 
mutants at E9.5 
a-d) Laminin expression (in red) in Vangl2
flox/+
;Isl1-Cre control (a) showing 
uniform basal expression (arrow heads in c). e-h) Laminin expression in 
Vangl2
flox/flox
;Isl1-Cre mutant (e) with disrupted expression with not being limited 
to basal side of the cells in the transition zone (arrow heads in g). i-l) Laminin 
expression in Wnt5a
+/-
 control (i) showing uniform basal expression (arrow heads 
in k). m-p) Laminin expression in Wnt5a
-/-
 mutant (m) with disrupted expression 
with not being limited to basal side of the cells in the transition zone (arrow heads 
in o). q-t) Laminin expression in Ror2
+/-
 control (q) showing uniform basal 
expression (arrow heads in s). u-x) Laminin expression in Ror2
-/-
 mutant (u) with 
disrupted expression with not being limited to basal side of the cells in the 
transition zone (arrow heads in w). A-apical, B-basal. Scale - 100µm. 
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However, when laminin expression was seen in the proximal outflow tract having 
differentiated cardiomyocytes it was observed that the expression was limited to 
the basal side and comparable in both Wnt5a
 
and Ror2
 
controls and mutants 
(figure 5.10 c,g,k,o arrow heads), showing that the expression is only disrupted in 
the transition zone.  
 
 
Figure 5.10: Basal expression of laminin in proximal outflow tract of Wnt5a
-/- 
and Ror2
-/- 
mutants at E9.5 
a-d) Laminin expression (in red) in Wnt5a
+/-
 control showing basal expression 
between the basement membrane and the cells (arrow heads in c). e-h) Laminin 
expression in Wnt5a
-/-
 mutant showing basal expression similar to control (g 
arrow heads). i-l) Laminin expression (in red) in Ror2
+/-
 control showing basal 
expression between the basement membrane and the cells (arrow heads in k). e-h) 
Laminin expression in Ror2
-/-
 mutant showing basal expression similar to control 
(o arrow heads). A-apical, B-basal. Scale - 100µm. 
 
 
These results suggested that the basal determinants of the cells in the transition 
zone are not limited to basal side in the absence of Wnt5a and Ror2, indicating 
loss of apical-basal identity of cells in the transition zone.                           
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 5.2.2 ROCK and Rac1 as downstream targets of PCP pathway 
The PCP pathway as discussed before in chapter 1 requires different proteins to 
work together in a coordinated manner. Vangl2 is one of the core proteins in this 
pathway and is upstream of Rac1 and ROCK. Expression of Rac1 and ROCK was 
specifically deleted/knocked down in cells derived from SHF and phenotype was 
compared with Vangl2
flox/flox
;Isl1-Cre mutants. 
 
 
5.2.2.1 Role of ROCK in SHF cells  
ROCKDN females, which were heterozygous for ROCKDN construct were 
incorporated with YFP and were crossed with Isl1-Cre males to get the mutant 
phenotype of ROCKDN;Isl1-Cre with YFP incorporated in the genome. Embryos 
which did not express ROCKDN, but were Isl1-Cre positive were used as 
controls (referred as ROCK Control). Figure 5.11 shows the cross to drive 
ROCKDN expression in SHF cells using Isl1-Cre. 
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Figure 5.11: ROCKDN cross with Isl1-Cre 
All ROCKDN females were incorporated with eYFP sequence. Isl1-Cre x 
ROCKDN
 
cross to have expression of ROCKDN in Isl1 expressing cells. CAT 
cassette ahead of ROCKDN and Stop cassette ahead of eYFP has loxP sites on 
either sides (shown in red), which gets removed with the expression of Cre. 
Resulting genotype would express ROCKDN and eYFP in all the cells which 
express Cre and leads to loss of function of ROCK as ROCKDN prevents 
function of ROCK1 and ROCK2 by binding to them and preventing them from 
binding with RhoA and hence blocks their function. 
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5.2.2.2 ROCKDN;Isl1-Cre embryos have cardiac outflow tract defects 
To check the occurrence of cardiac defects in ROCKDN;Isl1-Cre mutants, 
embryos were collected at E14.5. Five out of seven mutants were processed by Dr 
Jonathan Peat in the Henderson Lab. External phenotype was therefore analysed 
of only 2 mutant embryos. One embryo out of these 2 mutants had haemorrhage 
(figure 5.12 b arrow); however the other was indistinguishable from their control 
littermates (figure 5.12 a,c). Genotyping was done to identify the mutants and 
were further examined for heart phenotype. Both mutant and control embryos 
wax embedded and were transversely sectioned through heart to look at the heart 
phenotype (figure 5.12 d). H&E staining was done on the sections, which 
revealed there was 100% penetrance of an outflow tract defect in ROCKDN;Isl1-
Cre embryos, with 6/7 mutant embryos showing common arterial trunk (figure 
5.12 f) and 1/7 had double outlet right ventricle. Control embryos had a normal 
outflow tract with septation between aorta and pulmonary trunk (figure 5.12 e). 
All 7 mutant embryos had ventricular septal defect (figure 5.12h) and 3/7 had 
atrio-ventricular septal defect and 1/7 embryo has atrial septal defect. Six out of 
seven mutant embryos also had aortic arch defect, retroesophageal subclavian 
artery (figure 5.12 h). These range of heart defects are summarized in table 5.2.  
Table 5.2: Cardiac defects in ROCKDN;Isl1-Cre at E14.5 
Cardiac defects 
ROCKDN;Isl1-Cre 
(n=7) 
Outflow tract 
defects 
CAT 6 (86%) 
DORV 1 (14%) 
VSD 7 (100%) 
ASD 1 (14%) 
AVSD 3 (43%) 
RRESA 6 (86%) 
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Figure 5.12: External phenotype and cardiovascular defects in 
ROCKDN;Isl1-Cre embryos at E14.5  
a-c) Whole embryo at E14.5 with normal external phenotype of control embryo 
(a), mutant embryo with haemorrhage (b, arrow), and mutant embryo with 
normal phenotype (c). Scale - 2000µm. d-k) Transverse sections of heart from 
ROCKDN x Isl1-Cre litter. Transverse section through heart of ROCK control 
embryo showing normal heart development with separate aorta and pulmonary 
trunk (d), intra-ventricular septum (f) and normal left-sided aortic arch (j). Heart 
section from ROCKDN;Isl1-Cre embryo showing common arterial trunk (e), 
ventricular septal defect (g), atrial septal defect (h), atrio-ventricular septal defect 
(i) and retroesophageal subclavian artery (k). RA-right atria, LA-left atria, RV-
right ventricle, LV-left ventricle, A-aorta, PT-pulmonary trunk, CAT- common 
arterial trunk, IVS- intra-ventricular septum, VSD-ventricular septal defect, ASD-
atrial septal defect, AVSD-atrio-ventricular septal defect, RRESA-
retroesophageal subclavian artery. Scale - 20µm. 
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5.2.2.3 Role of Rac1 in SHF cells  
To look for cardiac defects caused by the absence of Rac1 from SHF cells, 
Rac1
flox/+;
Isl1-Cre and Rac1
flox/flox
;YFP
 flox/flox
 mice were generated and then these 
parents were crossed together to get Rac1
flox/flox
;Isl1-Cre embryos with Rac1 
deleted from all SHF derived cells and with YFP incorporated in the genome to 
label these SHF cells (figure 5.13). Embryos were collected to look at the external 
and heart phenotype. This was initially carried out by Dr Hong Jun Rhee and Dr 
Iain Keenan in the Henderson lab.  
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Figure 5.13: Rac1
flox 
cross specifically within SHF cells, using Isl1-Cre  
All Rac1
flox 
mice were incorporated with eYFP sequence.. c) Rac1
flox/+;
Isl1-Cre x 
Rac1
flox/flox
;YFP
 flox/flox
 cross to have deletion of Rac1 gene specifically in SHF 
cells using Isl1Cre (Rac1
flox/flox
;Isl1-Cre). 
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5.2.2.4 Rac1
flox/flox
;Isl1-Cre embryos have external and cardiac outflow tract 
defects  
External and cardiac phenotype analysis on Rac1;Isl1-Cre embryos was initially 
done by Dr Hong Jun Rhee and Dr Iain Keenan in the Henderson lab (Keenan et 
al., 2012). Embryos were collected at E14.5, and some of the Rac1
flox/flox
;Isl1-Cre 
mutant embryos showed abnormal external phenotype, including haemorrhage 
(figure 5.14 b,c white arrows) and oedema (figure 5.14 b red arrow) (Keenan et 
al., 2012). These embryos along with controls were further embedded in wax and 
sectioned. H&E staining was done to look at the heart morphology and it revealed 
that these mutants had 100% penetrance for outflow tract defects (4/5 had 
common arterial trunk and 1/5 had double outlet right ventricle) (figure 5.14 e) 
and ventricular septal defect (figure g), although only 2/5 showed atrial septal 
defect (figure g) and 1/5 embryos showed aortic defect, double sided aortic arch 
(figure 5.14 f). Rac1
flox/flox
;Isl1-Cre mutants also have lymphatic defects, where 
the jugular veins and lymph sacs did not separate and had accumulation of large 
numbers of blood cells (Keenan et al., 2012). These range of heart defects are 
summarized in table 5.3.  
Table 5.3: Cardiac defects in Rac1
flox/flox
;Isl1-Cre at E14.5 
Cardiac defects 
Rac1
flox/flox
;Isl1-Cre 
(n=5) 
Outflow tract 
defects 
CAT 4 (80%) 
DORV 1 (20%) 
VSD 5 (100%) 
ASD 2 (40%) 
DSAA 1 (20%) 
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Figure 5.14: External phenotype and cardiovascular defects in 
Rac1
flox/flox
;Isl1-Cre embryos at E14.5  
a-c) Whole embryo at E14.5 with normal external phenotype of control embryo 
(a), mutant embryo with haemorrhage (b,c white arrows) and oedema (b red 
arrow). Scale - 2000µm. d-g) Transverse sections of heart from Rac1
flox/+;
Isl1-Cre 
x Rac1
flox/flox
;YFP
 flox/flox
 litter. Transverse section through heart of control embryo 
showing normal heart development with separate aorta and pulmonary trunk (d). 
Heart section from Rac1
flox/flox
;Isl1-Cre embryo showing common arterial trunk 
(e), double sided aortic arch (f) and ventricular septal defect (g). RA-right atria, 
LA-left atria, RV-right ventricle, LV-left ventricle, A-aorta, PT-pulmonary trunk, 
CAT- common arterial trunk, DSAA- double sided aortic arch, VSD-ventricular 
septal defect, ASD-atrial septal defect. Scale - 20µm. 
210 
 
Results confirm that both Rac1 and ROCK, similarly to Vangl2, are regulating 
SHF cells in the outflow tract of the developing heart and are important for proper 
septation of the outflow tract during developmental stage. Hence it was 
considered important to do similar analysis as done on Vangl2
flox/flox
;Isl1-Cre 
mutants to understand the behaviour of the cells in this distal outflow tract. 
 
5.2.2.5 Disruption of adherens junctions in ROCKDN;Isl1-Cre and 
Rac1
flox/flox
;Isl1-Cre mutants 
To understand the mechanism behind the role ROCK and Rac1 plays in 
development of the heart, a similar hypothesis as was proposed for the role of 
Vangl2 was put forward. It was hypothesised that as both ROCK and Rac1 are 
downstream effectors of the PCP pathway, of which Vangl2 is a key component; 
both may also play a role in cellular polarity of SHF cells whilst they are moving 
into the heart. Mutation of ROCK or Rac1 will result in disrupted polarity, as in 
Vangl2 mutants, and hence lead to cardiac defects. 
Embryos were collected at E9.5 as previously, and genotyping was done to 
identify the mutants and total 3 control and 3 mutant embryos were used for 
analysis. As ROCK and Rac1 like Vangl2 are involved in morphogenesis of the 
outflow tract, the same markers were investigated in the transition zone of the 
outflow tract to look at the polarized nature of SHF cells. Embryos were 
embedded in wax and transverse sections were taken to label them with 
fluorescent antibodies, using immunohistochemistry method. AJ markers 
including E-cadherin and β-catenin were used. Both ROCKDN;Isl1-Cre mutants 
and Rac1
flox/flox
;Isl1-Cre mutants showed abnormal expression for E-cadherin as 
compared to the respective controls. Figure 5.15 shows E-cadherin expression in 
ROCK control embryo with expression at the apical-basal boundary of the cells in 
the distal outflow tract as seen in Vangl2
flox/+
;Isl1-Cre control (figure 5.15 c,k 
arrow heads). In contrast, expression was seen in basolateral compartment of 
some cells in the ROCKDN;Isl1-Cre mutant (figure 5.15 o arrow heads). This 
mislocalization of E-cadherin was also seen in Vangl2
flox/flox
;Isl1-Cre mutant 
(figure 5.15 f arrow heads). Rac1 embryos also showed similar disturbance in E-
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cadherin expression, with apical-basal expression in Rac1
flox/+
;Isl1-Cre control 
(figure 5.15 s arrow heads) and disruption of this expression in Rac1
flox/flox
;Isl1-
Cre mutant (figure 5.15 w arrow heads).  
 
Figure 5.15: Loss of apical-basal localization of E-Cadherins expression in 
transition zone of Vangl2
flox/flox
;Isl1-Cre, ROCKDN;Isl1-Cre and 
Rac1
flox/flox
;Isl1-Cre mutants at E9.5 
a-d) E-cadherin expression (in green) in Vangl2
flox/+
;Isl1-Cre control (a) showing 
apical –basal expression  (arrow heads in c). e-h) E-cadherin expression in 
Vangl2
flox/flox
;Isl1-Cre mutant (e) with expression  at basolateral compartment of 
some cells in the transition zone (arrow heads in g). i-l) E-cadherin expression in 
ROCK control (i) showing apical –basal expression  (arrow heads in k). m-p) E-
cadherin expression in ROCKDN;Isl1-Cre mutant (m) with disruption of 
expression  in some cells in the transition zone (arrow heads in o). q-t) E-
cadherin expression in Rac1
flox/+
;Isl1-Cre control (q) showing apical –basal 
expression  (arrow heads in s). u-x) E-cadherin expression in Rac1
flox/flox
;Isl1-Cre 
mutant (u) with disrupted expression  at cell boundary and expression at 
basolateral compartment of some cells in the transition zone (arrow heads in w). 
A-apical, B-basal. Scale - 100µm. 
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β-catenin expression was seen to mark the basolateral compartment of the 
epithelial SHF cells in the transition zone in Vangl2
flox/+
;Isl1-Cre control embryo 
(figure 5.16 c arrow heads) and showed disorganisation of cells in the zone in 
Vangl2
flox/flox
;Isl1-Cre (figure 5.16 g arrow heads). Similar expression pattern was 
seen in ROCK control (figure 5.16 k arrow heads) and Rac1
flox/+
;Isl1-Cre control 
(figure 5.16 s arrow heads) with cells in the transition zone showing β-catenin 
expression in their basolateral compartments. However, expression in mutants 
was present, cells were slightly disorganized in ROCKDN;Isl1-Cre mutant (figure 
5.16 o arrow heads) and much more disorganisation was seen in  Rac1
flox/+
;Isl1-
Cre mutant (figure 5.16  w arrow heads) like in Vangl2
flox/flox
;Isl1-Cre. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
213 
 
 
Figure 5.16: Disorganized expression of β-catenin in transition zone of 
Vangl2
flox/flox
;Isl1Cre, ROCKDN;Isl1Cre and Rac1
flox/flox
;Isl1Cre mutants at 
E9.5 
a-d) β-catenin expression (in green) in Vangl2flox/+;Isl1-Cre control (a) showing 
membrane bound expression (arrow heads in c). e-h) β-catenin expression in 
Vangl2
flox/flox
;Isl1-Cre mutant (e) with disorganized expression in some cells in 
the transition zone (arrow heads in g). i-l) β-catenin expression in ROCK control 
(i) showing membrane bound expression (arrow heads in k). m-p) β-catenin 
expression in ROCKDN;Isl1-Cre mutant (m) with disorganized expression in 
some cells in the transition zone (arrow heads in o). q-t) β-catenin expression in 
Rac1
flox/+
;Isl1-Cre control (q) showing membrane bound expression (arrow heads 
in s). u-x) β-catenin expression in Rac1flox/flox;Isl1-Cre mutant (u) with some cells 
in disorganized manner in the transition zone (arrow heads in w). A-apical, B-
basal. Scale - 100µm. 
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Expression of E-cadherin and β-catenin expression was looked at dorsal wall of 
aortic sac to check disruption of expression was limited only to the transition 
zone. It was observed that these adhesion proteins, E-cadherin and β-catenin are 
expressed in a comparable manner in controls and mutants in dorsal wall of aortic 
sac (figure 5.17 a2-h2 arrow heads) like in  Vangl2
flox/+
;Isl1-Cre controls, and 
show different expression pattern in transition zone only.  
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Figure 5.17: Comparable expression of E-cadherin and β-catenin in controls 
and mutants outside transition zone 
a-d) E-cadherin expression (in green) in ROCK control (a) and Rac1
flox/+
;Isl1-Cre 
control (c) showing apical–basal expression (arrow heads in a2,c2) and in 
ROCKDN;Isl1-Cre mutant (b) and Rac1
flox/flox
;Isl1-Cre mutant (d) also with 
apical-basal expression in cells in the dorsal wall of aortic sac (arrow heads in 
b2,d2). e-h) β-catenin expression (in green) in ROCK control (e) and 
Rac1
flox/+
;Isl1-Cre control (g) showing membrane bound expression (arrow heads 
in e2,g2) and in ROCKDN;Isl1-Cre mutant (f) and Rac1
flox/flox
;Isl1-Cre mutant (h) 
also showing membrane bound expression in cells in the dorsal wall of aortic sac 
(arrow heads in f2,h2). Scale - 100µm. 
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5.2.2.6 Disruption of tight junctions in Rac1
flox/flox
;Isl1-Cre and ROCKDN;Isl1-
Cre mutants 
Disruption of AJ indicate that absence of Rac1 or ROCK in SHF cells could lead 
to disruption in compartmentalisation of cells into apical and basal domains like 
in the absence of Vangl2, to confirm this, PKCζ expression was looked at in the 
same region of the distal outflow tract at E9.5 embryos. Embryos were wax 
embedded and section transversally and immunostained with PKCζ antibody. As 
expected and seen in Vangl2
flox/flox
;Isl1-Cre mutants, there was mislocalization of 
PKCζ in Rac1flox/flox;Isl1-Cre and ROCKDN;Isl1-Cre mutants (n=3). Figure 5.18 
compares PKCζ expression in Vangl2, ROCK and Rac1 controls embryos with 
their respective mutants. Vangl2
flox/+
;Isl1-Cre control shows apical enrichment of 
PKCζ in the SHF cells in the dorsal pericardial wall and as they move into the 
distal outflow tract in the transition zone (figure 5.18 c arrow heads). This apical 
enrichment was lost in Vangl2
flox/flox
;Isl1-Cre mutant, however only in the 
transition zone as cells in the dorsal pericardial wall still had apical localization of 
PKCζ (figure 5.18 g arrow heads). ROCK control and Rac1flox/+;Isl1-Cre control 
also show apical localization of PKCζ expression in the dorsal pericardial wall 
and the distal outflow tract (figure 5.18 k,s arrow heads), however in both 
ROCKDN;Isl1-Cre and Rac1
flox/flox
;Isl1-Cre mutant embryo similar 
mislocalization of PKCζ expression was seen as observed in Vangl2flox/flox;Isl1-
Cre mutant embryo, that too only in transition zone and had apical localization of 
PKCζ expression in the dorsal pericardial wall in both mutants (figure 5.18 o,w 
arrow heads).  
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Figure 5.18: Mislocalization of PKCζ expression in transition zone of 
Vangl2
flox/flox
;Isl1Cre, ROCKDN;Isl1Cre and Rac1
flox/flox
;Isl1Cre mutants at 
E9.5 
a-d) PKCζ expression (in red) in Vangl2flox/+;Isl1-Cre control (a) showing apical 
localization at tight junctions (arrow heads in c). e-h PKCζ expression in 
Vangl2
flox/flox
;Isl1-Cre mutant (e) with mislocalized expression in cells in the 
transition zone but apically localized expression in dorsal pericardial wall (arrow 
heads in g). i-l) PKCζ expression in ROCK control (i) showing apical localization 
at tight junctions (arrow heads in k). m-p) PKCζ expression in ROCKDN;Isl1-
Cre mutant (m) with mislocalized expression in cells in the transition zone but 
apically localized expression in dorsal pericardial wall (arrow heads in o). q-t) 
PKCζ expression in Rac1flox/+;Isl1-Cre control (q) showing apical localization at 
tight junctions (arrow heads in s). u-x) PKCζ expression in Rac1flox/flox;Isl1-Cre 
mutant (u) with mislocalized expression in cells in the transition zone but apically 
localized expression in dorsal pericardial wall (arrow heads in w). A-apical, B-
basal. Scale - 100µm. 
218 
 
5.2.2.7 Loss of apical-basolateral polarity in ROCKDN;Isl1Cre and 
Rac1
flox/flox
;Isl1Cre embryos 
Laminin is an extra-cellular marker and labels the basal side of the cells, which 
was observed in Vangl2
flox/+
;Isl1-Cre control embryo at E9.5 (figure 5.19 c arrow 
heads). This basal localization was disrupted in stage-matched Vangl2
flox/flox
;Isl1-
Cre mutant and expression was observed to be not limiting to basal side of the 
cells and present at the apical side of some cells in the transition zone (figure 5.19 
g arrow heads), indicating loss of apical-basal compartmentalization in 
Vangl2
flox/flox
;Isl1-Cre mutants. ROCK and Rac1 embryos (3 controls and 3 
mutants) were also collected at E9.5, wax embedded and sectioned transversally. 
ROCK control embryo showed basal localization of laminin in the transition zone 
(figure 5.19 k arrow heads), but this localization was disrupted in ROCKDN;Isl1-
Cre mutant with irregular expression and some cells showing expression towards 
their apical side as well (figure 5.19 o arrow heads). Similar disruption was seen 
in Rac1
flox/flox
;Isl1-Cre mutant (figure 5.19 s arrow heads) with expression 
throughout around the cells as compared to the uniform basal expression seen in  
Rac1
flox/+
;Isl1-Cre control (figure 5.19 w arrow heads).  
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Figure 5.19: Disruption of laminin basal expression in transition zone of 
Vangl2
flox/flox
;Isl1-Cre, ROCKDN;Isl1-Cre and Rac1
flox/flox
;Isl1-Cre mutants at 
E9.5 
a-d) Laminin expression (in red) in Vangl2
flox/+
;Isl1-Cre control (a) showing 
uniform basal expression (arrow heads in c). e-h) Laminin expression in 
Vangl2
flox/flox
;Isl1-Cre mutant (e) with disrupted expression with not being limited 
to basal side of the cells in the transition zone (arrow heads in g). i-l) Laminin 
expression in ROCK control (i) showing uniform basal expression (arrow heads 
in k). m-p) Laminin expression in ROCKDN;Isl1-Cre mutant (m) with disrupted 
expression with not being limited to basal side of the cells in the transition zone 
(arrow heads in o). q-t) Laminin expression in Rac1
flox/+
;Isl1-Cre control (q) 
showing uniform basal expression (arrow heads in s). u-x) Laminin expression in 
Rac1
flox/flox
;Isl1-Cre mutant (u) with disrupted expression with not being limited 
to basal side of the cells in the transition zone (arrow heads in w). A-apical, B-
basal. Scale - 100µm. 
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To check if apical-basal compartmentalisation is disrupted on in the transition 
zone in the distal outflow tract, laminin expression was checked in the proximal 
outflow tract having differentiated cardiomyocytes. Expression was limited to the 
basal side and comparable in both controls and mutants (figure 5.20 c,g,k,o arrow 
heads), showing that the expression is only disrupted in the transition zone.  
 
 
 
Figure 5.20: Basal expression of laminin in proximal outflow tract of 
ROCKDN;Isl1-Cre and Rac1
flox/flox
;Isl1-Cre mutants at E9.5 
a-d) Laminin expression (in red) in ROCK control showing basal expression 
between the basement membrane and the cells (arrow heads in c). e-h) Laminin 
expression in ROCKDN;Isl1-Cre mutant showing basal expression similar to 
control (g arrow heads). i-l) Laminin expression (in red) in Rac1
flox/+
;Isl1-Cre 
control showing basal expression between the basement membrane and the cells 
(arrow heads in k). e-h) Laminin expression in Rac1
flox/flox
;Isl1-Cre mutant 
showing basal expression similar to control (o arrow heads). A-apical, B-basal. 
Scale - 100µm. 
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5.3 Discussion 
Vangl2 upstream receptors, Wnt5a and Ror2, and downstream effectors, Rac1 
and ROCK, have been implicated in playing roles during heart development with 
their absence or loss of function resulting in defects affecting the outflow region 
of the heart. It was established in the previous chapter that Vangl2 regulates 
undifferentiated SHF cells in the transition zone and helps in lengthening of the 
outflow tract, and absence of Vangl2 disrupts this process leading to outflow tract 
defect. Outflow tract defects were also observed in Wnt5a
-/-
, ROCK and Rac1 
SHF mutants (ROCKDN;Isl1-Cre, Rac1
flox/flox
;Isl1-Cre) and to some extent in 
Ror2
-/- 
(1 out of 4 embryos), therefore a similar hypothesis of disrupted cell 
organization and polarity was tested in these mutants.  
Apart from cardiac defects, there were external defects seen in Wnt5a
-/-
, Ror2
-/-
, 
ROCKDN;Isl1-Cre and Rac1
flox/flox
;Isl1-Cre mutant embryos. Neural tube defect 
in Wnt5a
-/- 
and Ror2
-/-
 embryos can be explained because of the global loss of 
these genes, similar to the global loss of Vangl2 in Lp mutants. In ROCKDN;Isl1-
Cre and Rac1
flox/flox
;Isl1-Cre  haemorrhage and oedema were observed, which 
were not seen in Vangl2
flox/flox
;Isl1-Cre mutants. Oedema is defined as abnormal 
presence of fluid anywhere in the body and is considered as a good marker of 
heart problem because due to oedema heart loses its pumping ability. Jugular and 
umbilical haemorrhage were focussed because these are also markers of heart 
defects and second heart field progenitors are expressed in these regions (Keenan 
et al., 2012). It is known that Isl1 progenitors are also expressed in regions 
outside the heart (Keenan et al., 2012), which may accounts for the high 
incidence of abnormal external phenotypes in the ROCKDN;Isl1-Cre and 
Rac1
flox/flox
;Isl1-Cre mutants, apart from ROCK and Rac1 having other functions 
and having different response of other upstream pathways. 
Wnt5a deletion leads to cardiac defects like common arterial trunk and ventricular 
septal defect (Schleiffarth et al., 2007) and Ror2 deletion results in a less severe 
phenotype, with just ventricular septal defect (Oishi et al., 2003) and double 
outlet right ventricle (1/4 embryos). Although cardiac defects seen in Wnt5a
-/-
 
embryos are more severe than our Vangl2
flox/flox
;Isl1-Cre mutants, it could be due 
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to the fact that Wnt5a acts upstream of Vangl2 and has more broader range of 
action. However, the results confirm the importance of both Wnt5a and Ror2 
during embryonic heart development; however the particular cell type which is 
regulated still needs to be established.  
On the other hand, disruption of ROCK expression in NCC leads to double outlet 
right ventricle in 39% of mutant cases (Phillips et al., 2013) and deletion of Rac1 
specifically in NCC also results in cardiac defects like common arterial trunk and 
aberrant remodelling of pharyngeal arch arteries (Thomas et al., 2010). These 
studies have established the role of ROCK and Rac1 in outflow tract development, 
but only in NCC. This chapter establishes the role of both ROCK and Rac1 in 
regulating SHF cells during outflow tract development.  
We investigated whether these components work in a similar way to polarize SHF 
cells. The data shows that all of these components of the PCP pathway play an 
important role in regulating SHF cells while they are entering the outflow tract 
during heart development. Disruption of epithelial markers, E-cadherin, β-catenin 
and PKCζ in Wnt5a-/-, Ror2-/-, ROCKDN;Isl1-Cre and Rac1flox/flox;Isl1-Cre mutant 
embryos indicate loss of the epithelial nature of cells in the distal outflow tract 
along with abnormalities in adherens and tight junctions suggesting loss of ABP 
in the cells and misorientation of cells. Disruption of laminin expression in these 
affected cells and its expression being not limited to the basal side of the cells 
strengthens the possibility of loss of ABP and loss of orientation in the absence of 
Wnt5a, Ror2, ROCK and Rac1, as observed in the absence of Vangl2. 
The mechanism through which Wnt5a, Ror2, Rac1, ROCK and Vangl2 regulate 
SHF cells is similar and shares characteristics. Adherens junctions and tight 
junctions both are disrupted in the absence of any of these genes, indicating the 
loss of polarity in the cells. However, the phenotype of Ror2-/- embryos is less 
severe as compared to Wnt5a
-/-
 embryos when looked at heart defects, which was 
reflected in the analysis of the polarity markers as well (β-catenin and PKCζ). 
This may be because Ror2 absence leads to weakened Wnt signalling rather than 
complete loss of it (Gao et al., 2011).  Vangl2 protein is a trans-membrane 
protein and shows membrane localization in the cells while they are entering the 
outflow tract (figure 4.5). However, like in Lp mutants, Vangl2 protein fails to 
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reach the membrane in Wnt5a
-/-
 embryos resulting in no membrane localization 
and reduced localization in Ror2
-/- 
embryos as a result of weakened Wnt 
signalling (Gao et al., 2011). This interaction between Wnt5a, Ror2 and Vangl2 
could be the reason behind similar behaviour of cells in the distal outflow tract.  
Relating the results and analysis with the mechanism suggested in 
Vangl2
flox/flox
;Isl1-Cre mutants, it can be suggested that ROCK and Rac1 is also 
playing a role in undifferentiated precursor SHF cells along with role in NCC, 
unlike Vangl2.  It has been shown that absence of Wnt5a leads to migration defect 
of NCCs in the heart leading to loss of aorto-pulmonary septum (Schleiffarth et 
al., 2007). Apart from the already established connection between Wnt5a, ROCK 
and Rac1 with NCC, we have shown that Wnt5a, Ror2, ROCK and Rac1 
signalling could also be involved in the polarisation of SHF cells into the distal 
outflow tract. 
It is clear that it is not just Vangl2, but the whole PCP signalling pathway which 
regulates SHF during outflow tract morphogenesis. As PCP signalling starts as 
one pathway from Wnt5a, Ror2 to Vangl2, but is divided into two pathways, one 
with Rac1 leading to JNK activation and one with ROCK which plays a role in 
gene transcription and cellular actin cytoskeleton formation, disruption at any of 
the level of the signalling, in any component of the pathway would cause 
abnormal behaviour in SHF cells. This highlights the importance of whole non-
canonical wnt/PCP signalling pathway in proper functioning of SHF cells. These 
results give us an insight into how the SHF cells behave, which can be useful in 
finding alternate ways to bring SHF cells back to normal even while these 
proteins are not present. 
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Chapter 6 
Discussion 
Heart development is a very complex process which requires morphological and 
structural changes co-ordinated along with gene expression at the correction 
location and time. At early developmental stages of heart, SHF cells contribute as 
an extra-cardiac cell population and contribute to different parts of the heart. 
Genetic control of SHF cells has been studied using a range of gene knockout and 
tissue tracking experiments, which have shown the importance of several genes 
within the SHF. However, the exact function and regulation of these genes remain 
unclear to date. Also how SHF cells behave, move and polarise is still 
unanswered.  
Over the years, genes which are required for establishing cell polarity and its 
maintenance have been identified and shown to regulate developmental processes 
in a range of species. These genes are members of a highly conserved signalling 
pathway known as the non-canonical Wnt signalling pathway or PCP pathway. 
More recently, studies have suggested a link between PCP and embryonic cardiac 
development with defects in the PCP genes resulting in abnormal cardiac 
morphogenesis leading to cardiovascular defects.  
Vangl2 is a PCP gene, which is mutated in naturally occurring Lp mice, has a 
potential role in cardiac development. This is suggested because of the various 
cardiac abnormalities including cardiac alignment defects such as double outlet 
right ventricle, ventricular septal defect and pharyngeal arch artery remodelling 
defects seen in Lp mutants. Thus, this study was aimed to investigate a possible 
role for Vangl2 during early cardiac development.  
The Vangl2 Lp mutant has been used extensively to understand the role Vangl2 
plays during mammalian embryonic development. Lp mice have gross 
morphological defects, including craniorachischisis and incomplete axial rotation, 
which are characteristic of this mutant. However, mutation in Vangl2 in all body 
cells leading to neural tube defects limit the use of Lp mice in dissecting out the 
role of Vangl2 gene during heart morphogenesis. Lp mutants display a spectrum 
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of cardiac defects which specifically affect the outflow region of the heart, 
including double outlet right ventricle, ventricular septal defect, and aortic arch 
abnormalities (Henderson et al., 2001). But global loss of Vangl2 in Lp mice 
makes it inadequate for the purpose of establishing the precise role of Vangl2 in 
heart development. It was suggested that these heart abnormalities could be 
secondary to the neural tube defects and axial turning defects (Henderson et al., 
2001). However, even if these cardiac defects are not secondary to other 
embryonic defects, the role of Vangl2 in embryonic heart development could still 
be complex, given the number of different cell populations that contribute to the 
developing outflow tract. Defects identified within the developing outflow tract of 
Lp mutants could arise from disruptions to either NCC or SHF derived cells, but 
the integration of cells from these two lineages into this region makes dissecting 
the causes of malformation extremely difficult. To answer this, a more specific 
conditional knockout of Vangl2 was required to knock out Vangl2 in particular 
cell types. Thus, a floxed allele of Vangl2 was generated. The generation of mice 
that allowed for the conditional deletion of Vangl2 in specific cell types within the 
heart has enabled us to establish the cardiac cell type that is critically dependent 
on Vangl2 function – the SHF.  In addition to this, immunofluorescence 
experiments have allowed us to study the cellular localisation of Vangl2 and the 
affect its loss has on polarity of SHF, further enabling us to attempt to unravel its 
role within the developing heart. 
Vangl2 is a trans-membrane protein, with exon 4 of Vangl2 gene containing its 
trans-membrane domains. These domains are essential for its activity; therefore 
Vangl2flox line was generated where loxP sites flank exon 4 of Vangl2, and 
remove the trans-membrane domain. A neomycin selection cassette was used 
within the targeting vector. Vangl2
floxneo/+ 
embryos were normal showing that 
Vangl2 gene is not haploinsufficient. However, Vangl2
floxneo/floxneo 
embryos, which 
had the neomycin selection cassette on both alleles, were hypomorphic for Vangl2. 
They showed a more variable external phenotype (displayed craniorachischisis 
and spina bifida) as compared to the phenotype seen in Lp/Lp (displayed 
craniorachischisis only). This hypomorphic phenotype has previously been 
reported because of the presence of neomycin, for example Fgf8neo and Pax9neo 
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(Meyers et al., 1998; Kist et al., 2007), but it still needs to be established to what 
extend the function is Vangl2 is affected in its presence, which could be taken up 
in further studies. Vangl2 level can also be analysed in Vangl2
floxneo/floxneo 
which 
would aid in understanding the level of expression in the presence of neomycin. 
Although heart abnormalities in both Lp/Lp and Vangl2
floxneo/floxneo 
were the same, 
to eliminate any influence neomycin might have, the cassette was removed by 
crossing the Vangl2fn mice with FLPe mice.  
To analyse whether this flox line is able to recapitulate the Lp phenotype, 
Vangl2flox mice was then crossed with globally expressing Cre, PGK-Cre 
(Lallemand et al., 1998) and Sox2-Cre (Hayashi et al., 2002) and as expected, 
mutants from both the crosses recapitulated Lp/Lp phenotype, both external and 
cardiac, confirming our flox line was suitable to be used to genetically dissect the 
role of Vangl2 using cell specific Cre. Recombination due to the activity of the 
enzyme Cre deletes exon 4, creates a frame shift and a stop codon that truncates 
the protein at amino acid 78 and is predicted to give rise to a small 8KDa protein, 
which lacks the four trans-membrane domains required of Vangl2 activity and C-
terminal PDZ-binding domain through which Vangl2 interacts with various other 
proteins (Torban et al., 2004; Montcouquiol et al., 2006). Recombination was 
confirmed by RT-PCR and western blotting. RT-PCR showed loss of Vangl2 
transcript; however, western blotting showed a faint Vangl2 band in the mutants 
although the developmental defects were present. Therefore, even if the truncated 
protein is stable, it is predicted to be non-functional and even if there is some 
protein left, the deletion is enough to cause the developmental abnormalities.  
The genesis of outflow tract defects was originally hypothesised to be solely 
dependent upon the contribution of the neural crest to the outflow tract and 
pharyngeal arch arteries; which was confirmed by the spectrum of phenotypes 
seen in the neural crest ablated embryos.  However, studies have shown that SHF 
cells are also involved in outflow tract development and in their absence outflow 
tract defects are observed (Cai et al., 2003). Therefore, to look at the role Vangl2 
plays during the outflow tract development; its expression was deleted 
specifically from cells involved during the process. When Vangl2 was deleted 
only in NCC using Wnt1-Cre (Danielian et al., 1998) there were no neural tube or 
227 
 
cardiac abnormalities and mutants mice when born were healthy and 
indistinguishable from controls littermates and had normal heart analysed at P28. 
However, when Vangl2 was deleted specially from SHF cells using Isl1-Cre 
(Yang et al., 2006) the mutant embryos showed same cardiac outflow defects as 
seen in Lp/Lp (double outlet right ventricle and ventricular septal defect), but the 
external phenotype was normal. Immunostaining confirmed the loss of Vangl2 
specifically in Isl1 positive cells; however with Wnt1cre positive cells 
colocalization of Vangl2 was not observed, suggesting Vangl2 is not expressed in 
NCC. In the Lp mouse, there is disorganization of cardiomyocytes in the early 
stages of cardiac development which affects the integrity of the early heart tube 
and thus prevents it from looping correctly, resulting in alignment and septation 
defects of the heart (Phillips et al., 2005).  However, the observation that heart 
defects in Vangl2
flox/flox
;PGK-Cre, Vangl2
flox/flox
;Sox2-Cre and Lp/Lp embryos 
were only found in embryos with NTDs or gastroschisis, suggests that the cardiac 
alignment defects (double outlet right ventricle and peri-membranous ventricular 
septal defect) may be secondary to the axial rotation and changes in body plan 
caused by these gross abnormalities in body form and not primarily as a result of 
loss of Vangl2.  Henderson et al (2001) originally suggested that the cardiac 
looping defects observed in the Lp mutant may be secondary to the neural tube 
closure and axial turning defects (Henderson et al., 2001), as heart development 
is quite sensitive to disturbances in cervical flexure and axial rotation (Manner et 
al., 1993; Melloy et al., 1998). The body form abnormalities and axial rotation 
defects could affect cell movement and prevent the heart from looping correctly, 
both of which would ultimately prevent the correct remodelling of the heart and 
lead to the ventricular septation and alignment defects identified in the mice with 
NTDs and/or gastroschisis. However, loss of Vangl2 in SHF cells recapitulates 
the cardiac malformations seen in Lp mice with normal external phenotype, and 
looking at these results in addition to Vangl2
floxneo
 result, where double outlet 
right ventricle was observed in heart in the absence of craniorachischisis, shows 
that heart defects are not secondary to the neural tube defects and axial rotation 
defects as been suggested before. Moreover, it shows that Vangl2 has an 
important role in SHF cells and deletion of Vangl2 in only SHF cells is causing 
the cardiac defects seen in Lp/Lp mutants. It can also be stated that SHF do not 
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contribute to the neural tube defects but are responsible for heart morphogenesis. 
Although, the aortic arch abnormalities seen in Lp (Henderson et al., 2001), and 
in the Vangl2
flox/flox
;PGK-Cre and Vangl2
flox/flox
;Sox2-Cre mutants, may be 
secondary to these abnormalities in body form, as they are only observed in the 
presence of craniorachischisis. 
The results showed that loss of Vangl2 from SHF cells leads to outflow tract 
defect and colocalization between Vangl2 and SHF in different regions of heart 
concludes that cells derived from SHF express Vangl2 in respective regions of 
heart and validates the histological results observed showing heart defects when 
Vangl2 was deleted specifically in SHF. Loss of Vangl2 in differentiated SHF 
cells, in myocardium derived from SHF, using Mlc2v-Cre (Chen et al., 1998), 
and endothelial cells, using Tie2-Cre (Kisanuki et al., 2001) showed normal 
outflow tract development suggesting importance of Vangl2 in undifferentiated 
precursor SHF cells. However, Vangl2 can also be deleted in SHF cells at 
different stages of development to establish at which stage Vangl2 plays the 
critical role. 
Undifferentiated precursor SHF cells enter the distal outflow tract from the dorsal 
pericardial wall and transitions to differentiated myocardium while moving 
proximally in the outflow tract. This zone where the transition is taking place is 
termed as transition zone and when Vangl2 expression was seen in this zone, it 
was observed to have membrane localized expression. However as cells move 
more proximally and differentiate into myocardium, Vangl2 expression becomes 
more cytoplasmic. It is known that loss of Vangl2 expression from the membrane 
causes Lp phenotype (Torban et al., 2007) underlining the importance of 
membrane localization of Vangl2 in the outflow tract in the transition zone. When 
cells are entering the outflow tract, there is loss of nuclear Isl1 expression in the 
Vangl2
flox/flox
;Isl1-Cre mutants, indicating premature differentiation of cells into 
cardiomyocytes (Ramsbottom et al 2014), suggesting the role of Vangl2 in 
keeping SHF cells in undifferentiated progenitor state. This was validated by 
early onset of αSMA expression, marking smooth muscle cells in the mutants, 
meaning loss of Vangl2 leads to early differentiation. The particular region in the 
distal outflow tract where Vangl2 changes its expression and become membrane 
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localized and undifferentiated SHF precursor cells are moving into the outflow 
tract was hence used as the zone under observation for further experiments. 
Vangl2 is a polarity protein and after further analysis of transition zone, epithelial 
nature of the cells and loss of polarity was revealed in the cells. ABP was 
disrupted, with apical and basal determinants not being limited to their 
compartments along with abnormal orientation of cells. Similar affect has been 
observed with loss prickle, another PCP protein, in Drosophila leading to 
disturbances in ABP (Tao et al, 2009; 2012). In zebrafish, mislocalisation of ABP 
markers leads to cardiac malformations and similar phenotype is observed in 
mouse as well with disturbances in cellular polarity leading to cardiac 
malformations (Rohr et al., 2006). 
AJ and TJ are present forming a belt around the cell, dividing the cell into apical 
and basal compartments. They also keep a check that apical and basal 
determinants remain in their boundary and disruption in these junctions lead to 
loss of ABP (Kaplan et al., 2009). Our results show change in expression pattern 
of cadherins (N and E) and PKCζ which are a part of AJ and TJ respectively, 
along with disruption in β-catenin expression which associates with cadherins in 
AJ. These markers apart from marking AJ and TJ are classic epithelial markers as 
well and therefore disruption in their expression in the transition zone leads to loss 
of ABP in the SHF cells along with loss of epithelial nature of the cells. This was 
confirmed by showing the position of MTOC, which should be present apically in 
epithelial cells, but in the Vangl2
flox/flox
;Isl1-Cre mutants they were not restricted 
to the apical side of the cell, and by expression of extra-cellular markers, laminin 
and fibronectin, which marks the basolateral side of the cells, but were extended 
to apical part of the cells in the mutants only in the transition zone and had normal 
expression in the proximal outflow tract with differentiated myocardium cells. 
These SHF cells in the transition zone lack Vangl2, solidifying our finding that 
loss of Vangl2 leads to loss of ABP. However, apart from disruption of ABP, 
another possibility could be abnormal orientation of cells which makes these 
apical and basal determinants look misoriented. Mislocalisation of cellular 
component like MTOCs and an extra cellular marker, like laminin suggests it 
could be because of the abnormal orientation of cells and loss of ABP. Hence, it 
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could be a combination of both the factors. Apart from ABP, loss of Vangl2 also 
leads to loss of PCP. PCP pathway is a multi-protein complex, of which Vangl2 is 
one key component, but when 2 other proteins involved in the pathway, Dvl2 and 
Celsr1, were looked in Vangl2
flox/flox
;Isl1-Cre mutants, there expression was also 
lost from the membrane similarly to Vangl2. A shortcoming of this study would 
be that the analysis of the loss of ABP, PCP and abnormal localisation of cells in 
the transition zone in the distal outflow tract as done at E9.5, but the cause behind 
this affect hasn’t been checked. This could be done by looking at these markers at 
an earlier stage and analyse their expression along with quantification of cells 
showing abnormal expression. 
Loss of Vangl2 globally (Lp, Vangl2
flox/flox
;PGK-Cre and Vangl2
flox/flox
;Sox2-Cre) 
and specifically from SHF cells (Vangl2
flox/flox
;Isl1-Cre) leads to double outlet 
right ventricle suggesting the role cells derived from SHF play for proper 
orientation of the outflow vessels to the ventricles. SHF move as an epithelial 
sheet of cells (Van Den Berg et al., 2009) with cohesion and organization between 
the cells. This is analogous to the movements of epithelial sheets in other organ 
systems (Muñoz-Soriano et al., 2012; Guillot and Lecuit, 2013). This organization 
is disrupted by the loss of cellular polarity by the loss of Vangl2 in SHF cells 
leading to disorientation of the outflow vessel causing double outlet right ventricle. 
The possible explanation would be that loss of Vangl2 from SHF-derived cells 
results in loss polarity in SHF which leads to disorganization of the cells and their 
early differentiation. These disorganized cells fail to move into the outflow tract 
and thus a failure to form adequate length of the outflow tract and differentiate 
into myocardium leading to shortened outflow tract which hampers the rotation of 
the vessel, which is essential for correct orientation. Link between a shortened 
outflow tract and double outlet right ventricle is already known (Yelbuz et al., 
2002; Ward et al., 2005). As the rotation doesn’t happen, aorta and pulmonary 
trunk both comes out parallel from the right ventricle. Although it is suggested 
that Vangl2 plays a key role in SHF deployment and movement leading to 
outflow tract lengthening, this can be substantiated by looking at the actual 
movement of SHF cells. This can be done by 2 ways; firstly SHF cells can be 
labelled by injecting BrdU at E8.5 and then examining their position and 
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distribution at E9.5 which would help in determining the movement of SHF cells 
into the outflow tract in the absence of Vangl2. Another method could be using cell 
culture techniques. Outflow tract can be dissected out and cells grown using cell 
culture. Immunostaining using anti-GFP antibody would mark Isl1 positive cells 
and show their movement pattern in both controls and mutants. They could be 
colabelled with another antibody, like MTOC antibody which would determine 
the apical side and indicate the direction in which the cells would move. Therefore, 
it would be beneficial to obtain mutant embryos at earlier stages to investigate the 
movement and initial addition of SHF cells, and at later stages to define ultimate 
SHF cell distribution.  
The role polarity plays in the cardiac development and malformations has been 
extensively studied before, but the thesis explains the role of Vangl2 and the 
possible mechanism of the cardiac defect caused by its absence. Wnt5a is one of 
the main ligand implicated in activating PCP signalling, and Vangl2 works after 
phosphorylation by Wnt5a-Ror2 complex (Gao et al., 2011) and activates 
downstream targets of the PCP pathway. Wnt5a and Ror2 have been looked 
separately for cardiac defects and to check the polarity. Results showed that although 
loss of Ror2 had a milder phenotype as compared to loss of Wnt5a, absence of both 
leads to cardiac defects and disruption of cellular polarity along with abnormal cell 
orientation confirmed by looking at the same markers as for Vangl2;Isl1-Cre 
embryos. Vangl2 acts via RhoA/ROCK1 in the non-canonical Wnt signalling 
pathway, therefore downstream PCP components (ROCK and Rac1) were looked 
at in SHF as well. Interestingly, outflow defects were observed in Rac1
flox/flox
;Isl1-
Cre and ROCKDN;Isl1-Cre mutant embryos because of the disruption in cellular 
polarity and abnormal cell orientation in the distal outflow tract. Thus, Vangl2 
may be acting with these other factors in a network that regulates the addition of 
SHF to the lengthening outflow tract. There is loss of Vangl2 membrane 
localisation in Wnt5a
-/- 
and reduced localisation in Ror2
-/-
 (Gao et al., 2011), 
suggesting these upstream factors are involved in Vangl2 localisation. An 
additional experiment for future work can be looking at Rac1 and ROCK 
expression in Vangl2 mutants. As these are downstream targets of Vangl2, loss of 
Rac1 and ROCK localisation would be expected when Vangl2 is deleted. Whole 
PCP pathway is important for cardiac development, and mutation in different 
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components leads to defect in the outflow region, for example, in Dvl 1-3 
(Hamblet et al., 2002; Etheridge et al., 2008), Celsr1 (Curtin et al., 2003), Wnt5a 
(Schleiffarth et al., 2007), Wnt11 (Zhou et al., 2007b; Nagy et al., 2010), Fz1/Fz2 
(Yu et al., 2010), Scrib (Phillips et al., 2007) and Ptk7 (Paudyal et al., 2010), 
highlighting the importance of cellular polarity during outflow tract development. 
Our results provide more insight to it and solidify the conclusion that all 
components of the pathway are involved in outflow tract morphogenesis and 
absence of any component leads to loss of polarity and hence outflow defects. 
We found that Vangl2 is required for the correct localization for the junctional 
components of SHF and potentially accounting for the disrupted cell-cell 
adhesion and cardiomyocytes disorganization seen in the early heart of the Lp. 
The establishment of polarity within cardiomyocytes, and the correct formation of 
cell-cell junctions between them, is critical for their correct organization and 
ultimately the integrity, maturation and normal function of cardiac tissue.  Our 
results indicate that Vangl2 may be essential for both of these early processes, 
categorizing its role as crucial for correct cardiac morphogenesis.  Thus, disruption 
of Vangl2 in the undifferentiated precursor SHF cells leads to clinically relevant 
congenital heart defects at later stages of cardiogenesis. The findings of this study 
confirm the possible role of not only Vangl2, but also other components of non-
canonical Wnt/PCP signalling pathway in the establishment of ABP and PCP, and 
in the development of the heart.  
The results not only confirm the role of whole PCP pathway in SHF cells during 
heart development in the embryo, but also suggest a possible mechanism which 
hasn’t been shown before. Studies have suggested NCC as the cell type which is 
regulated by PCP signalling, however we confirm that NCC are not dependednt 
on Vangl2. Role of other PCP components like ROCK and Rac1 have been 
reported in NCC, but their potential role in regulating SHF cells gives a new 
dimension of whole PCP pathway in SHF movement, differentiation as well as 
their nature. Recently Sinha et al studied the abnormalities in outflow tract 
morphogenesis in Dvl2 mutants in more detail, concluding they resulted from 
abnormalities in the incorporation of SHF progenitors into the dorsal pericardial 
wall, prior to movement into the outflow vessel (Sinha et al., 2012). The 
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mechanism by which a disruption of a key PCP protein disrupts SHF 
contributions to the outflow region appears to differ between the Vangl2 and Dvl2 
mutants, perhaps reflecting multiple roles for PCP signalling in deployment of 
SHF cells to the heart.   
Apart from the role of PCP signalling in regulating SHF cells, the thesis also 
gives an insight about the nature of the SHF cells. SHF cells haven’t been 
described to have an epithelial nature before, and this novel finding makes the 
understanding of SHF behaviour during heart morphogenesis much easier and 
clearer. Therefore SHF cells can form continuous sheets attached to each other 
by adherens junctions and tight junctions, and also being polarised in nature. This 
would be helpful in understanding role of other genes in SHF cells, keeping their 
epithelial nature in consideration. Hence, the work provides a mechanistic insight 
with regards to outflow tract morphogenesis and these findings provide a 
framework for understand this process in humans, unravelling answers about 
etiology of congenital heart defects. 
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